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ζ (crystallography) Sigma-level of an electron density map (refers to probability of 
finding an electron within the volume enclosed by the map. It 
provides a way of accessing the "noise" level of the respective 
electron density map.) 
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w/v Weight per volume 
WT wild type 
X-ray Electromagnetic radiation, also called Röntgen radiation 
(wavelength: 10 – 0.01 nanometers, typical wavelengths used for 
X-ray crystallography are around 1 Å (= 0.1 nanometer), which is 
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Protein crystallography is a powerful tool in drug discovery and development and is 
applied for, e.g. the determination of de novo protein structures as well as the 
investigation of protein-ligand complexes. The crystallographic analysis of unknown 
protein structures can help to understand in case of enzymes the involvement of the 
essential amino acids in the catalytic mechanism and reveal crucial substrate binding 
pockets that should be addressed by inhibitors. The investigation of protein-ligand 
complexes can provide exact spatial positioning of the compound within the active site 
helping to understand the key interactions of inhibition.   
However, the application of protein crystallography was limited by several parameters 
in the past. Apart from the challenging identification of crystallization conditions, the 
application of protein crystallography required time consuming data collection and huge 
computational resources for structure refinement. To minimize this experimental effort, 
further analyses are performed in drug discovery. Prior to structure determination 
another faster screening method is preceded in order to achieve a pre-selection of 
promising compounds that are subsequently analyzed by crystallographic experiments. 
Besides these expenses, the number of experiments that are necessary for successful 
determination of a protein-ligand complex can vary from case to case. Parameters, such 
as ligand size, ligand solubility and crystal stability take inherent impact on the success 
of the crystallographic experiment.  
Especially protein complexes with rather small molecules (molecular weight < 250 Da), 
so called fragments, are usually difficult to determine. Along the refinement process the 
localization of the compound within the active site is determined by the difference 
electron density. Apart from the resolution, the quality of the density is mainly 
dependent on the compound affinity, the applied ligand concentrations and thus on the 
occupation of the ligand at its position. Compounds of increased molecular weight 
substituted with several functional groups can perform more interactions to the protein 




density. Accordingly, it is well comprehensible that fragments which can occupy 
diverse binding modes within the same active site are not easily placed into a protein 
structure. The success rate of determining protein fragment complexes suffers from 
these multiple binding modes and therefore, increased crystallographic effort is required 
to screen for optimal crystallization conditions as often several soaking and 
cocrystallization experiments have to be performed. 
Systematical fragment screenings via protein crystallography were rather unusual in the 
past. Nevertheless, the entire field has been stimulated by a series of successful 
screenings using NMR. Stephen Fesik et al. first reported successful detection and 
utilization of fragments in drug design which became popular as the SAR-by-NMR 
approach (Structure-Activity-Relationships by Nuclear Magnetic Resonance) (Shuker, 
Hajduk et al. 1996). In their study, two-dimensional, isotope-edited NMR spectroscopy 
was used to detect two fragment leads that bind at two proximal sites on the protein 
surface. Using three-dimensional structural information about the bound ligands, the 
fragments were successfully joined together to produce a high affinity ligand.  
Nevertheless, in the last 10 to 15 years protein crystallography has advanced and 
emerged to a kind of routine analytical tool also applicable for screening purposes. The 
availability of synchrotron beam time and improved in-house radiation sources has 
increased remarkably and in combination with improved computing power the 
collection of 50 datasets within 24 hours is possible. In addition, low temperature data 
collection, robotic-systems for protein crystallization, fast protein-crystal mounting and 
diffraction screening as well as automated structure refinement tools support the speed 
of this method. The advancement in these technologies can also be demonstrated by the 
number of protein structures that are deposited each year in the protein data bank (PDB) 
(Figure 1.1). The number of structures that are uploaded to the PDB has increased 
annually reaching nearly 7500 structures in 2009. Actually, the collected and publicly 
available data only represent a fraction of the determined protein structures since 
pharmaceutical companies usually do not publish their data. The increasing impact of 
protein crystallography being an analytical tool allows application of this method for 




only in very legitimate case of promising compounds exhibiting high affinity in a 
functional bioassay the crystallographic analysis was attempted.  
 
Figure 1.1 : Number of deposited protein structures in the Protein Data Bank (PDB; red: total; 
blue: year) (www.pdb.org – 03/2010). 
1.2 Aims of this Thesis 
The aim of this thesis was to take advantage of these enhancements in protein 
crystallography and predominantly apply this method to a variety of rather diverse 
fragment-based experiments. How can interactions of proteins with small molecules be 
exploited? Are we able to, e.g. monitor in situ reactions via protein crystallography? 
Will a tethering approach increase the success rate of fragment-based crystallography?  
Carbonic anhydrase II has been selected as a model protein for these experiments as this 
enzyme has been studied exhaustively in our group. Several protein-ligand complexes, 
in most cases with high resolution, have been determined so far. Diverse experiments 
with small molecules should be performed and followed by protein crystallography. In 
principle, crystallographic investigation performed in each experiment should provide 
the structural basis to understand the processes executed in the active site of CA II and 
help to develop new approaches. 
The following issues have been investigated: 
1. Cloning, expression and mutagenesis of CA II: In order to perform the broad 













the gene coding for CA II has to be recombinantly available and modified by 
mutagenesis. The protein has to be accessible in high amounts to perform the 
planned crystallographic and in-solution experiments. 
2. Artificial copper center: One initial idea of this work was the introduction of an 
artificial copper center at the surface of CA II. Copper-coordinating protein 
residues should be introduced into the target protein via site-directed mutagenesis. 
The investigation of each mutation and Cu affinity experiments should be followed 
by protein crystallography revealing structural information about the formed 
complexes.  
3. In situ click chemistry: Addressing this metal center azide and alkyne building 
blocks should be brought to reaction to form a triazole product via Cu-catalyzed 
2+3 cycloaddition. The cycloaddition reaction should be illustrated in the same way 
allowing comprehension of the reaction by determining protein-reactants, protein-
intermediate and protein-product complexes. 
4. Tethering: The tethering method allows investigation of fragments with weak 
binding affinity by covalently attaching the compound via a thiole containing 
moiety to a surface exposed cysteine residue (Erlanson, Braisted et al. 2000). The 
screening of fragment libraries can be investigated by HPLC-MS analysis and 
protein crystallography. Via a computational docking approach a large fragment 
library should be pre-selected to a number of fragments feasible to synthesize 
which should be tested subsequently by different HPLC-MS experiments. The most 
promising compounds should be investigated crystallographically for their key 
interactions with the protein. This allows identification of scaffolds for different 
binding regions of CA II. Subsequently, the fragments should be enlarged to 
improve their binding affinity to finally release the compound from the tether.  
5. Investigation of a sulfamide inhibitor series: A series of sulfamides should be 
investigated with respect to their binding to the target CA II. Starting with 
compounds of fragment size the series is completed by inhibitors with a molecular 




al. and kinetically characterized by Supuran et al. Protein-ligand key interactions 
should be revealed by protein crystallography.  
6. Investigation of new zinc binding groups coordinating to the active site of CA 
II: The sulfonamide is the most prominent CA II zinc coordinating moiety and is 
present in the majority of all known CA II inhibitors. In this study different 
fragment-like zinc coordinating groups should be investigated for the affinity to CA 
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2 Introduction Carbonic Anhydrase II 
2.1 Carbonic Anhydrases 
Carbonic anhydrases (CA) (EC 4.2.1.1) belong to the class of hydrolyases containing a 
catalytic active Zn
2+
 ion at the bottom of the binding pocket. CAs are ubiquitous present 
in all animals and plants as well as bacteria and divided into α-, β-, γ- and δ-families: 
α-CAs are mainly present in vertebrates, also in plants, algae and some bacteria 
(Chegwidden and Carter 2000; Kerry and James 2000), β-CAs mainly in leaves of 
plants in eubacteria, archaea and some algae, γ-CAs mainly in archaea and some 
eubacteria and δ-CAs in diatoms (Supuran and Scozzafava 2007). With a molecular 











The 16 different α-CA isoforms described so far in mammals, including homo sapiens, 
are involved in pH and CO2 homeostasis, respiration and transport of CO2/bicarbonate 
between metabolizing tissues and lungs, electrolyte secretion in a variety of 
tissues/organs, biosynthetic reactions (e.g. gluconeogenesis, lipogenesis and 
ureagenesis), bone resorption, calcification, tumorigenicity, and many other processes 
(Maestrelli, Mura et al. 2002; Supuran, Scozzafava et al. 2003; Stiti, Cecchi et al. 2008; 
Supuran 2008; Winum, Rami et al. 2008).  
The most prominent CA-isoenzyme, the carbonic anhydrase II (CA II) is located in 
many organs showing a very high catalytic efficacy.  With a transformation rate of 10
6
/s 
CA II belongs to the fastest enzymes known so far (Khalifah 1971). The direction of the 
reaction is pH dependent. At a pH above 7, CO2 is hydrated to hydrogen carbonate; 
below 7 the backwards reaction occurs (Silverman, Tu et al. 1976). At a pH between 7 
and 9 the enzyme shows the highest activity. 
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2.2 Structure of CA II 
2.2.1 Folding of CA II 
The ellipsoidal enzyme CA II exhibits the size of approximately 55 x 44 x 39 Å. 260 
amino acids participate in the primary structure of CA II. Determining the tertiary 
structure, Liljas et al. showed that the protein exists of only one domain (Liljas, Kannan 
et al. 1972). The protein is divided by a 10-fold beta-sheet, which is the predominant 
secondary element (Figure 2.1). Besides two parallel strands the beta sheet is 
antiparallel.   
 
Figure 2.1: Tertiary structure of human carbonic anhydrase II (α-helices; sheets; loops). The 
active site Zn
2+
 ion (grey sphere) is coordinated by three histidine residues. 
It has been shown via structure determination that there are no disulfide bridges present. 
Furthermore, all lysine residues are located at the surface of the enzyme which are in 
close contact to the side chains of the neighboring molecules. Within the folding pattern 
of CA II, there are two clusters formed by aromatic residues. The first cluster consists of 
four aromatic amino acids: Trp5, Trp7, Trp16 and Phe20. The other one is formed by 
eight residues Phe66, Phe70, Phe93, Phe95, Phe176, Phe179, Phe226 and Trp97. The 
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latter cluster is also present in carbonic anhydrase I and partially in carbonic anhydrase 
III (Eriksson, Jones et al. 1988).  
2.2.2 Active Site of CA II 
The active site of CA II is amphiphilic. Without a bound ligand the binding pocket is 
filled by a network of water molecules which provides direct contact to the solvent 
surrounding of CA II. At the bottom of the 15 Å deep binding pocket the catalytic active 
Zn
2+
 ion is coordinated by three histidine residues. His94 and His96 coordinate with the 
Nε-Atom, whereas His119 uses its Nδ-Atom to interact with the metal ion. Via these 
primary histidine residues Zn
2+
 is connected to four additional amino acids. His94 (Nδ1) 
forms a hydrogen bond to the oxygen atom of Gln92 (Oε1) with a distance of 2.7 Å, 
likewise His119 (Nε2) with the carboxyl side chain of Glu117 (Oε2) at a distance of 
2.7 Å. Furthermore, His96 (Nδ1) is in close contact with the backbone oxygen of 
Asn244 via an H-bond (2.8 Å) (Figure 2.2) (Christianson and Fierke 1996). A water 
molecule, most probably present as OH¯
 
ion, completes as fourth ligand the 
coordination geometry at the Zn
2+
 ion forming a distorted tetrahedron (Silverman and 
Lindskog 1988; Merz and Banci 1997). A further water molecule, the so called "deep 
water", is located in the conically shaped binding pocket. This water is displaced by 
CO2 during the catalytic reaction (Figure 2.2) (Eriksson, Jones et al. 1988). 
Thr199 adopts a fundamental role in the catalytic mechanism stabilizing the Zn
2+
 bound 
hydroxide ion via H-bonding. Additionally, it forms an H-bond to the substrate CO2 
(Figure 2.2 and Figure 2.3a). The substrate binding pocket is shaped by Val121, Val143 
and Val207 as well as Trp209, Thr200, Glu106, Thr199 and His119. Considering the 
entire amphiphilic binding pocket the amino acids can be divided into two groups 
according to their hydrophilic and hydrophobic properties. The hydrophobic portion 
consists of Ile91, Val121, Phe131, Val135, Leu141, Val143, Leu198, Pro202 and 
Leu204. The hydrophilic amino acids in the binding pocket are: Tyr7, Asn62, His64, 
Asn67, Gln92, His94, His96, Glu106, Glu117, His119, Thr199 and Thr200 (Figure 
2.3b). The active site Zn
2+
 ion can be replaced by a variety of metal ions. Only the Co
II
 
containing protein shows a comparable activity as the Zn
2+
 enzyme (approx. 50%). Cu, 
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Fe, Ni and Mn develop only minor or no activity while showing similar properties in 




Figure 2.2 Substrate and active site water in the binding pocket of CA II (PDB-code: 2VVA). The 
catalytic relevant residues are shown in stick representation (protein: C, N, O; ligand: C, O); Zn
2+
 ion as 
grey sphere; active site water molecule as red sphere. 
 
Figure 2.3 Active site of CA II. (a) Substrate and active site water in the binding pocket of CA II 
(PDB-code: 2VVA). The solvent accessible surface is shown in white; Zn
2+ 
is shown as grey sphere; 
water molecule as red sphere. Relevant residues and CO2 are shown in stick representation (protein: C, N, 
O; ligand: C, O). The binding pocket of CA II can be divided into a hydrophobic (indicated by red line) 
and a hydrophilic binding region (blue line). (b) Amphiphilic binding pocket of CA II; hydrophobic 
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2.3 Catalytic Mechanism of CA II 
During the catalytic mechanism the Zn
2+
 ion plays the central role. The impressive turn-
over rate of CA II is achieved by the local vicinity of all participating reactants. 
However, the actual mechanism is controversially discussed in literature (Silverman and 
Lindskog 1988; Hakansson, Carlsson et al. 1992; Kiefer and Fierke 1994; Jackman, 
Merz et al. 1996). The transient catalytic process cannot be investigated by X-ray 
diffraction techniques. The mechanism proposed by Lindskog was proven by extensive 
mutagenesis and QM/MM
1
 calculations (Figure 2.4) (Behravan, Jonsson et al. 1990; 
Alexander, Nair et al. 1991; Nair and Christianson 1991b; Nair and Christianson 1991a; 
Kiefer, Krebs et al. 1993; Krebs and Fierke 1993; Nair and Christianson 1993; Lindskog 
























































































Figure 2.4  (a) Catalytic mechanism and (b) orientation within the binding pocket of CA II. The 
Zn
2+
 ion facilitates the deprotonation of the active site water (1). The emerging hydroxide ion performs a 
nucleophilic attack towards the CO2 molecule that is fixed by an H-bond to Thr199 and lipophilic 
interactions to Leu198, Val143 and Val121 (2). HCO3
- 
is formed next to the Zn
2+
 ion (3). The 
hydrogencarbonate ion is replaced by another water molecule and released into the solvent (4). The 
regeneration of the hydroxide ion at the Zn
2+ 
ion is mediated by a proton transfer via two additional water 
molecules and the histidine 64 residue (1). The function of this "proton shuttle" is dependent on two 
conformations that His64 can adopt (in- and out-positions).  
The residues that are important for the catalytic mechanism are on the hydrophilic side 
(Thr199, Glu106 and His64) and on the hydrophobic side (Val121, Val143, Leu198 and 
Trp209). The hydrophobic residues form a pocket which allows CO2 or the "deep 
                                                 
1
 QM/MM: Quantum Mechanical and Molecular Mechanical 
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water", respectively, to bind. The high catalytic rate is among others explained by the 
fact that after desolvation, CO2 is only loosely bound while the interaction to the NH 
group of Thr199 is formed by the CO2/HCO3¯ intermediate. Weak polar interactions to 
the Zn
2+
 ion help orienting the CO2 molecule within the binding pocket. Thereby, the 
Zn
2+
 bound OH¯ ion is not replaced by CO2. HCO3¯ is formed upon nucleophilic attack 
of OH¯ towards the immobilized CO2. Furthermore, it is proposed that Thr199 
functions as a kind of "doorkeeper" allowing only those anions to bind to the active site 
Zn
2+
 ion, which are able to form an H-bond to the side chain oxygen of Thr199 
(Christianson and Fierke 1996). The distinct H-bond acceptor functionality of Thr199 is 
induced by a strong H-bond of its hydroxyl proton to Glu106 (Merz 1991). Different 
mutations of Thr199 have shown a stabilizing effect on the HCO3¯/Zn
2+
-complex 
thereby inhibiting the fast dissociation of HCO3¯ to leave the binding pocket. This 
dissociation process is assumed to be the rate-determining step. An additional water 
molecule binding to the Zn
2+
 ion pushes the hydrogencarbonate out of the active site 
and after deprotonation it takes part in the next catalytic cycle of hydrating CO2. 
Mediated by two water molecules the residue His64 functions as a "proton shuttle" 
transporting the proton to the surrounding buffer solution. Crystal structure analysis at 
pH values of 5.7, 6.5, 8.5 and 9.5 revealed a pH dependent transition in conformational 
states of His64 (Nair and Christianson 1991b; Nair and Christianson 1991a). His64 
clearly rotates away from the binding pocket at a pH of 5.7. Furthermore, mutational 
studies exchanging His64 by diverse amino acids demonstrated that histidine is the best 
catalyst for the transformation of CO2 to HCO3¯ since it regenerates the active Zn
2+
- 
OH¯ form and shows the lowest pH dependency (Lindskog 1997). The kcat-values are 
pH dependent as shown by modifying the buffer medium (Silverman and Lindskog 
1988). At a pH value close to 8 the Lys64 mutant shows a five times decreased 
efficiency compared to the wild type while the Glu64 mutant is inactive. In contrast at 
pH 6 the Lys64 mutant is inefficient and the Glu64 mutant seems to be a 2-3 times more 
effective proton shuttle with respect to the His64 form (Engstrand, Forsman et al. 1992).  
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2.4 Carbonic Anhydrase Inhibitors 
2.4.1 Anionic Inhibitors 
Anions, such as HS¯, CN¯, NCO¯, N3¯, HSO3¯, I¯ and HCOO¯ develop in general 
only weak inhibition of CA II by coordinating to the active Zn
2+
 ion. There are three 
possibilities for the coordination to the metal: Displacement of the catalytic water 
molecule forming a tetrahedral geometry, or occupation of the fifth coordination site 
thus forming a distorted trigonal pyramidal geometry or equilibrium between both states 
is observed.  
Anions that provide a proton to coordinate to the OH
-
 group of Thr199 (HS¯, HSO3¯) 
displace the metal coordinating water molecule without affecting coordination 
geometry. The Zn
2+ 
coordination remains tetrahedral in a pH range of 5.7 to 8.0 
(Lindskog 1997). Upon displacement of the "deep water", HSO3¯ forms an additional 
H-bond to the NH-group of Thr199. 
Most proton free anionic inhibitors change only slightly the position of the Zn
2+ 
bound 
water molecule and do not affect the H-bond to Thr199. Anions such as nitrate bind in 
the vicinity of the metal pushing the water molecule aside. They form an H-bond to the 
NH-group of Thr199. Furthermore, nitrate occupies the fifth coordination site at the 
Zn
2+
 ion forming a distorted trigonal pyramidal structure (Mangani and Kansson 1992).  
2.4.2 Inhibitors of the Proton Shuttle 
Cu
2+
 ions and Hg
2+ 
ions develop an extraordinary inhibition mechanism. These 
coordinate to the imidazole nitrogen of His64 thereby prohibiting its function as a 
proton shuttle. With respect to CA II at pH 7.3 an IC50 of 0.5 µM was determined for 
Cu
2+
 binding.  
2.4.3 Hydroxamate Inhibitors 
For the compounds acetohydroxamic acid and trifluorohydroxamic acid the IC50 values 
against CA II were measured (IC50 (CH3CONHOH) = 47 µM; IC50 (CF3CONHOH) = 
3.8 µM) (Scolnick, Clements et al. 1997). Crystal structure analysis of a CA II – 
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acetohydroxamic acid complex reveals a binding mode analog to the binding geometry 
known from sulfonamide inhibitors. The carbonyl oxygen of the hydroxamic acid forms 
an H-bond to the NH-group of Thr199 (Figure 2.5). The hydroxyl oxygen of Thr199 
operates as an H-bond acceptor towards the hydrogen of the hydroxamic hydroxyl 
group. Furthermore, the hydrogen atom of the Thr199 OH-group forms an H-bond to 
Glu106. The deprotonated nitrogen of the hydroxamic acid is tetrahedrally coordinated 
to the Zn
2+
 ion. By introducing suitable substituents this class of CA II inhibitors 
achieves inhibition in the nanomolar range (Scozzafava, Banciu et al. 2000). 
 
Figure 2.5 Binding mode of acetohydroxamic acid within the binding pocket of CA II. (a) in 
schematic representation (b) Crystal structure (PDB-Code: 2AM6). The solvent accessible surface is 
shown in white. Relevant amino acids and the ligand are shown stick representation (protein: C, N, O; 
ligand: C, N, O). Zn
2+
 is shown as grey sphere. Hydrophobic residues are indicated by the red line and 
hydrophilic residues by the blue line.  
2.4.4 Sulfonamide Inhibitors 
Sulfonamides show a highly conserved interaction pattern to CAs. The active site water 
molecule and the "deep water" are displaced and the sulfonamide group coordinates 
with its deprotonated nitrogen to the Zn
2+
 ion (Figure 2.6). The remaining hydrogen of 
the NH-group functions as a donor forming an H-bond to the side chain oxygen of 
Thr199. The first oxygen of the sulfonamide moiety acts as an acceptor forming an 
H-bond to the hydrogen of the main chain nitrogen of Thr199, while the second oxygen 
is in weak contact to the Zn
2+
 ion. The affinity of the sulfonamide is strongly modulated 












































Introduction Carbonic Anhydrase II 
29 
 
Due to the binding mode of sulfonamides the substitution at the nitrogen of the primary, 
terminal sulfonamide group mostly leads to the loss of inhibitory potential (Krebs 
1948). Hence it is astonishing that Saccharin develops inhibition against CAs. In 
contrast to common sulfonamide CA-inhibitors, in the latter compound the sulfonamide 
moiety is endocyclic and neighbored by a carbonyl group. Thereby a sulfimide is 
formed decreasing the pKa-value for the NH-group to 1.5. 
 
Figure 2.6 Binding mode of dorzolamide within the binding pocket of CA II. (a) Schematic 
representation (b) Crystal structure (PDB-Code: 1CIL). The solvent accessible surface is shown in white. 
Relevant amino acids and the ligand are shown in stick representation (protein: C, N, O; ligand: C, N, O, 
S). Zn
2+
 is shown as grey sphere. Hydrophobic residues are indicated by the red line and hydrophilic 
residues by the blue line.  
2.4.5  Therapeutically Applied Carbonic Anhydrase Inhibitors 
For over 40 years acetazolamide (Figure 2.7) was applied as diuretic drug. However, 
since 1997 it is no longer approved for this indication. Inhibiting the carbonic anhydrase 
in the kidneys, acetazolamide decreases the resorption of HCO3¯ and consequently 
increases diuresis (Maren 1967). Classic CA-inhibitors 1-4 are also applied in the 
therapy of glaucoma. However, the systematic application of these unselective 
CA-inhibitors does not simply affect CAs in the eye. Also CAs in the kidney, the liver, 
the gastrointestinal tract, the pancreas and the brain are inhibited. This leads to 
undesired side effects such as anorexia, fatigue, depressions, renal calculi, 
gastrointestinal disorder and metabolic acidosis (Maren 1967; Supuran and Scozzafava 
2000). To prevent these side effects, topically administered sulfonamides that endow 
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6, brinzolamide, Azopt®). These novel CA inhibitors show sufficient water solubility 
and adequate lipophilic properties to still pass the cornea (Maren 1995; Supuran and 
Scozzafava 2000). The classic CA-inhibitors 1-4 are not appropriate for the topical use 
since the concentrations reached at the target tissues are not sufficient. These 
compounds show either rather lipophilic or hydrophilic properties. Next to the therapy 
of glaucoma, acetazolamide 1 is also applied in the therapy of different forms of 
epilepsy, of cerebral oedema and of anoxia (Larson, Roach et al. 1982; Reiss and Oles 
1996; Carrion, Hertzog et al. 2001). Methazolamide 2, topiramate 7 and zonisamide 8 
are likewise used as anticonvulsant (Dodgson, Shank et al. 2000; Masereel, Rolin et al. 

































































































Figure 2.7 Therapeutically applied CA inhibitors. 1 acetazolamide, 2 methazolamide, 3 
ethoxzolamide, 4 dichlorphenamide, 5 dorzolamide, 6 brinzolamide, 7 topiramate, 8 zonisamide.  
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3 Cloning, Expression, Purification and Crystallization of CA II and 
CA II Mutants 
3.1 Introductory Remarks 
Cloning of the CA II gene was performed during a four week stay in the group of Prof. 
Pastorekova, Institute of Virology - Slovak Academy of Sciences (Bratislava). 
Subsequently, the expression system was optimized for high protein yields in our lab. 
Up to 30 mg pure protein can be achieved of 1 l expression culture. Site-directed 
mutagenesis allows creation of desired mutants.  
3.2 Cloning and Mutagenesis 
Cloning of CA II gene: The gene coding for CA II was amplified by PCR from a 
construct, generously provided by the group of Pastorekova (12.2.1.1) applying the 
primers XhoICA2a and EcoRICA2s (Table 12.4). The PCR-fragment and the plasmid 
pGEX-4T1 (GE Healthcare) were each incubated with the restriction enzymes XhoI and 
EcoRI to create the sticky ends for ligation (12.2.1.2). After ligation (12.2.1.3) the 
plasmid was transformed into E.coli XL-2Blue (Table 12.5) competent cells and 
incubated for plasmid multiplication (12.2.1.5). A sequencing experiment showed that 
the sequence was identical to the original copy (Appendix 13.3). For high gene 
expression the plasmid was transformed into E.coli BL21 CodonPlus cells (Table 
12.5;12.2.1.5).  
Creation of CA II mutants: All CA II mutants were made by site-directed mutagenesis 
using the expression vector containing the wild-type CA II coding region with the 
primer listed in Table 3.1 and in Table 12.4(12.2.1.4). The point mutations were made 
using the QuikChange II Kit for site-directed mutagenesis. The mutations were 
introduced focusing on different objectives (Table 3.1). The mutants CA II-W5C, CA 
II-G63C, CA II-H64C, CA II-W5C-H64C and CA II-W5C-H64M were created in the 
context of in situ click chemistry to evaluate their affinity towards Cu ions monitored by 
protein crystallography. In order to perform tethering and tethering-assisted 
azide/alkyne cycloaddition experiments the mutant CA II-H64C was created. In 
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addition several other mutations were introduced into the active site replacing amino 
acids that are relevant for the binding of typical CA II inhibitors.  
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2
  Plasmids have each been transformed into Xl2-blue and BL21Codon plus Cells. The strains are named: bacterial strain-vector-
gene; double and triple mutations were introduced in the equivalent single or double mutant. 
3
  2+3 C. = 2+3 Cycloaddition 
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3.3 Expression and Purification 
Gene expression: CA II and CA II mutants were expressed and purified according to 
the Glutathione-S-Transferase (GST) gene fusion system handbook (Amersham 
Biosciences) with the following adjusted protocol. A first 100 ml culture was incubated 
in the presence of 100 µg/ml amp and 34 µg/ml cam overnight at 37 °C. 10 ml of this 
solution was used to inoculate a 1000 ml expression culture with 100 µg/ml amp. 
Expression of the CA II glutathione-S-transferase fusion protein was induced at an 
optical density at 600 nm (OD600) of 0.6-0.8 with 2 mM IPTG, and incubation was 
continued for 4 h at 32 °C.  
Lysis: Cells were harvested by centrifugation at 5,000 rpm for 15 min at 4 °C. The cell 
pellet was resuspended with 100 ml PBS buffer (Table 12.3), which contained a 
protease inhibitor cocktail tablet and approximately 100 mg of lysozyme. After chilling 
for 30 min on ice, the cells were lysed by ultrasonic sonication using a Branson Sonifier 
250, applying 7 cycles of 2 min with duty cycle set to 70 and output control to 4. This 
solution was centrifuged at 20,000 rpm for 45 min at 4 °C and filtered (0.45 µM) to 
separate the soluble fractions from the insoluble material.  
Protein purification: The flow-rate along all purification steps was adjusted to a 
maximum pressure of 0.25 MPa. The sample was applied to a HiPrep GSTPrep FF 
16/10 column (GE Healthcare) at a flow-rate of 1 ml/min to ensure that all the fusion 
protein, which shows very low binding kinetics, binds to the sepharose (Figure 3.1). 
Afterwards the column was washed with 10 column-volumes of PBS buffer at a flow-
rate of 3 ml/min. For cleaving the GST-tag 500 I.U. of thrombin (from Beriplast, CSL 
Behring) were added with 1 ml/min and the column was slightly shaken for 20 hours at 
room temperature. After incubation, the target protein was eluted from the column with 
approximately three column-volumes of PBS at a flow-rate of 1 ml/min. The elution 
volume was mixed with the same volume of 100 mM Tris-HCl pH 7.4, 1 M NaCl 
buffer. This mixture was purified over a HiTrap Benzamidine column (Amersham 
Bioscience) to separate the thrombin from CA II. As a final purification step, the probe 
was applied on a HiLoad 26/60 Superdex200 size exclusion column (GE Healthcare) to 
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purify the target enzyme from any last impurity and change the buffer to 50 mM Tris 
pH 7.8. To monitor the different purification steps, the probes were controlled by SDS-
PAGE (Figure 3.2) (Laemmli 1970).  
The final purification of 1 l expression culture yielded approximately 30 mg CA II. 
Finally the GSTPrep column was washed with reduced gluthathione buffer to elute the 
GST-tag from the column and check for full thrombin cleavage. The purified enzyme 
was concentrated using Vivaspin20 (MW: 10 kDa) columns to a final concentration of 
10 mg/ml, which was used for crystallization experiments. For further measurements 
the enzyme was diluted to the required concentration using a 50 mM Tris-HCl pH 7.8 
buffer.  
 
Figure 3.1 Elution profile of CA II and CA II mutant purification. The samples were applied on 
the column (first peak). After purification with 10 column volumes of buffer 500 I.U. of thrombin were 
added and the column incubated for 20 hours. Thrombin cleaves CA II from the GST-tag which is eluted 
after incubation (second peak). Finally adding a reduced gluthathione buffer, the GST-tag can be eluted 
from the column (third peak). 
 
Figure 3.2 SDS-gel- Fractions of CA II expression: M: Marker (68 kDa, 45 kDa, 36 kDa, 29 kDa, 
24 kDa, 20 kDa 14 kDa, 6.5 kDa); 1: before induction; 2: after induction; 3: after lysis; 4: flow-through 
upon sample application; 5-7: fractions 1-3 upon elution of the target protein; 8: cleavage of the GST-Tag 
 
        sample application                protein elution      tag cleavage 
min 
mAU 




The CA II-WT crystals were grown using the sitting drop vapor diffusion method at 
18 °C by mixing 5 µl of the protein solution (~10 mg/ml) with 5 µl of a well solution 
(2.75 M (NH4)2SO4, 0.3 M NaCl, 0.15 mM p-chloromercurybenzoicacid 0.1 M Tris-
HCl pH 7.8). After a few days the crystallization drops were seeded with a seeding 
solution from old CA II crystals. Crystals appeared within 1 – 4 weeks in space group 
P21 and took up to 6 months to reach their maximum size. Complex structures were 
obtained by cocrystallization of the enzyme with the compounds at concentrations of 
1 mM or soaking in 3 M (NH4)2SO4, 50 mM Tris pH 7.8 + 0.5 - 1 mM inhibitor. For 
cryoprotection, crystals were briefly soaked in mother liquor containing 25% glycerol 
(Acros organics).  
Since we have introduced certain cysteine residues at the surface of CA II, which could 
possibly be coordinated by the mercury, we applied for these mutants the following 
crystallization conditions: 2.75 M (NH4)2SO4, 0.1 mM Tris pH 7.8. As the mercury 
provides an exceeded crystal growth, the mercury-free crystallization of these mutants 
did not result in the typical crystal size, showing the shape of flat plates. However, the 
diffraction pattern showed still sufficient quality to collect in-house and synchrotron 
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4 Introduction of an Artificial Cu Binding Site at the Surface of CA 
II: Pitfalls of Rational Design Finally Scooped by Serendipity  
4.1  Introductory Remarks 
The following chapter has been prepared for submission to a scientific journal. The aim 
of this study was the introduction of an artificial copper center at the surface of CA II. 
This metal ion should show catalytic effect on enzyme bound azides and alkynes to 
perform 2+3 cycloadditions. Protein Crystallography was mainly applied to evaluate 
different mutants. Altogether approx. 100 datasets were collected in the context of this 
project. Extensive protein mutagenesis, gene expression and crystallization experiments 
have been performed. 
4.2  Introduction 
Carbonic anhydrase II is a zinc metalloenzyme that catalyzes the reversible hydration of 
carbon dioxide to bicarbonate. It is involved in a variety of physiological processes 
(Alberty and Hammes 1958). At the bottom of the 15 Å deep active site of CA II the 
catalytically relevant Zn
2+
 ion is coordinated by His94, His96 and His119. During the 
catalytic reaction also His64 plays an important role by shuffling protons from the 
binding pocket to the surface and vice versa (Steiner, Jonsson et al. 1975).
 
The 
preference of this residue to recognize and interact with positively charged species 
could be demonstrated by a recent crystallographic study in our group of a CA II 
inhibitor complex that revealed the density for a metal ion coordinating to this His64 at 
the rim of the binding pocket (s. also Chapter 6). According to the applied 
crystallization conditions it was identified as a Zn
2+
 ion.  
Already previously, it has been demonstrated that this residue is capable to experience 
the coordination of metal ions. Silverman et al. observed that Cu
2+
 ions inhibit human 
CA II through binding to a site remote from the active site zinc ion. Even though 
lacking crystallographic information they concluded that the copper ions bind tightly to 
His64 since the ion inhibits the catalytic mechanism without affecting the equilibrium 
rate of CO2 hydration (Tu, Wynns et al. 1981). Evidence for this hypothesis was 
provided later by a crystal structure of CA II in complex with Cu
2+
 (Figure 4.1) 
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(Hakansson, Wehnert et al. 1994). Apart from replacing the active site zinc ion, a 
second Cu
2+
 ion is coordinating to His64 and His4 at a distance of approximately 2.5 Å 
each. The refinement revealed only partial occupation of the metal ion at this site. 
Obviously, occupancy is influenced by the applied pH conditions since the histidine 





able to occupy this site while being coordinated by His64, Asp62 and a water molecule 
(Eriksson, Kylsten et al. 1988).  
 
Figure 4.1 Crystal structure of carbonic anhydrase II in complex with Cu
2+
 (PDB-Code: 1RZC). 
The solvent accessible surface of the protein is represented in white. Relevant amino acids are shown in 





 while a second copper ion is coordinated by His64 and His4. 
Stimulated by these observations we were interested to transform this apparently weak 
secondary metal ion recognition site into a solid copper binding site. Introduction of a 
Cu center at the surface of CA II could establish new catalytic opportunities since Cu
+
 is 
able to catalyze a variety of chemical reactions, among these the 2+3 cycloaddition of 
an azide with an alkyne. The reaction results in the formation of a triazole. In previous 





we were not able to reliably achieve full metal ion population at this binding site. The 
accommodated metal ion showed only weak coordination and partial occupation. In 
order to generate a firm catalytic site we decided to design by appropriate introduction 
of novel residues an artificial Cu center in the proximity of His64 and Trp5.  
Different approaches were successfully employed in literature for the design of artificial 
metal ion centers in the binding pocket of proteins. Schwarz et al. have shown that the 
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introduction of histidyl residues at the antagonist-binding site of the human NK-1 
receptor gradually converts it into a high-affinity metal ion binding site (Elling, Nielsen 
et al. 1995). This procedure could be used as a general tool in structural and functional 
characterization of helix-helix interactions in G-protein-coupled receptors. Furthermore, 
by site-directed mutagenesis single amino acids or even entire turns were exchanged or 
introduced into the target protein (Regan and Clarke 1990; Klemba, Gardner et al. 1995; 
Pinto, Hellinga et al. 1997; Shields and Franklin 2004; Toyama, Sasaki et al. 2006). 
However, considering the small size of CA II it appears rather intractable to correctly 
predict the impact of such dramatic changes on protein folding simultaneously keeping 
the characteristics of this enzyme by replacing entire loops or inserting larger peptide 
chains. Therefore, we decided to apply a strategy based on rational design concepts. It 
appeared most promising to us to virtually copy the coordination geometry found in 
other copper coordinating proteins across to our case. 
We selected the copper centers found in two well-known biological systems. As our 
first model reference served the so-called “type I” copper sites observed in blue copper 
proteins. These enzymes are involved in electron transfer, as they are capable to host the 
Cu ion in both oxidation states. In azurin, a prominent example, the copper is 
coordinated by two histidines and one cysteine residue with trigonal planar geometry 
exhibiting two additional weakly interacting groups in axial position (Figure 4.2) 
(Karlsson, Nordling et al. 1991). The additionally coordinating ligands can take 
important impact on the formation of the Cu center. They can stabilize certain oxidation 
states of the metal ion. In consequence, the redox potential of enzymes with such 
centers is dependent on the actual composition of the coordinating ligands (Li, Webb et 
al. 2004). Hellinga, Caradonna and Richards tried to introduce such a copper center into 
the binding site of thioredoxin from Escherichia coli by exchanging particular amino 
acids according to a computational prediction (Hellinga, Caradonna et al. 1991; 
Hellinga and Richards 1991). Following the computationally suggested site-directed 
mutagenesis into the fold of the target enzyme they were actually able to constitute a 
copper binding site at the anticipated place. However, the introduced artificial Cu
2+
 
center showed a coordination pattern deviating from the original design as they found 
two histidines and two additional carbonyl groups form the binding site to chelate the 
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metal ion. The especially introduced cysteine residues do not participate in the metal ion 
coordination. These results demonstrate that computational approaches are a good 
starting point and provide valuable suggestions; however, they hardly reflect all the 
impact amino acid mutations will develop on a highly functional biological system. The 
study suggests that a stepwise approach as planned in our case is perhaps a bit more 
conservative but provides higher conceptional flexibility since information gained upon 
a single mutation can be considered in subsequent steps of further design. 
 
Figure 4.2 Crystal structure of Azurin (PDB-Code: 2CCW). His48, His117 and Cys112 (C, N, O, 
S) form a trigonal-planar conformation coordinating the copper ion (brown sphere). Gly45 and a Met121 
are located in axial positions influencing the oxidation state of the ion.   
As the second reference system for our modeling considerations we selected the human 
metallochaperone HAH1, a small soluble protein, which delivers Cu
+
 ions to a target 
enzyme. HAH1 carries a Cu
+
-ion at its surface (Klomp, Lin et al. 1997; Pufahl, Singer 
et al. 1997; Jordan, Natale et al. 2000; O'Halloran and Culotta 2000; Puig and Thiele 
2002). This ion is coordinated by two cysteine residues at a distance of 2.2 Å each and a 
chelating angle of 152.5° (Figure 4.3). Both cysteines are located at the transition of a 
loop to an α-helix and they are separated by two amino acids (Cys12-Gly13-Gly14-
Cys15). In solution the copper ion appears to be coordinated by these two cysteine 
residues as the stoichiometry of the formed complex could be examined by EXAFS and 
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monomers coordinate the ion via four cysteine residues (Ralle, Lutsenko et al. 2003; 
Wernimont, Yatsunyk et al. 2004). According to the latter structural data it appears 
reasonable that the introduction of two cysteine residues in similar fashion into CA II 
could allow creation of a copper
 
center in the target protein. Considering the mobility of 
amino acids at protein surfaces we can assume a certain flexibility of the introduced 
residues that might assist adaptation to form the correct conformation required for metal 
coordination. In contrast, too pronounced residual flexibility could instead be 
detrimental for efficient coordination and possibly the residues will escape the planned 
metal chelation. 
 
Figure 4.3 Crystal structure of Human metallochaperone HAH1 (PDB-Code: 1TL4). The copper 
ion (brown sphere) is coordinated by Cys12 and Cys15 (C, N, O, S). Both cysteines are located at the 
transition of a loop to an α-helix and are separated by two amino acids. 
Here, we present the introduction of an iteratively designed artificial Cu ion binding site 
at the surface of CA II. We created different mutants designed according to the above-
mentioned reference systems that actually show such centers. Following a stepwise 
approach, different mutants were subsequently created according to literature and the 
crystal structures obtained with our mutants. Our initial mutations were not yet 
competent to bind copper ions. Upon further mutations we finally obtained a copper 
center on the enzyme´s surface. Crystal structure analysis shows also in our case that the 
actually obtained coordination pattern deviates from the anticipated one: a square planar 
geometry is formed by three nitrogen and one oxygen atom, whereas participation of the 
especially introduced cysteine residues is not observed. An azide group, which has been 
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4.3 Results  
In order to create an artificial metal ion binding site certain amino acids at the surface of 
CA II were exchanged. We started with single amino acid mutations, crystallized the 
mutated protein and used the obtained structural insights to plan our subsequent design. 
The enzyme was recombinantly produced, purified and either cocrystallized or after 




 metal ion solution, the applied concentrations 
ranged from 100 µM to 5 mM. The obtained geometry was characterized by protein 
crystallography, which enables a detailed analysis of the coordination properties of a 
potentially created metal binding site. 
Design of mutants: As a first step, which amino acid mutations of CA II could be 
competent to create the required geometry? Figure 4.4 shows the crystal structure of 
native CA II (PDB-code: 3D92). Our selected target residue His64 is located at the rim 
of the binding pocket typically adopting two conformations important for proton 
shuffling. The N-terminus of CA II (green loop) adopts a conformation in the spatial 
vicinity of this residue. It ideally exhibits some mobility that could be favorable to assist 
formation of the required metal ion coordination geometry. In type I copper centers two 
histidine and one cysteine residue establish a trigonal planar Cu coordination site. As 
cysteine residues are not only present in this Cu-binding site but also involved in that of 
our second reference protein we attempted introduction of such a residue as initial step. 
Spatially close to His64, CA II exhibits two additional histidine residues, His3 and His4 
(Figure 4.4c,d). Exchanging one of these residues by the favored cysteine should allow 
copper coordination. Furthermore, His10, also in the flexible part of the N-terminus, 
could be ideally located for coordination. Apart from the residues desired to form a 
trigonal planar coordination geometry, Met240 is found in a position to potentially 
interact as a coordination partner with a putative metal site. However, its accessibility 
will depend on the orientation of Phe230 which occupies the space between His64 and 
Met240. Finally, we decided to select Trp5 as a first candidate for cysteine introduction. 
Thereby His64, His3 and His4 could experience rearrangements of the N-terminus to 
adopt a geometry competent for metal coordination.  
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Figure 4.4 Crystal structure of carbonic anhydrase II. (a) Overview of carbonic anhydrase II. The 
solvent accessible surface of the protein is represented in white in (a) and (b) (C, N, O, S). (b) The area 
for Cu-center introduction in surface representation from a close up view. (c) The area for Cu-center 
introduction in stick representation. The backbone of the flexible N-terminus is represented by a green 
cartoon, of the Cys64 region by a blue cartoon. (d) (c) rotated by 90°. 
Similar considerations propose exchange of His64 by a cysteine residue. Such mutation 
would reduce the distance of the anticipated copper center to the binding pocket of CA 
II. This center was planned to host possible reagents for further chemical reactions 
involving the newly created copper center. Considering the human metallochaperone 
HAH1 the described double cysteine mutant, exchanging His64 as well as Trp5 was 
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Structural investigation of CA II-W5C: The W5C mutation was performed and its 
crystal structure shows Cys5 to be rotated away from His64 (Figure 4.5).  
 
Figure 4.5 Crystal structure of CA II and CA II-W5C. (a) Crystal structure of CA II. The area for 
Cu-center introduction is shown in stick representation (C, N, O, S). The backbone of the flexible N-
terminus is represented by a green cartoon, of the His64 region by a blue cartoon. (b) Crystal structure of 
CA II-W5C (C, N, O, S). The 2Fo – Fc map for the mutated amino acid is displayed a ζ level of 1.0 as 
blue mesh. (c) (b) rotated by 90°. Cys5 is located at a distance of 3.2 Å to Asp19. A rotamer of Cys5 
experiences a distance of 5.1 Å to His64. (d) Crystal structure of CA II-W5C after Cu soaking in cartoon 
representation. The N-terminus experiences high mobility which is indicated by weak or missing electron 
density. The residues that are missing after the copper soaking are shown in red. 
The sulfur atom is oriented towards Asp19 with a distance of 3.2 Å. The geometry of 
His3 cannot be determined as no difference electron density is observed for this residue. 
Similarly, the preceding two amino acids experience very high flexibility and can 
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spatial arrangement of the involved amino acid which seems capable to form the desired 
copper center. A possible rotamer of Cys5 would experiences a distance of 5.1 Å to 
His64. The residual mobility of the N-terminus could assist formation of the 
coordination site. A trigonal-planar coordination with two histidine and one cysteine 
residue known from Pseudomonas aeruginosa azurin seems therefore achievable 





solutions (10 mM) binding of Cu ions to CA II-W5C was not observed. Moreover, the 
crystal structure does not show any density for the N-terminal residues (Figure 4.5d). 
The amino acids 1 to 19 are disordered and seem to adopt multiple conformations. The 
weakly defined electron density prohibits any identification of single amino acid 
conformations. 
Structural investigation of CA II-W5C-H64C: Taking HAH1 as a reference, the N-
terminal flexibility suggests introduction of a second cysteine mutation within this area 
of the protein. Therefore, His64 was exchanged as the next step (Figure 4.6a). The 
crystal structure of CA II-W5C-H64C reveals extensive conformational changes at the 
protein surface (Figure 4.6b, PDB-code: 3M1W). The N-terminus is shifted towards 
Cys64 as a disulfide bond is formed between Cys5 and Cys64. This disulfide bond is 
apparently fully established as it is indicated by a very well resolved electron density. 
The amino acids His4 and His3 experience high mobility as they are not visible in the 
diffraction pattern. Residues Tyr7 and the following ones are not affected by this 
mobility and adopt a conformation commonly found in many structures. 
From HAH1 it is known that the two cysteine residues coordinate the copper ion 
forming an angle of 152.5°. The observed terminal mobility of the CA II-W5C mutant 
provides the necessary prerequisite to accommodate Cu with reasonable affinity. Both 
cysteines should be able to arrange in the required manner. In order to verify this 
assumption the disulfide bond was reduced prior to Cu soaking. In previous 
thermostability measurements we were able to determine the TCEP and DTT 
concentration required for the disulfide reduction. In such an assay, the enzyme is 
gradually heated until denaturation of the protein is indicated. Shifts in the "melting" 
temperature correlate with enzyme stability. The experiment showed that in case of CA 
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II-W5C-H64C 1.5 mM TCEP and 5 mM DTT are sufficient to reduce the disulfide bond 
(data not shown). The protocol to grow protein crystals involves several steps starting 
with protein expression, purification and concentration to finally crystallization. In each 
step disulfide bond reduction and copper center constitution were tested, separately. 
 
Figure 4.6 Crystal structure of CA II-W5C and CA II-W5C-H64C. (a) Crystal structure of CA II-
W5C. The area for Cu center introduction is shown in stick representation (C, N, O, S). The backbone of 
the flexible N-terminus is represented by a green cartoon, of the His64 region by a blue cartoon. (b) 
Crystal structure of CA II-W5C-H64C (C, N, O, S) superimposed with CA II-W5C (C, N, O, S). The 2Fo 
– Fc map for the mutated amino acids is displayed a at ζ level of 1.0 as blue mesh. The formed disulfide 
bond is indicated by an arrow. (c) b rotated by 90°. (d) Crystal structure of CA II-W5C-H64C (C, N, O, 
S) after disulfide bond reduction superimposed with the closed form (C, N, O, S) and CA II-W5C (C, N, 
O, S). The N-terminus readopts the original orientation. (e) (d) rotated by 90° (C, N, O, S). A rotamer of 
Cys5 is located at a distance of 6.1 Å to Cys64. 
Each thus treated protein charge was crystallized and tested for Cu center formation by 
X-ray crystallography. None of the produced crystalline samples showed the desired 
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takes between weeks to months, the DTT concentration supplemented to the 
crystallization drops was obviously not sufficient to keep the thiole groups in the 
reduced state until dataset collection. Most likely the initially ruptured disulfide bond 
was reformed possibly as a consequence of small traces of oxygen present during the 
crystallization experiments. As an alternative we tried to soak the reducing agent and 
copper ions, however also these soaking experiments failed to reduce the disulfide 
bond. In the crystallization protocol of the wild type p-chloromercuribenzoic acid is 
added to the crystallization drop to significantly increase crystal growth in all 
dimensions. Considering that both cysteine residues might be capable to coordinate the 
mercury ion and thus could possibly hamper Cu coordination we performed all 
crystallization trials in the absence of mercury. Unfortunately, under these conditions 
protein crystals grow rather slow, remain small and lack the required stability over a 
sufficient soaking time. We also performed our experiments under anaerobic conditions 
but no formation of a Cu center could be detected by crystallography. We also dialyzed 
the protein under anaerobic conditions, without success. Possibly, the applied Cu 
concentrations were too harsh and the enzyme was denaturated to some degree. Finally, 
after repeating soaking experiments and crystal growth for six months we revealed a 
crystal used for data collection that showed an opened disulfide bond (Figure 4.6d,e, 
PDB-code: 3M1Q). The N-terminus adopts the previously seen conformation. Cys5 and 
Cys64 are separated by a distance of 6.1 Å. Nevertheless, considering the inherent 
mobility of the residues of this mutant the formation of a copper center appeared 
feasible. Unfortunately, additional experiments with varying soaking conditions 
remained unsuccessful. We therefore considered further mutations.  
Structural investigation of CA II-H64C: CA II-H64C shows the same backbone 
conformation as the wild type (Figure 4.7b, PDB-code: 3M5S). Interestingly enough, 
the newly introduced cysteine residue induces a rotation of the proximal His3. The 
imidazole moiety shows a very well defined electron density and adopts a conformation 
placing its side chain in close distance to Cys64 (3.2 Å). After crystals had grown to 




 solutions were performed. 
However, similar to the other mutants no constitution of a copper center could be 
detected.  
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In addition to the above described Cys and His mutants we performed additional site-
directed mutagenesis to introduce the potentially Cu coordinating residues His, Cys and 
Met at various positions. Unfortunately, for the CA II-W5H, CA II-W5C-H64M, CA II-
G63C and CA II-H64M mutants no crystallization conditions could be found and thus 
no insights into the putative formation of a geometry competent to coordinate a copper 
ion could be obtained. 
 
Figure 4.7 Crystal structure of CA II and CA II-H64C. (a) Crystal structure of CA II. The area for 
Cu-center introduction is shown in stick representation (C, N, O, S). The backbone of the flexible N-
terminus is represented by a green cartoon, of the His64 region by a blue cartoon. (b) Crystal structure of 
CA II-H64C. The 2Fo – Fc map for the mutated amino acid and His3 is displayed at a ζ level of 1.8 as 
blue mesh. His3 is rotated towards Cys64. (c) (b) rotated by 90°. His3 is located at a distance of 3.2 Å to 
Cys64. 
We therefore reconsidered our initial design concept. The introduction of the copper 
center has been attempted to generate an additional catalytic site to bring reagents such 
as an azide and an alkyne to reaction. During the reaction the azide is assumed to show 
transient coordination with the copper center. By this coordination step a possible 
stabilization of the copper center can also be anticipated. In order to profit from this 
strategy of an additional stabilization of the designed copper coordination center we 
tethered different azide components via disulfide linkage to the introduced cysteine 
moieties in our mutants. Admittedly more by serendipity than by rational design 
concepts we succeeded to determine a crystal structure with an actually formed copper 
center. In this structure an azide was tethered to the CA II-H64C mutant followed by the 
exposure to Cu
+
 ions. This exposure was primarily attempted to initiate reaction with an 
alkyne component added to the specificity pocket of CA II. Crystal structure analysis of 
thus treated crystals surprisingly shows the desired copper center to be formed at the N-
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the azide, the Cu center has been established. Interestingly, Ser2, His3 and His4 become 
well ordered in this structure and arrange with square planar coordination geometry 
around a copper ion exhibiting distances from 2.0 to 2.2 Å (Figure 4.8b). 
 
Figure 4.8 Crystal structure of CA II-H64C. (a) Artificially introduced copper binding site in CA II-
H64C. The area of the Cu center is shown in stick representation (C, N, O, S). The 2Fo – Fc map for the 
coordinating amino acids is displayed at a ζ level of 1.0 as blue mesh in (a) and (b). The backbone of the 
flexible N-terminus is represented by a green cartoon, of the Cys64 region by a blue cartoon. (b) Cu 
binding site from a close-up. The metal ion is coordinated by His4, His3 and Ser2 at distances between 
2.0 Å to 2.2 Å. (c) b from a different orientation. (d) Overview of CA II-H64C. The Cu binding site is 
located at the N-terminus on the left hand side of the binding pocket. The solvent accessible surface of the 
protein is schematically represented in white. 
Remarkably this coordination pattern matches well with those known for type II copper 
centers, where the metal ion is coordinated by nitrogen and oxygen atoms in a square 
planar geometry. Residues Met1, Ser2 and His3 are usually not visible in the electron 
density of CA II crystal structures. Since the crystals were soaked with a CuSO4 
solution containing five-fold excess of ascorbic acid we assume that a Cu
+
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coordinated by Ser2, His3 and His4. Additionally, a water molecule contributes to the 
coordination geometry and occupies a fifth site in axial position. The colorless crystals 
provide additional evidence for the presence of Cu
+
, since enzyme crystals, such as of 
azurin show a blue color after Cu
2+
 soaking. Performing a CSD database search for 
known Cu coordination reveals that the observed arrangement matches well with a 
square planar geometry about a Cu ion and argues in favor of a Cu
+
 center.  
Currently it is not obvious how the azide moiety might have contributed to the 
formation of the Cu binding site. We tested further azides with different linker length. 
For all azides the metal center was formed under the described conditions. We assume 
that the azide plays an important role in the pre-formation of the metal center. Possibly, 
as the azide finally engages in triazole formation it is only transiently available to 
contribute to the coordination sphere. For this it could adopt a minor conformation 
placing the terminal azide nitrogen in an axial position. Once the coordination site has 
been formed the involved amino acids seem to establish a stable arrangement. We have 
repeated this procedure with numerous protein crystals and in all cases we revealed the 
metal ion center to be formed after Cu soaking. This supports the assumption that a 
stable metal center has formed providing the properties to be available for further 
experiments. The formation of this center in solution has to be confirmed and its 
catalytic properties will be investigated in subsequent studies. 
4.4 Conclusion   
In summary, we have created more by serendipity than by rational design a Cu binding 
site at the surface of carbonic anhydrase II next to its catalytic zinc site. Focusing on 
known Cu binding sites observed in other structures we tried to imitate the required 
binding geometry for such a metal ion. Therefore, single amino acids were exchanged 
by site-directed mutagenesis. If possible, for each produced mutant a crystal structure 
analysis was performed to obtain insights into the revealed structural modifications. 





and the achieved modifications were investigated again by protein crystallography. 
Numerous mutants were created and tested. In case of CA II-W5C a conformational 
change of the N-terminus could be observed upon Cu soaking. This mobility seems to 
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be an important prerequisite for metal center constitution. However, optimization of the 
individual N-terminal residues remained impossible due to ill-defined electron density. 
We also attempted to introduce a copper center similar to the one observed in HAH1, by 
placing two mutually facing cysteine residues in CA II-W5C-H64C. The initial crystal 
structure of this mutant revealed a disulfide bond between Cys5 and Cys64. This 
disulfide bridge could be reduced by DTT soaking; however, a Cu center could not be 
introduced upon Cu supplementation.  
Finally, the formation of a copper center could be achieved more by serendipity than 
design obviously temporarily supported by an azide substituent tethered to Cys64 in the 
CA II-H64C mutant. The geometry of this metal binding site is related to the type II 
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5 Stereo- and Regioselective Azide/Alkyne Cycloadditions in 
Carbonic Anhydrase II via Tethering Followed by Protein 
Crystallography and Mass Spectrometry 
5.1 Introductory Remarks 
The following chapter has been submitted to the scientific journal for publication. In the 
following the original text is depicted. The introduction is elaborately described to 
provide a detailed view of click chemistry. In addition, extensive experimental work 
concerning HPLC-MS analysis is presented at the end of the results section.  
The present study was accomplished in cooperation with Dong Sun and Nicola Sandner, 
group of Prof. Koert, and Uwe Linne, group of Prof. Marahiel from the Chemistry 
department, Philipps University Marburg. Dong Sun collaborated in the entire project, 
performed the synthesis of all compounds applied in the experiments and supported in 
the design of the building blocks. Nicola Sander joined the project in March 2009 and 
contributed to the refinement and deposition of crystal structures and to the 
development of the HPLC-MS experiments. Uwe Linne performed sample purification 
and mass spectrometric analysis of the HPLC-MS experiments. 
5.2 Abstract 
A carbonic anhydrase II mutant has been created which can be employed for the 
selective synthesis of triazoles via the Huisgen reaction from azides and alkynes. The 
azide is covalently attached by tethering to a mutationally introduced cysteine residue 
on the surface of CA II. The alkyne has been fixed reversibly to the protein surface via a 
sulfonamide anchor which coordinates the zinc ion at the original catalytic center. The 
2+3 cycloaddition is enormously accelerated by the thus achieved spatial 
preorganization of both building blocks. The triazole formation has been monitored by 
protein crystallography and HPLC-MS which allows the successive observation along 
the reaction time. The dependence of product formation on the applied reaction 
conditions was studied in detail. It can be shown that the CA II surface takes 
determining influence on product formation while Cu
+ 
ions even accelerate the turn-
over. Apart from optimization of product yields we were able to develop building 
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blocks for regio- and stereoselective triazole synthesis resulting in the formation of a 
stereochemically pure 1,5-S-triazole.  
5.3 Introduction 
Reactions, classified as click chemistry, are expected to be modular, stereospecific, 
wide in scope, excellent in yields and will generate only safe byproducts that are easily 
removable by non-chromatographic methods. Furthermore, the applied reaction 
conditions have to be simple, the starting materials and reagents readily available and at 
best water can be used as solvent (Kolb, Finn et al. 2001). The synthesis of 1,2,3-
triazoles via the Huisgen reaction has been established as one of the best-suited 
transformations out of the entire repertoire of organic reactions to meet the criteria of 
click chemistry (Huisgen, Szeimies et al. 1967). This cycloaddition based on azides and 
alkynes facilitates the generation of large triazole libraries, particularly as a large variety 
of alkyne and azide components can be introduced into a broad range of molecular 
skeletons. However, for more than 40 years the impact of this reaction was regarded as 
minor due to low selectivity yielding in mixtures of 1,4- and 1,5-regioisomers (Tron, 
Pirali et al. 2008). As further drawback these cycloadditions require high activation 
energy often resulting in rather slow turn-over. Therefore either elevated temperatures 
and/or pressures were applied (Zhang, Chen et al. 2005). To accelerate the reaction rate, 
different strategies have been developed for alkyne activation. The addition of electron-
withdrawing groups to the alkyne, the reaction of azides with arynes or the activation by 




 are just a few features to mention (Zhang, Chen et al. 
2005; Berkel, Dirks et al. 2008; Shi, Waldo et al. 2008). Particularly, the latter ions have 
productively changed click chemistry since they allow the selective synthesis of 1,4- 
and 1,5-substituted triazoles. The addition of Ru
2+
 ions to Huisgen reaction conditions 
leads to the regioselective synthesis of 1,5-disubstituted triazoles in acceptable reaction 
time (Zhang, Chen et al. 2005). Cu
+
 shows an even higher impact on the Huisgen 
reaction. Sharpless and coworkers demonstrated that the rate of cycloaddition between 
azides and alkynes can be accelerated ~10
6
-fold using catalytic amounts of Cu
+
, leading 
to 1,4-triazole products (Rostovtsev, Green et al. 2002; Tornoe, Christensen et al. 2002). 
Apparently, the mechanism of this click reaction is well understood. Most likely the 
reaction does not proceed through a concerted mechanism, as frequently discussed for 
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cycloadditions. Instead, a stepwise reaction pathway is favored, as confirmed by kinetic 
data and molecular modeling and supported by simulations of activation barriers (Hein, 
Liu et al. 2008). These studies suggest that up to two Cu
+
 ions are involved in the 
catalysis. In the first step, subsequent to the deprotonation of the terminal alkyne 
carbon, the two Cu
+
 ions and the acetylide form a complex. Thereafter the innermost 
nitrogen of the azide displaces one of the coordinating ligand atoms from the second 
Cu
+
 ion thus activating the terminal nitrogen for nucleophilic attack towards the alkyne. 
After cyclization and protonation, the catalyst releases the 1,2,3-triazole product (Himo, 
Lovell et al. 2004; Rodionov, Fokin et al. 2005; Bock, Hiemstra et al. 2006; Rodionov, 
Presolski et al. 2007). The isolation of a crystalline Cu
+
 triazolide strongly supports the 
existence of such click-intermediates (Nolte, Mayer et al. 2007). Apart from Cu
+
 ions 
several other copper derivatives serve as catalysts with deviating reaction profiles in the 
Huisgen reaction; e.g. Cu colloids, Cu powder, Cu shavings or CuSO4/ascorbate. For 
these systems a detailed mechanistic analysis is still of major interest. Remarkably, for 
all copper catalysts mentioned above an incubation, e.g. for Cu
2+
/ascorbate of up to 
5 hours, is required before any clickproduct can be detected, however no satisfactory 
explanation for this observation can yet be provided (Pachón, van Maarseveen et al. 
2005).  
With respect to pharmaceutical research click chemistry provides novel opportunities, 
e.g. for polymeric micelles, nanoscale delivery systems and DNA labeling (Hein, Liu et 
al. 2008). Furthermore, libraries produced by Click chemistry can be tested in High 
Throughput Screenings on pharmaceutically interesting targets. However, the need of a 
copper catalyst for the Huisgen reaction is detrimental to pharmaceutical applications as 
possibly remaining copper impurities might create toxic side effects, such as hepatitis, 
neurological disorder, kidney diseases, and Alzheimer´s disease (Wang and Guo 2006). 
In light of such risks significant effort has been spend to develop metal-free click 
reactions with the required turn-over and stereochemistry.   
It has recently been shown that the protein environment of an enzyme can function as 
such an activator for the Huisgen reaction catalyzing triazole formation without the 
need of supplementary metal ions (Krasinski, Radic et al. 2005; Mocharla, Colasson et 
al. 2005). This opportunity is particularly supported by the fact that alkynes and azides 
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are essentially inert and chemically orthogonal to most biological and organic 
conditions, including highly functionalized biological molecules, e.g. as given in the 
binding pockets of enzymes. Cycloaddition reactions can be accelerated tremendously 
once the reacting building blocks are brought into favorable spatial vicinity (Mock, Irra 
et al. 1983; Mocharla, Colasson et al. 2005). This strategy is exploited in the so called 
target-guided synthesis (TGS) using a protein environment as constraint. The enzyme is 
incubated with a mixture of diverse building blocks which exhibit graded affinities to 
the site of mutual interaction. This site will thus select mainly those fragments that 
experience highest affinity, in consequence, the product with the strongest binding 
affinity will overwhelmingly be found. The enzyme operates as a kind of blueprint, 
filtering out the most potent inhibitor from a large number of possible products. 
Applying this TGS approach, Sharpless et al. showed in several studies that enzymes 
such as acetylcholinesterase (AChE) or carbonic anhydrase II (CA II) can be exploited 
successfully for the assembly of triazoles (Krasinski, Radic et al. 2005; Mocharla, 
Colasson et al. 2005).  
The goal of the present study was to examine the azide/alkyne cyloaddition in a protein 
environment by integrating a tetherering approach into the target-guided synthesis 
concept (Erlanson, Braisted et al. 2000). The tethering method facilitates to introduce 
fragments with weak affinity into the binding pocket of proteins by covalently attaching 
the ligand to a cysteine residue close to or within the active site. This system should be 
appropriate to keep track of the reaction geometry by crystallographic diffraction 
techniques to obtain reliable insight in the produced stereochemistry. For this purpose 
we selected the binding pocket of carbonic anhydrase II. By covalently attaching the 
azide component to a mutationally introduced cysteine residue next to the binding 
pocket and linking the alkyne component via an appropriate sulfonamide anchor to 
coordinate efficiently the active site zinc ion we were able to monitor the reactions 
accomplished in the binding pocket by denaturating HPLC-MS analysis performed in 
parallel to protein crystallography. Qualitative and quantitative considerations are 
possible as the click reaction system is covalently attached and upon triazole product 
formation the protein mass increases by the mass of the added alkyne. In particular, we 
were interested in the influence of the enzyme binding pocket on the yield and the rate 
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of triazole formation (1), the regioselectivity (2) and the stereodiscrimination of chiral 
starting materials (3). 
Large scale test series with different reaction components showed that already the CA 
II-H64C mutant is able to induce triazole formation. However, the presence of Cu
+
 ions 




 have only minor 
effects. We decided to monitor the influence Zn
2+
 takes on this system as a control as it 
is almost impossible to create Zn-free conditions in biological systems. Furthermore, 
reactant-dependent the degree of product formation along with the produced regio- and 
stereoselectivity could be recorded. Our study provides the perspective to design 
selective triazoles catalyzed by the protein environment since site-directed mutagenesis 
allows creating a specific protein surrounding that drives triazole formation towards a 
desired product. 
5.4 Results and Discussion 
The general concept for a tethered approach to study azide/alkyne cycloaddition 
reactions in the binding pocket is shown in Scheme 5.1. An arylsulfonamide bearing a 
substituent with a terminal alkyne group 1 and an azide-functionalized disulfide 2 react 
with CA II-H64C to form the complex 3. In 3 the alkyne component is bound to a 
lipophilic pocket and reversibly coordinated via its sulfonamide anchor to the zinc ion 
in the original catalytic center of CA II (His94, His96, His119). The azide component is 
connected covalently via a disulfide bond to Cys64. After 2+3 cycloaddition the formed 
triazole remains covalently attached to Cys64. Principally, the two regioisomers, the 
1,4-triazole 4 and the 1,5-triazole 5 can be formed. This strategy facilitates formation of 
a complex with both reaction components in close vicinity and allows to record 
successive situations along chemical transition by crystallography. Furthermore, this 
setup allows tracing the reaction turn-over by HPLC-MS under denaturating conditions. 
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Scheme 5.1 Tethered enzyme mediated alkyne-azide cycloadditions. (a) Reaction of the alkyne 
component 1 and the azide component 2 with CA II-H64C yields the complex 3 which results in the 
formation of the tethered triazoles 4 and 5. (b) By site-directed mutagenesis histidine 64 is replaced by a 
cysteine residue. The azide is covalently attached to this cysteine residue under mild reducing 
conditions. The alkyne coordinates with its sulfonamide anchor to the active site Zn
2+
 ion. The triazole 
is formed upon incubation. 
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Initial Experiments: Molecular modeling considerations suggested 1a and 2a as first 
prospective candidates for azide and alkyne starting materials (Scheme 5.2). 
 
Scheme 5.2 Tethered cycloaddition (1a + 2a + CA II-H64C  4a). 
Both compounds were incubated with CA II-H64C. The formed ternary complex could 
be structurally characterized by crystallography (Figure 5.1a,d,e). The alkyne 
immobilized via the coordination of the sulfonamide to the zinc ion accommodates its 
ethinyl substituent into a small hydrophobic crevice flanked by Phe130, Val121 and 
Leu197 (Figure 5.1e). The azide component attached covalently via a propylene 
disulfide linker to Cys64 occupies a surface exposed hydrophilic canyon next to the 
exit of the catalytic site of CA II. Both components show well-defined electron density 
indicating only minor residual mobility. The terminal group of the azide component 
establishes an extensive hydrogen-bond network mediated by three water molecules 
with Tyr7, Asn11, Gly63, Lys169, Phe230 and one of the terminal oxygens of Glu235 
(Figure 5.1d). Furthermore, the azide moiety lies in close vicinity to the terminal 
oxygens of Glu238 indicating a possible interaction. More detailed considerations 
about the established interaction pattern are impossible due to unresolved protonation 
states. With the cycloaddition components 1a and 2a no triazole formation was 
observed in the crystalline state at room temperature. We subsequently treated the 
protein crystals (CA II-H64C + 1a + 2a) with solutions containing Cu
+
 ions at 18 °C to 
induce triazole formation. Crystal structure analysis performed with a crystal from the 
accordingly treated batch after 48 hours revealed clear changes in the difference 
electron density (Figure 5.1b,c,f).  
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Figure 5.1 Crystal structure of (1a + 2a + CA II-H64C → 4a). Distances are shown in Å (a) 
Ligand geometries of 1a and 2a (protein: C, N, O, S; ligand: C, N, O, S) in the cocrystal structure with 
CA II-H64C. The Fo – Fc omit maps for the reactants are displayed in (a) and (c) - (e) at a ζ level of 2.0 
as green mesh (before cyclization). The solvent accessible surface of the protein is schematically 
represented in white in all images. Both building blocks bind with distinct orientation from each other to 
CA II-H64C, not facing each other. (b) Ligand geometry of the cyclization product (protein: C, N, O, S; 
ligand: C, N, O, S) formed out of 1a and 2a individually cocrystallized with CA II-H64C and incubated 
with Cu
+
-solution for 48 hours. The 2Fo – Fc map for the cyclization product is displayed in (b) and (c) 
at a ζ level of 1.0 as blue mesh (after cyclization). (c) Ligand geometry of the click product 
superimposed with the reactants 1a und 2a before cyclization. (d) Ligand geometry of 2a in the 
cocrystal structure with CA II-H64C. The azide is fixed to the surface by an H-bond network to Tyr7, 
Asn11, Gly63, Lys169, Phe230, Glu235, Glu238 mediated by three water molecules. (e) Ligand 
geometry of 1a in the cocrystal structure with CA II-H64C. The sulfonamide adopts the typical 
conformation, coordinating to the Zn
2+
 ion, while the alkyne moiety lies within a lipophilic pocket 
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Even though the molecular arrangement detected in the first structure clearly argues 
against a geometry competent to execute the planned triazole formation, the electron 
density in the crystal of the second structure shows the alkyne component to be rotated 
by 180° now facing toward the azide component. The latter azide component 
experiences even larger rearrangements now orienting its side chain towards the 
rotated alkyne component. Even though the difference electron density is only weakly 
defined next to the region where the novel triazole ring should have assembled to the 
likely generated 1,4-click product, the trace of the electron density agrees with the 
geometry of this product. We assume that enhanced residual mobility of the central 
part of the reaction product which is not in close surface contact with the protein and 
incomplete product formation across all unit cells of the protein crystal are responsible 
for the partially defined difference electron density.  
To further characterize the anticipated product formation we applied HPLC-MS 
analysis under denaturating conditions. To increase the reaction rate we raised the 
temperature from 18 °C applied for our crystallographic studies to 37 °C in solution. 
After incubation for 48 hours in the presence of Cu
+ 
we subjected the protein to mass 
analysis. The enzyme mass was determined after purification over a size exclusion 
column to remove any protein-unbound compounds and therefore to prevent non-
specific background reactions during denaturation. Furthermore, any unreacted and 
non-covalently attached sulfonamide component will be removed upon denaturation. 
The analysis of the turned-over protein variant shows a mass peak in agreement with 
the size of the formed triazole-sulfonamide reaction product covalently attached to the 
enzyme. In consequence, part of the covalently bound azide reacted with the non-
covalently coordinated alkyne to the cyclization product resulting in the above-
mentioned enzyme mass modification. In conclusion, the components 1a and 2a react 
in the presence of CA II-H64C to the triazole product only with Cu
+
 assistance. 
Crystallographic evidence suggests formation of the 1,4-regioisomer 4a, which is in 
accordance with the general Cu
+
 catalyzed Huisgen reaction. Within experimental 
accuracy no indication for the formation of the 1,5-product 5a were found.  
However, as seen before in the crystallization experiments, the reaction rate (1a + 2a + 
CA II-H64C) seemed to be rather slow, most likely resulting in an incomplete triazole 
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cyclization. For what reason is such a low reaction rate observed and why can the 
initial crystal structure with the separated reaction components prior to the click ring 
formation be trapped? Obviously, both components are rather tightly immobilized in 
local depressions of the protein surface additionally fixed through hydrogen bonds. 
Furthermore, the supplemented Cu
+
 ions appear to be essential to catalyze the triazole 
formation with these reactants. Finally, the building blocks might simply not feature 
the spatial requirement necessary for a fast cyclization. At least the rather strained 
arrangement of the formed product suggests that the geometry of the reaction 
components has not yet been ideal for the case (1a + 2a + CA II-H64C). 
Triazole formation with optimized building blocks: Accordingly, we decided to 
replace 1a by an extended reagent putatively orienting its alkyne component in a more 
favorable orientation. Therefore, we screened the known crystal structures in the PDB 
for binding geometries of CA II inhibitors to find a more promising scaffold.  
 
Scheme 5.3 Tethered cycloaddition (rac-1b + 2c + CA II-H64C  5c). 
We selected the ligand 6 shown in Scheme 5.3 from an appropriate CA II complex 
crystal structure (PDB-code: 1G1D) as a starting point for the design of an improved 
alkyne component 1b (Kim, Chang et al. 2000). Extended by an amide group the 
Stereo- and Regioselective Azide/Alkyne Cycloadditions in Carbonic Anhydrase II via Tethering 
Followed by Protein Crystallography and Mass Spectrometry  
63 
 
carbon atom attached to the amide nitrogen and substituted by a second phenyl moiety 
suggests ideal spatial positioning to hook up the alkyne substituent (Figure 5.2a). 
However, attachment of the alkyne will create a stereocenter which in the following 
will give rise to two different orientations of this reacting component towards the 
azide. Parallel to the replacement of 1a by 1b we exchanged the likely too short 2a by 
2b and 2c. Both elongated azides with additional linker atoms should minimize the 
distance to the alkyne and avoid pronounced H-bond fixing of the azide on the protein 
surface. This reagent component should then experience the required mobility for 
reaction. Rac-1b (racemic mixture), 2b and 2c were synthesized and each 
cocrystallized with the enzyme. A first crystal structure of CA II-H64C cocrystallized 
with 2c under mild reducing conditions and subsequently soaked for 2 hours with the 
racemic mixture 1b could be determined. Crystals were shock-frozen for data 
collection shortly after soaking. The structure shows that the new reactants bind in a 
favorable orientation for the click reaction (Figure 5.2b,c). 2c is no longer immobilized 
by an H-bond network on the surface and experiences residual mobility which is 
indicated by the weakly defined electron density and the high B-factors assigned to the 
terminal atoms of the azide. The soaked racemic rac-1b populates the binding pocket 
in terms of both enantiomeric forms and correct positioning for triazole formation can 
be anticipated. According to the fact that both enantiomers are present in the binding 
pockets, the density for the alkyne side chain is only weakly defined (Figure 5.2c). To 
evaluate whether also for this setup the click reaction is executed in crystalline state, 
we allowed the crystals of a CA II-H64C, rac-1b and 2c cocrystallization setup to 
grow for 2 months. With these crystals we were able to observe a difference electron 
density of the formed click product 5c (Figure 5.2d,e). The product 5c was formed 
without any additional Cu
+
 soaking. The electron density of the formed triazole is very 
well defined indicating high cyclization yields and regioselective formation of the 
1,5-regioisomer. The phenyl ring and aromatic sulfonamide anchor remain virtually in 
the binding pose attributed to the 1b alkyne prior to cyclization. In contrast, the azide 
component has to rotate by 180° for the reaction, very similarly as observed for the 
cyclization of 1a with 2a. The linker atoms of the azide show some flexibility. They 
adopt two conformations in agreement with the electron density and the conformation 
of the formed triazole.  
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Figure 5.2  Crystal structures of (rac-1b + 2c + CA II-H64C → 5c). Distances are shown in Å (a) 
Crystal structure of 6 (PDB-Code 1G1D; protein: C, N, O, S; ligand: C, N, O, S) used as template for 
the design of 1b superimposed with the subsequently determined crystal structure of the rac-1b (C, N, 
O, S). The solvent accessible surface of the protein is schematically represented in white in all images. 
The two racemic alkynes place their triple bond into different directions which takes significant 
influence on product formation. (b) Crystal structure of rac-1b and 2c in complex with CA II-H64C. 
The 2Fo – Fc maps for the reactants are displayed in (b) – (c) at a ζ level of 1.0 as blue mesh; (c) Crystal 
structure of rac-1b in complex with CA II-H64C seen from close-up. (d) Crystal structure of the in situ 
formed 1,5-S-triazole 5c (C, N, O, S). The Fo – Fc omit map for the cyclization product is displayed in 
(d) and (e) at a ζ level of 2.0 (green mesh). The product participates in hydrogen bonds to Thr200, 
Pro201, Asn67 and Gln92 partially mediated by two water molecules (e) Crystal structure of the in situ 
formed triazole 5c seen from a close-up view. (f) Superimposition of the crystal structure of 1b and the 
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The carboxyl oxygen of the distal amide bond forms, due to the splitting in two 
conformations, either a hydrogen bond to Asn67 or to Thr200 (Figure 5.2e). In the 
latter orientation it is also involved in an H-bond to Pro 201 mediated through a water 
molecule. A second interstitial water molecule forms an H-bond to the proximal amide 
oxygen of the ligand and to Gln92. The crystals were grown at 18 °C, which indicates 
that the cyclization can already take place at this temperature. Even though, we started 
with rac-1b and detected accommodation of both enantiomers in the binding pocket 
prior to cycloaddition only one stereochemically unique product 5c with 
S-configuration is observed. This stereochemistry results directly from R-1b as priority 
rules invert assignment of absolute configuration. Furthermore, the 1,5-triazole is 
formed. Modeling considerations show that also the 1,4-triazole product would 
geometrically fit into the binding pocket. Possibly only the 1,5-product is observed as 
in this second experiment no Cu
+
 ions were present.  
Reaction kinetics: Our elaborate crystallographic analysis only defines the end point 
of the reaction. It hardly allows to record details about the reaction kinetics, 
particularly under varying conditions. Thus, we decided to monitor the triazole 
formation by mass spectrometric experiments in parallel under solvent conditions. The 
HPLC-MS analysis of CA II-H64C incubated with the thiole-azide component showed 
one definite mass peak for the covalent CA II-H64C azide complex (with 2c: 
29729 Da + 173 Da = 29902 Da; (Figure 5.3a). Subsequently, the racemic alkyne 
component (rac-1b) with the sulfonamide anchor was added to this mixture and the 
reaction batch was incubated for 12 to 144 hours at 37 °C. As long as the non-
covalently attached alkyne has not reacted the enzyme mass is not altered since under 
denaturating conditions the non-covalent component will be removed. Once the 
reaction gradually forms the triazole product an additional mass peak is detected 
(29902 Da + 314 Da = 30216 Da). As time proceeded the mass spectra showed a shift 
in the ratio of enzyme-azide to enzyme-product peaks (Figure 5.3b). Relative 
quantitative rating could be revealed by integration over the peaks. Analyzing the click 
product after 30 hours at 37 °C we observed a yield of approximately 20% for either 
the reaction of rac-1b with 2a, 2b, and 2c respectively.  
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To further accelerate and influence this reaction, we studied the reaction of rac-1b 
with 2c, as this combination showed the best yields. Figure 5.4 shows the 
cycloaddition rates along reaction time. Subsequent to an induction time, the triazole 
formation occurs with similar reaction rate until reaction components are fully 
transformed to the product. Recorded via approx. 1500 mass analyses, we 
systematically altered the reaction conditions by modifying temperature and reaction 
time along with the exposure of different metal ions. 
 
Figure 5.3 Monitoring reaction progress via HPLC-MS. (a) Reaction pathway for (CA II-H64C + 
2c + rac-1b → 5c) monitored by HPLC-MS experiments. CA II-H64C shows a mass of 29729 Da. After 
addition of 1b, 2c and 100 µM DTT to reduce the azide internal disulfide bridge, the HPLC-MS analysis 
shows one definite mass peak of 29902 Da representing the mass of the enzyme with the covalently 
attached azide. Upon incubation with the alkyne at 37 °C the triazole formation is induced by the 
enzyme and an additional mass peak of 30216 Da appears in the mass spectrum. (b) Incubating the setup 
mentioned in (a) for 12 to 144 hours taking samples every 12 hours we could monitor the rate of triazole 
formation by comparing the peaks corresponding of the enzyme-azide with the enzyme-triazole 
products. Within 132 hours full conversion of enzyme-bound azide and alkyne components can be 
observed. 
Temperature dependence: Experiments were performed at 20 °C, 37 °C and 55 °C. 
The conversion was analyzed between 12 and 144 hours taking samples every 


















30216.000 30216.000 30216.000 30216.000 30216.000 30216.000 30216.000
= + triazole (488 Da)
30216.000
Stereo- and Regioselective Azide/Alkyne Cycloadditions in Carbonic Anhydrase II via Tethering 
Followed by Protein Crystallography and Mass Spectrometry  
67 
 
peak could be detected after 96h indicating 10% click product. At 37 °C during the 
same time span the triazole yield was increased to 80%. After 48 hours at 55 °C 
already full product formation (100%) can be observed.  
 
Figure 5.4 Time dependent 2+3 cycloaddition (CA II-H64C + 2c + rac-1b → 5c). The triazole 
formation rate of the CA II-H64C-azide to CA II-H64C-triazole complex is shown in percent with 
respect to the reaction time in hours.  
Effect of metal ion supplementation: The following metal ions have been tested as 









. The solvated samples were incubated with metal ions for 12 to 144 hours at 
37 °C. In case of Cu
+
, the samples showed pronounced acceleration also at room 
temperature transforming 20% of the azide within 96 hours compared to 10% for 
samples lacking Cu
+
 presence. At 37 °C we accomplished 100% product formation 
after 84 hours, remarkably without copper 132 hours were not sufficient for complete 
turn-over. We performed the same experiments with exposure to Cu
2+
 ions. A similar 
catalytic impact was observed, however with reduced efficiency compared to Cu
+
. It is 
difficult to elucidate whether actually the Cu
2+
 ions are catalytically active, or whether 
they are reduced to Cu
+
 ions by the always present low DTT concentrations applied to 




 did not 
reveal any significant influence on the reaction rate. Interestingly enough, in all test 
series the triazole formation starts with significant delay. For the first 10 to 15 hours 
we could not detect any product formation. Similar findings have been reported for the 
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Regio-/stereoselectivity: Finally we addressed our attention to the produced regio- 
and stereoselectivity. In our crystallographic experiments we exposed the racemic rac-
1b as alkyne component, interestingly enough resulting exclusively in the 
1,5-S-triazole product (Figure 5.2d,e). The previous study with 1a and 2a revealed 
1,4-triazole formation (Figure 5.1b). At least for the reaction of rac-1b and 2c 
modeling considerations could not exclude 1,4-triazole formation for steric reasons. 
However, in the crystal only the 1,5-stereoisomer is observed notably in the absence of 
any copper ions. Our HPLC-MS experiments revealed product formation with and 
without the presence of copper ions, however, we have no information which 
regioisomers are produced possibly as a mixture and whether the presence or absence 
of copper takes any directional influence. Additional crystallographic studies will be 
necessary to get better insights into the role of Cu
+
 in this system. Attempts to 
cocrystallize the system appear rather impracticable since crystal growth takes months 
and during this period the copper-free cyclization will already be fully executed. As an 
alternative, soaking experiments in presence of Cu
+
 might help to reveal an answer to 
this important aspect of the copper-guided regio- and stereochemistry, but might be 
unfeasible due to lacking stability of the crystals over sufficient time.  
Nevertheless, we further studied the influence of the stereochemistry of the chiral 
alkyne component on product formation. Even though, we observed 
crystallographically the binding of the racemic rac-1b to CA II-H64C we only 
detected the 1,5-S-triazole. We therefore synthesized the alkyne enantiopurely and 
performed additional HPLC-MS measurements. R-1b and S-1b were separately 
reacted in the enzyme with 2c for 144 hours. The HPLC spectra revealed that both 
enantiomers are capable to initiate triazole formation. In agreement with the above-
described crystallographic evidence, the R-enantiomer showed higher reaction rates. 
The question remains why do we see in the crystal exclusively the S-product and not, 
at least to some extent, also the R-product? Does the selective synthesis depend on a 
raised affinity of one enantiomer compared to the other or on the spatial organization 
of both components?  
The structure with the racemic starting material was obtained by short time soaking. 
Likely both enantiomers exhibit very similar binding affinity to the enzyme as 
Stereo- and Regioselective Azide/Alkyne Cycloadditions in Carbonic Anhydrase II via Tethering 
Followed by Protein Crystallography and Mass Spectrometry  
69 
 
indicated by inhibition data measured in a bioassay. Crystallographic experience 
shows that the solid state is highly discriminative with respect to the binding of 
stereoisomers, particularly, if the crystals were grown over sufficiently long time. Then 
only one isomer is usually found even though a racemic (or diastereomeric) mixture of 
similarly potent ligands was exposed. Through equilibrium over the long time of 
crystal growth even small affinity differences are sufficient to finally populate only the 
more potent ligand in the binding pocket.  
In our case the crystals had two months time at 18 °C to accomplish the cycloaddition 
reaction whereas for the complexes with the reagents where we could detect the 
racemic mixture of the starting material a short soaking over 2h has only been allowed. 
Most likely, as the racemic alkyne component is only bound to the enzyme reversibly, 
S-1b could be gradually exchanged by R-1b present in excess in the crystallization 
buffer. The latter R-enantiomer adopts a more favorable orientation for the cyclization 
reaction (Figure 5.2f) with better suited spatial orientation of the cyclization step, thus 
after two months exclusively the 1,5-S-product is revealed. 
Control-experiments: Up to now, it could only be evidenced indirectly that the 
triazole formation occurs within the active site of a protein (Lewis, Green et al. 2002). 
Triazoles formed in solution might imitate in situ generated click products. To verify 
in our case that the click reaction has actually been executed in the binding pocket we 
performed several control experiments. First, we added the potent CA II inhibitor 
ethoxzolamide to the reaction batch. After exposure at 37 °C for 72 hours the HPLC-
MS spectra did not indicate any product formation. Only the mass-shift for the tethered 
2c bound to the enzyme (29729 Da  29902 Da) could be recorded. Obviously, 
Ethoxzolamide replaces or prevents binding of the less potent sulfonamide 1b. In case 
a background reaction would have occurred in solution, the generated clickproduct 
should also be tethered to Cys64, leading to the product mass shift. Similarly any 
reaction of the covalently tethered azide component with the protein unbound 
sulfonamide-type alkyne can be excluded. In consequence the alkyne is only 
competent for the cyclization once bound to the active site. To validate this conclusion 
we tried to react the azide 2c with different alkynes lacking a sulfonamide anchor. 
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Also under these conditions no product formation could be observed. Finally, in 
another control experiment the enzyme was purified over a size exclusion column after 
short incubation at room temperature with the azide and the alkyne. Thereby the 
enzyme was purified from any unbound reactants. Only the tethered and zinc-
coordinated building blocks remained in the samples. After exposure at 37 °C for 
48 hours and HPLC-MS analysis of these samples, product formation could be 
observed with the same rate as observed for all the other test series. Furthermore, we 
analyzed the solutions from which the protein has been extracted. If any solvated 
reactants would have been present, a background reaction might have occurred. 
However no triazoles click product could be detected.  
5.5 Conclusion 
In summary, we have developed a CA II mutant that can be used for covalent disulfide 
attachment of azide click reactants on the enzyme surface. The immobilized 
components can be reacted with appropriate alkyne components fixed through an 
attached sulfonamide anchor that allows to reversible coordinate the CA II active site 
zinc ion. This experimental setup permits unique structural and kinetic insights into the 
complex reaction conditions driving the in situ triazole formation, in parallel it gives 
access to structural information via crystal structure analysis and to kinetic data via the 
achieved reaction turn over along the reaction path by HPLC-MS. Systematically 
modifying the reaction conditions, we were able to elucidate the time-, temperature-, 
additive catalyst- and reactant-dependency of the in situ click chemistry performed on 
the protein surface. Elevated temperatures as well as the additional supplementation 
with Cu
+
 ions accelerate the triazole cyclization. Furthermore, the stereochemical 
properties of both building blocks influence the reaction rates as interactions with the 
protein surface characterized by crystallography can diminish the mobility of the 
reactants and thus slow-down turn over. We have proven via appropriate control 
experiments that the studied click reaction occurs actually exclusively in the binding 
pocket of CA II. Furthermore, our in situ click reaction is performed under regio- and 
stereo-selective control as we could demonstrate that only the selective synthesis of the 
1,5-S-triazole is observed. Furthermore, the synthesis of 1,4-triazoles can be achieved 
most likely induced by Cu
+
 supplementation. The proposed system provides the 
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perspective to create protein surface exposed reaction sites. The next step would be to 
omit the tether in an efficient system evolved to go towards catalytic applications.  
5.6 Experimental Section 
Cloning, expression, purification and mutagenesis of CA II: This is described in 
Chapter 3. 
Crystallization of CA II complexes: The CA II crystals were grown using the sitting 
drop vapor diffusion method at 18 °C by mixing the protein solution (5 µl: ~10 mg/ml) 
with well solution (5 µl: 2.75 M (NH4)2SO4, 50 mM Tris-HCl pH 8.0). After a few 
days the crystallization drops were seeded with a seeding solution from old CA II 
crystals. Crystals appeared within 2 – 4 weeks in space group P21 and took up to 
2 months to reach their maximum size. Complex structures were obtained by 
cocrystallization or soaking of the enzyme with the building blocks (1 mM). For 
cryoprotection, crystals were briefly soaked in mother liquor containing 25% glycerol.  
Data collection, phasing, and refinement: The data sets were collected at the 
synchrotron BESSY II in Berlin/Germany on PSF beamline 14.2 (PDB codes: 3KIG, 
3KNE). Data were processed and scaled with Denzo and Scalepack as implemented in 
HKL2000 (Otwinowski, Minor et al. 1997). The structures were determined by the 
molecular replacement method with Phaser (Storoni, McCoy et al. 2004) with our first 
inhouse CA II-H64C structure as search model. Refinement was continued with CNS 
(Brünger, Adams et al. 1998) and SHELXL-97 (Sheldrick, Schneider et al. 1997). For 
each refinement step at least 10 cycles of conjugate minimization were performed, 
with restraints on bond distances, angles, and B-values. Intermittent cycles of model 
building were done with the program COOT (Emsley and Cowtan 2004). The 
coordinates have been deposited in the PDB (http://www.rcsb.org/pdb/) with the 
following access codes: 3KIG, 3KNE. The statistics are shown in the Appendix 13.1. 
HPLC-MS analysis: For HPLC-MS measurements 10 µl of the CA II-H64C mutant 
(75 µM), 5 µl DMSO, 10 µl DTT-solution (500 µM), 0.5 µl azide (100 mM), and 
0.5 µl alkyne (100 mM) was diluted to a final volume of 50 µl with buffer (50 mM 
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Tris-HCl pH 7.8). The samples were incubated at different temperatures (20 °C – 
55 °C) between 12 and 144 hours. After incubation the sample solutions were pre-
purified by size-exclusion chromatography (Illustra AutoSeq G-50 columns – GE 
Healthcare) to separate from excess substrates to avoid undesired side reactions. 
Complete desalting of the protein was achieved by HPLC using an Agilent 1100 
system, samples were applied to a monolithic 50/1 ProSwift RP-4H column (Dionex). 
Desalted protein samples were eluted by the following gradient of buffer A 
(water/0.05% formic acid) and buffer B (acetonitrile/0.045% formic acid) at a column 
temperature of 40 °C and a flow rate of 0.2 mL/min: Isocratic elution with A (5%) for 
two minutes, followed by a linear gradient to B (95%) within 8 minutes and holding B 
(95%) for additional 4 minutes. Online mass spectrometric analysis was done with a 
Qstar Pulsar I mass spectrometer (Applied Biosystems) equipped with an ESI source. 
Measurement parameters were as follows: DP1 75, FP 265, DP2 15, CAD 2, GS1 35, 
CUR 25. The applied voltage was 5000 V. Positive ions within the mass range of 500-
2000 m/z were detected. For better performance, the “enhance all” mode was 
activated. 









 (RuCl2*DMSO4) were added before incubation. Cu
+
 was gained by adding 
five-fold excess of ascorbic acid to a Cu
2+
 solution. We applied metal ion 
concentrations ranging from 10 µM to 1 mM. At concentrations above 40 µM the 
samples often showed spectra which were difficult to interpret most probable due to 
denaturation. To analyze the impact the metal ions develop on the mutant without any 
building block, we performed initial measurement by incubating CA II-H64C with 
each metal ion solution. In case of Cu
+
 we observed in several samples an additional 
mass peak which shows the size of the mutant reduced by a mass of 35 Da. This by-
product is dependent on the reaction time and the applied temperature and its 
occurrence increased with raised concentrations along solvent evaporation. We assign 
these changes to some redox instabilities of the protein upon exposure to Cu
+
 ions.  
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6 Saccharin Inhibits Carbonic Anhydrases: Possible Explanation for 
its Unpleasant Metallic Aftertaste 
6.1 Introductory Remarks 
This chapter has been published in Angewandte Chemie. In the following the original 
text is depicted. The present study was accomplished in cooperation with Karen 
Köhler, Alexander Hillebrecht and Alessio Innocenti. The crystal structure 2Q38 has 
been contributed to this publication. The same structure has been used as a starting 
point for a tethering approach on carbonic anhydrase II (Chapter 7).  
6.2 Introduction 
Saccharin is the oldest artificial sweetener, discovered by serendipity in 1879 by 
Fahlberg and Remsen (Fahlberg and Ira 1879). About 450 times as sweet as sucrose, it 
displayed a very important discovery, particularly for diabetics. Commercialization 
started shortly after its discovery and became increasingly popular in recent years as 
calorie-free sugar surrogate. Blended with cyclamate, it receives huge success, e.g. 
sold as „Sweet „n Low‟. Saccharin is not only known for its extreme sweetness, but 
also for a bitter and metallic aftertaste. Even though there have been worries about its 
safety since its introduction, particularly in the 60ties and 70ties, speculations about its 
putative carcinogenicity have been put forward. Obviously at normal doses no clear 
evidence for a causal correlation of saccharin consumption and health risks for humans 
could be demonstrated (Weihrauch and Diehl 2004). 
Saccharin is applied as its sodium salt. Chemically it represents a sulfimide with a 
lactame and cyclic sulfonamide moiety. The latter functionality is responsible for the 
acidic character of the molecule and suggests its potential to interact with the zinc ion 
at the floor of the binding pocket of carbonic anhydrases. The family of carbonic 
anhydrases is an important class of ubiquitously present proteins distributed over many 
compartments and organs of our body. At present 15 isozymes have been characterized 
(Supuran 2007) (presently 16 s. Chapter 1.1). They all catalyze the same reaction: the 
fixation of carbon dioxide by water to bicarbonate. As such, the different carbonic 
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anhydrases are involved in various essential tasks, e.g. CO2 transportation, pH 
regulation or delivery of C1 building blocks in biosynthesis (Supuran, Scozzafava et 
al. 2003). 
6.3 Results 
We determined the inhibition profile (Khalifah 1971) of saccharin against a panel of 
different carbonic anhydrase isoenzymes. Surprisingly enough, the compound shows 
up to nanomolar inhibition of some members of this protein family (Table 6.1). 
Compared to the classical and therapeutically well-established CA inhibitor 
acetazolamide (AAZ) and other sulfonamides, such as furosemide, 
hydrochlorothiazide, or topiramate (TPM), saccharin shows remarkable selectivity 
discrimination among the different isoforms. This fact is in particular impressive as all 
CAs possess largely conserved catalytic centers and medicinal chemists have to fight 
hard to equip their development compounds with a sufficient selectivity profile. With 
respect to the ubiquitously distributed CA II saccharin shows low micromolar 
inhibition. This made us confident to embark into the structure determination of 
saccharin in complex with carbonic anhydrase II (Figure 6.1, crystal data 13.1). 
Saccharin coordinates, most likely in deprotonated state, with its nitrogen to the 
catalytic zinc producing a flattened distorted tetrahedral environment at the metal 
center. The nitrogen itself adopts a pyramidal local environment and prolongated along 
the assumed lone pair direction, the oxygen atom Oγ of the Thr199 side chain is found. 
The mutual distance of 3.3 Å advocates for a weak H-bond formation, however, the 
latter oxygen atom is also in H-bond donor distance of one carboxylate oxygen of 
Glu106 (2.5Å). One oxygen of the neighbouring sulfoxy group expands the 
coordination at zinc towards distorted bipyramidal geometry (3.1 Å), whereas the 
second oxygen forms a weak hydrogen bond to the backbone NH group of Thr199. 
The lactam carbonyl oxygen is in hydrogen-bond distance to Thr200 Oγ. Furthermore, 
it forms a hydrogen bond to an active site water molecule. Another peculiarity 
indicated by the present structure is the incorporation of a putative second zinc ion to 
the active site. His64 involved in shuttling protons in and out of the catalytic site is 
found distributed over two conformations. The first conformer is superimposed by a 
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strong density peak that could be refined as a second partially populated zinc ion 
(67%). It coordinates to His64 Nδ in the second conformer, the backbone NH of the 
same residue and the backbone carbonyl group of Asn62. Furthermore, two water 
molecules complete the coordination sphere of this second zinc ion. Zinc ions are 
prevalently available, usually in micromolar concentration, thus they can be picked-up 
from the buffer conditions and incorporated into the structure.  
 
Figure 6.1 Crystal structure of CAII Saccharin complex. (a) Binding site of carbonic anhydrase II 
(catalytic residues C, N, O, S) with bound saccharin (C, N, O, S, difference electron density (blue) 
contoured at 3 ζ). The picked-up active-site water is shown to the right as red sphere. (b): Crystal 
structure from the left (protein residues: C, N, O, S; saccharin (C, N, O, S) and active site water (red 
sphere), zinc (violet sphere)) with superimposed residues mutated in the other isoforms: His200 (C, N, 
O, S, CA I), Val200 (C, N, O, S, mCA XIII), Ser65 (C, N, O, S, CA VII), Leu65 (C, N, O, S, CA Va), 
Thr65 (C, N, O, S, CA XIV). 
On the basis of the present structure determination, it is tempting to speculate about the 
impressive selectivity discrimination of saccharin among the different isozymes. 
Nearly exclusively, the well-established and clinically approved CA inhibitors exhibit 
a terminal exocyclic sulfonamide, sulfamate or sulfimine functionality (Abbate, 
Supuran et al. 2002). In contrast, saccharin shows a cyclic structure and its lactam 
carbonyl group in the five-membered heterocycle manifests an exclusive feature not 
given in the other usually considered inhibitor skeletons. Saccharin shows moderate 
inhibitory potency towards CA II, but nanomolar binding is recorded for CA VII. As 
no crystal structure is available for this isoform, a homology model retrieved from the 
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Swiss-Model Repository was used.
4
 Interestingly, at the far end of the binding pocket 
in the vicinity of the lactam carbonyl oxygen an alanine residue is replaced by a serine 
(Figure 6.1b). In the crystal structure of the saccharin CA II complex a water molecule 
is observed which is ideally placed to mediate a contact between the lactam carbonyl 
and the serine Oγ. This additional contact is likely to enhance ligand binding. In a 
recent study on aldose reductase we could show that an inhibitor which picks-up a 
contact-mediating water molecule gains a significant affinity advantage over a closely 
related ligand (Steuber, Heine et al. 2007). The latter one lacks formation of a similar 
contact to an incorporated interstitial water molecule. Interestingly, a sequence 
alignment shows that this Ala/Ser replacement is also given in CA I, CA IV, CA Vb, 
CA IX, CA XII and murine CA XIII.  
Table 6.1 Inhibition data of the clinically used compounds acetazolamide (AAZ), 
topiramate (TPM), furosemide and hydrochlorothiazide together with saccharin against isozymes 
I – XIV (stopped-flow, CO2 hydrase method (Khalifah 1971)). 
 
Also CA IX and XII show enhanced saccharin binding, whereas for CAI and CA XIII 
a dramatic drop in affinity is observed. In the latter two isoforms Thr200 is replaced by 
either His200 or Val200. Both require significantly more space next to the lactam 
                                                 
4
 http://swissmodel.expasy.org/repository 
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carbonyl group. Thus, they are expected to produce steric conflicts with the bound 
saccharin. A dramatical drop in affinity can be expected. Also in CA Va weak 
inhibition is observed. Here, the crucial Ser to Ala replacement is exchanged by a 
spatially more demanding Leu. In addition, this residue would be inadequate to 
promote a water-mediated contact. As the Ala mutation, this residue will be 
detrimental for potent saccharin binding. Finally, also CA VI and CA XIV are 
remarkably inhibited by saccharin. Interestingly, they possess a Thr residue at the 
position of Ala65 in CA II. This residue should be equally well suited to pick-up a 
water-mediated contact from the ligand.  
The question arises whether the observed potent in-vitro inhibition of some of the CA 
isoforms has any pharmacological consequences, e. g., in terms of desired or undesired 
cross-reactivities or side effects. Saccharin is expected to activate the sweetness-
sensing receptors on the tongue. Apart of this function, an ideal sweetener should pass 
the intestinal system without an unwanted penetration into the blood stream or even 
passing the blood brain barrier. CA VII, the most strongly inhibited isoform, is located 
in the brain. Unlikely, considering the acidic character of saccharin, the compound will 
arrive in the brain at significant concentration by passive transportation. Only under 
acidic conditions of the stomach a considerable amount of saccharin will be present in 
the uncharged more hydrophobic state. In this state some passive penetration might be 
given, however absorption at pH 6-8 is rather unlikely. Nevertheless, it has been 
shown that saccharin is nearly completely absorbed from the gut and rapid elimination 
in the urine occurs as unchanged compound (Renwick 1985). In rat a distribution of 
saccharin across most organs has been described. A possible active transport has been 
suggested (Renwick 1985). Obviously, the compound is chemically rather inert and 
not easily metabolized in vivo. Nevertheless, the decrease in plasma levels after oral 
dosing has been reported as slow and limited by the rate of absorption from the gut 
(Renwick and Sweatman 1979). It remains, however, speculative, whether this latter 
observation can be attributed to putative inhibition of different CAs present in various 
compartments of the organism. Recently, CA VI, the only secreted form of CAs has 
been discussed for its putative involvement in olfaction, taste and pH regulation in the 
oral cavity (Charles, Antonio et al. 2006). As such, it contributes to the acidification of 
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the enamel pellicle and speculations about its inhibition with respect to caries 
protection have been put forward (Kimoto, Kishino et al. 2006; Nishimori, Minakuchi 
et al. 2006). Saccharin possesses an unpleasant bitter or metallic aftertaste, a property 
shared with clinically approved systemic carbonic anhydrase inhibitors (Supuran and 
Scozzafava 2000). This may in fact be due to the inhibition of the salivary CA VI for 
which also saccharin shows submicromolar inhibition. Nevertheless, as the various 
CAs are repeatedly discussed as putative targets for drug therapy with respect to 
diuresis, glaucoma, tumor suppression, or obesity, saccharin might tell the medicinal 
chemists a lesson how to equip their molecules with additional features to achieve 
impressive selectivity discrimination. 
  




7 Tethering Approach on Carbonic Anhydrase II Supported by Pre-
selecting Computational Docking Experiments 
7.1 Introductory Remarks 
The following chapter was prepared for submission to a scientific journal. This study 
was performed in cooperation with Dr. Sascha Brass and Dr. Uwe Linne. The 
compounds for the tethering experiments were synthesized by Dr. Sascha Brass and 
Thomas Kronenberger. All HPLC-MS samples were analyzed by Dr. Uwe Linne from 
the Chemistry Department.  
7.2 Introduction 
The amount of well-characterized proteins is rapidly increasing due to multiple 
methodological improvements in modern molecular and structural biology. This 
enormous body of information is available and demands adequate techniques that can 
be used to screen and validate these targets for the development of drugs. In the last 
decades high-throughput screening (HTS) increasingly provided first hits as putative 
candidates for a subsequent lead optimization (Klebe 2009). At first up to a several 
million compounds are tested for binding to the target protein of interest. Upon 
discovery of an active compound a second in-depth screening is performed hopefully 
providing compounds of narrow chemical space to further profile and validate binding 
of the initial hit. Such data assists the hit validation step. Once the relevance of a 
detected hit can be approved it is taken to further optimization through iterative drug 
design cycles. Meanwhile, HTS has provided for various therapeutic applications 
valuable hits that could be translated into blockbusters. However, besides these 
benefits, HTS also suffers from certain disadvantages and is not always the gold 
standard.  
The screening of large compound libraries under high throughput conditions requires 
an assay that reliably and effectively delivers affinity data for each tested candidate. 
This demands high financial resources to produce sufficient amount of the target 
protein, either isolated from the parent organism or recombinantly produced, a 




sufficiently large compound library and appropriate automated test facilities. Besides 
these investment costs, there are also methodological limitations inherently related to 
HTS. The compounds detected by HTS usually reveal affinities in the micromolar 
range. To improve the interactions with the target protein structural changes are 
necessary, e.g. by the addition of further functional groups. This easily leads to 
molecular masses exceeding beyond 500 to 600 Da, which is usually defined as a 
border line for sufficient bioavailability. Therefore, a selected hit has often to be 
reduced in size prior to further optimization which parallels an initial loss in affinity. 
The FDA excludes certain functional groups, such as phenols, therefore current 
research tries to avoid such groups in detected hits to follow up. "Ligand efficiency" 
allows first rating of identified hits. It is calculated by dividing the binding affinity of a 
compound by its number of non-hydrogen atoms (Hopkins, Groom et al. 2004). The 
ligand efficiency of screening hits often shows that small compounds provide a better 
value and accordingly suggests them as a favorable starting point compared to larger 
compounds exhibiting the same affinity. The ligand efficiency therefore captures better 
the actual potency of discovered hits and ranks them with respect to the space left for 
further optimization (Hopkins, Groom et al. 2004; Abad-Zapatero and Metz 2005). 
Keeping these requirements for screening hits in mind, consideration about compound 
libraries have been extended toward smaller and smaller size exceeding the range of so 
called fragments. All fragment-based experimental approaches to lead discovery 
attempt to identify low molecular weight (50 - 250 Da) molecules with high intrinsic 
binding affinity for the target. The affinity of these hits typically range from high 
micromolar to low millimolar binding. A crucial step in fragment-based lead discovery 
is an appropriate library design. There are numerous attempts for such design which 
vary in a number of parameters (Lyne 2005). Researchers first emphasize on molecular 
weight, cLogP distributions, numbers of hydrogen bond donors and acceptors and the 
number of rotatable bonds. In our group such a library was developed by Tobias Craan 
constrained by the following parameters: cLogP ≤ 3; heavy atoms < 20; ring systems = 
1; non-ring atoms ≥ 1; free rotatable bonds ≤ 3 and molecular weight 120 – 230 Da (in 
case of a bromide or sulfonamide group present also exceeding this threshold). Slight 




deviations in these parameters can result in drastic changes of chemical properties of 
the library potentially excluding important parts of chemical space.  
The screening of fragments against a given target can be performed by different 
methods. Nuclear magnetic resonance - (NMR) and X-ray crystallography are methods 
that reveal initial structural information about the binding mode of putative hits in the 
binding pocket of the target protein. Inhibition assays, ThermoFluor
®
 assay technology 
and surface plasmon resonance (SPR – Biacore) technology provide additional 
information about the affinity of the fragments towards the enzyme (Ericsson, Hallberg 
et al. 2006). S. Fesik et al. first reported successful detection and utilization of 
fragments in drug design which became famous as the SAR by NMR approach 
(structure-Activity-Relationships by Nuclear Magnetic Resonance) (Shuker, Hajduk et 
al. 1996). In their study, two-dimensional, isotope-edited NMR spectroscopy was used 
to detect two fragment leads that bind to two proximal sites about a protein surface. 
Using three-dimensional structural information on the bound ligands, the fragments 
were successfully joined together to produce a high affinity ligand. This so called 
additivity in binding suggests assembly of drug candidates from pieces, which offers a 
tremendous combinatorial advantage compared to the screening of drug size molecules 
(Erlanson, Wells et al. 2004). Linking two different fragments taken from a 1000 
entry-large library in binary combinatorial fashion can cover a virtual space of 
1,000,000 compounds. Apart from this combinatorial advantage, the main benefits of 
fragment-based drug discovery methods are the following: better access to small 
pockets; synthetic accessibility; good solubility and simple handling of such a small 
library. Interestingly enough, in several cases, potent leads were produced using 
fragment-based drug design even though a conventional high-throughput screen failed 
to produce prospective leads (Hajduk 2006). This indicates that HTS libraries can 
possibly lack sufficient chemical diversity for certain targets while a fragment-based 
approach can more easily cover the required diversity in chemical space. Many 
pharmaceutical companies appreciate this fact and extended their efforts to both the 
depth and breadth of chemical diversity in their corporate compound repositories 
(Leach and Hann 2000; Jacoby, Schuffenhauer et al. 2005). Considering these aspects 




a combination of different techniques such as fragment-based approaches and HTS 
appears most advisable to perform a successful screening for a novel drug target.  
However, there are also some major pitfalls in fragment-based lead discovery. As 
fragments experience rather low affinity to the target enzyme, they frequently remain 
undetected in an assay. To measure the affinity of a fragment properly, researchers 
have to apply high concentrations of the fragments in such an assay. This might lead 
on the one hand to solubility problems and on the other hand to false positives. 
Shoichet and colleagues have demonstrated that a number of molecules can act as 
"promiscuous binders" at a wide range of targets, probably by forming extensive 
aggregates (McGovern, Caselli et al. 2002). Furthermore, the evaluation of the binding 
mode of fragments within the binding pocket of the target protein can be quite difficult 
since crystallization conditions of a protein are highly dependent and extremely 
sensitive to externally modified properties for example added high ligand 
concentrations. Furthermore, protein crystals often do not survive harsh soaking 
conditions. There are numerous examples for different fragments that have 
successfully been soaked into protein crystals at concentrations about 50 - 100 mM. 
Jürgen Behnen has identified diverse probe molecules that can be used to map the 
binding pocket for favorable interaction sites. However, even in case of a successful 
soaking or cocrystallization experiment such cocrystal structure often lacks sufficient 
difference electron density for the bound fragment. This can result from various 
reasons, e.g. the concentration is not adequate or the fragment adopts multiple 
conformations resulting in low occupancies and therefore the obtained difference 
electron density can hardly be interpreted. 
To circumvent these problems and still benefit from all the described advantages of a 
fragment-based approach the so called "tethering" method has been developed by 
J. Wells and coworkers of the Sunesis company in San Francisco (Erlanson, Wells et 
al. 2004). Only 30 to 50 mg of enzyme are needed for the screening of 10,000 
compounds. This method allows the detection of fragments which develop only weak 
affinity towards the target enzyme and cannot be identified by common inhibition 
assays. Additionally, it facilitates the generation of 3D structures of the protein 
inhibitor complex by X-ray crystallography. Tethering relies on the reversible covalent 




bond formation between a fragment and a protein of interest. To apply the method, a 
cysteine residue is required to be present within or in close vicinity to the active site 
(Figure 7.1). A distance of 5 – 10 Å to the site of interest appears most favorable. In 
case there is no cysteine residue present in this region of the protein it can be 
introduced by site-directed mutagenesis. 
Thereafter, the enzyme is tested against a library of disulfide-containing fragments. In 
a screening campaign the target protein is incubated with a mixture of 5 to 10 entries 
from such a fragment library under mild reducing conditions. In principle, 
appropriately placed cysteine thiole groups should be able to form a disulfide with 
each of the exposed fragments, and the exchange should occur rapidly. If one of the 
fragments has inherent affinity for the protein, the thiole-disulfide equilibrium is 
shifted in favor of the disulfide-protein complex with this fragment.  
 
Figure 7.1 Schematic presentation of the tethering approach. A cysteine-containing protein is 
equilibrated with a disulfide-containing mixture in presence of a reducing agent, such as 2-
mercaptoethanol. Most of the library members will have little or no inherent affinity for the protein, and 
thus by HPLC-MS analysis of the equilibrium will lie toward the unmodified protein. However, if a 
library member experiences inherent affinity for the protein, the equilibrium shifts toward the modified 
protein. After affinity improvement through decoration with favorable functional groups the fragment 
can be released from the leash. 
Since the substance is covalently attached to the enzyme the modification can easily be 
detected by HPLC-MS. With respect to the mass spectrometric experiments 
considering the reaction of the protein with one single disulfide, four deviating mass 
peaks can principally be expected: unreacted protein, protein + reducing agent, protein 
+ fragment, protein and amine (Figure 7.2). To decide whether any of the fragments in 
the applied mixture has reacted, the mass of each fragment needs to be unique and 
favorably deviating by 5 to 10 mass units. Wells et al. have shown that identification 
of a single compound out of a pool of 100 different fragments is achievable (Erlanson, 
Braisted et al. 2000). However, mixtures of 10 compounds appear to be most 












Considering the fact that the probability of the formation of disulfide bond between 
fragment and protein depends on the binding affinity of the non-covalent contact, the 
success rate of such screening can be adjusted to some degree by the concentration of 
the added reducing agent (e.g. 0.1 – 1%). Gradually increasing the concentration will 
successively reduce the formed disulfide bonds between enzyme and fragments and 
most likely the bond to the fragment with strongest affinity will remain intact up to the 
highest concentration. Such a sequential analysis to all successfully tethered fragments 
will help to rank them in terms of binding affinity. At Sunesis, Wells et al. have 
published successful tethering for more than 10 different drug targets (Erlanson, Wells 
et al. 2004). To mention a few examples, in case of interleukin-2 (IL-2) a protein-
protein interface was targeted by the tethering approach. The chemical information that 
the experiment provided was applied to existing hits to generate higher-affinity 
compounds (Braisted, Oslob et al. 2003). Initial tethering hits found for thymidylate 
synthase could be optimized to result in fragments that also bind sufficiently strong to 
avoid the covalent attachment (Erlanson, Braisted et al. 2000). Finally, for proteins 
which only exhibit catalytically relevant cysteine residues close to the active site as 
attachment point; however, which have to remain untouched, Wells and coworkers 
suggested introduction of thiole groups beyond the binding pocket to hook up an 
extender for fragment coupling.  
 
Figure 7.2 Possible modifications of the protein that can occur along the tethering experiment. 
The protein mass can be increased by the mass of the fragment, the mass of an amine from the disulfide 
counterpart or the mass of a DTT molecule. 
Tethering provides many opportunities in the field of drug design particularly 
facilitating the identification and the design of fragments. Compound libraries with 
more than 10,000 entities have been synthesized at Sunesis to cover chemical space 
rather exhaustively. Major commitment with respect to the synthesis resources are 
required which appears rather unpractical in academic research. Therefore, we decided 
to move part of the library selection into the computer and performed docking 
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experiments to select the most promising fragments for synthesis from a large virtual 
library. The disulfides composing the docking library are reduced to a number feasible 
for synthesis and subsequent HPLC-MS and crystallographic analysis. For our case 
study carbonic anhydrase II was selected as target protein.  
The crystal structure of CA II in complex with Saccharin was recently determined in 
our group and we could show that two Saccharin molecules bind to CA II (Köhler, 
Hillebrecht et al. 2007). Apart from a molecule coordinating to the active site zinc ion 
a second molecule binds to the surface of CA II close to the catalytically relevant 
proton shuttle His64 (PDB-code: 2Q38). The sulfolactam moiety of Saccharin is fixed 
via an H-bond network, partially mediated by three water molecules, to six protein 
residues, among others His64. It is well established that His64 can adopt multiple 
conformations (in and out conformation) thus being able to shuffle a proton from the 
catalytic center to the protein solvent (Tu, Silverman et al. 1989; Nair and Christianson 
1991b; Liang, E. et al. 1993; Smith, Alexander et al. 1994). Apart from His64, also 
His3, His4, His10, His15 and His17 are part of an extended histidine cluster which 
seems to perform the proton transfer. As this step is rate-determining for the catalytic 
turn-over (Steiner, Jonsson et al. 1975) the binding of compounds such as Saccharin in 
this area might take influence on the reaction rate. In consequence this additional 
binding site might emerge as interesting target site for drug design to modulate the 
properties of CA II. Interestingly enough, it has recently been shown that Timolol, 
which exhibits activating effects on CO2 hydration in CA II, is proposed to bind to this 
site, similarly to Saccharin (Sugimoto, Ikeda et al.). Evidence for this assumption was 
provided by docking experiments, which were performed with the docking tool 
Autodock (Morris, Goodsell et al. 1998). The calculated binding mode, however, 
deviates to some degree from that of well known CA II activators, e.g. histamine or 
L-histidine. Consistent with the suggested Timolol docking pose, His64 also 
participates in the coordination of these compounds. Inconsistent with the proposed 
binding mode of Timolol, histamine and L-histidine are further coordinated by Asn67, 
Gln92 and via a water network to the zinc ion located in the active site of CA II 
(Briganti, Mangani et al. 1997; Scozzafava and Supuran 2002; Temperini, Scozzafava 
et al. 2005; Temperini, Scozzafava et al. 2006a; Temperini, Innocenti et al. 2007). This 




described activator binding pocket is proposed to be an important binding site in CAs, 
in addition to the metal center to coordinate the nucleophile OH
-
 and the hydrophobic 
pocket which recognizes the substrate (Briganti, Mangani et al. 1997).   
In this study, we performed a tethering approach on CA II to identify fragments with 
inherent affinity to the protein. Therefore, a cysteine residue was mutationally 
introduced at the entrance of the active site, replacing His64. This setup should allow 
exploring the different binding pockets of CA II: the active site zinc ion, the 
hydrophobic pocket for substrate recognition, the binding site to host CA II activators 
and the recently discovered Saccharin binding area at the CA II surface. A fragment 
library which was designed by a computational docking screen was incubated with the 
mutant and putative disulfide tethering was evaluated by HPLC-MS analysis. 
Fragments identified by this mass spectrometry study should be subsequently 
characterized with respect to their binding mode and analyzed in terms of activating or 
inhibiting properties.  
7.3 Results  
At the entrance of the CA II binding pocket His64 was exchanged by a cysteine 
residue using site-directed mutagenesis. Prior to the initial tethering procedures a 
control experiment was performed to verify that Cys64 is modified by such an 
approach. Apart from the mutationally introduced Cys64, CA II exhibits a second 
cysteine residue at the protein surface (Cys205). Therefore, the protein was incubated 
with Ellman´s reagent (5,5´-Dithiobis(2-nitrobenzoic acid) - DTNB), a compound that 
binds virtually to any accessible cysteine residue at the protein surface (s. experimental 
section 7.4). This experiment revealed that primarily one cysteine residue is modified 
by DTNB while a second cysteine experiences compound tethering at increased DTNB 
concentrations. Tryptic digestions revealed that both residues are accessible for DTNB 
modification. We believe that most CA II-H64C mass modifications observed as a 
response to our tethering experiments only occur at the Cys64 residue as attached to 
this residue the fragments can experience interactions to the different binding pockets. 
A tryptic digestion which in principle can elucidate which cysteine has been modified 




is not necessary in the present case. Nevertheless, for all promising fragments the exact 
binding mode has to be determined via protein crystallography.   
In order to allow the covalent attachment of fragments to a cysteine residue, a thiole 
group has to be coupled to each candidate fragment. Therefore, an appropriate 
synthetic route had to be established which allows fast and reliable coupling of a broad 
range of diverse fragments. We applied the synthesis strategy similarly suggested by 
Wells et al. (Erlanson, Braisted et al. 2000). A cystamine scaffold can easily be linked 
to putative candidate fragments and additionally assures sufficient solubility in case 
increased compound concentrations are required, particularly if fragments are tested in 
terms of well assembled cocktails.   
 
Figure 7.3 Synthesis of tethering compounds. (a) Synthetic route to asymmetric disulfides. (b) 
Tethering Scaffolds. R: Fragment (Carboxylic acid); Red: Linker – diverse length with different scope; 
Green: Fragment counterpart for better solubility. 
Insufficient compound solubility is improved by protecting one of the two amine 
functionalities of the cystamine skeleton along the synthesis (Figure 7.3). The (CH2)x-
linker (x = 2-4) between candidate fragment and thiole expands the leash of the tether 
in order to explore the different cavities in CA II with appropriate linker distance 
(s. experimental section 7.4). Almost any carboxylic acid can be attached to cystamine 
by this synthesis. This facilitates the generation of chemically diverse libraries as 
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Nevertheless, to avoid costly and time consuming synthesis of large compound 
libraries a pre-selection via docking experiments has been accomplished. A dataset of 
commercially available carboxylic acids, generously provided by Dr. Christof 
Wegscheid-Gerlach, represented the starting point of our library design 
(s. experimental section 7.4) (Gerlach, Münzel et al. 2007). For the docking 
calculations the carboxylic acids were computationally attached to the thiole group 
with the desired linker, attached to Cys64 and docked into CA II using the program 
GOLD. Each generated docking pose was evaluated by a scoring function and 
subsequently ranked according to their docking score. With regards to this ranking, the 
most promising candidate fragments were selected by visual inspection, in the 
following synthesized and applied in the tethering experiments. 
Altogether three fragment libraries were synthesized and evaluated for binding to CA 
II by means of HPLC-MS and in selected cases by protein crystallography 
(s. Appendix: tethering-series 1-3). The first series was composed of carboxylic acids 
available on stock in-house without any pre-selection considerations. This series was 
synthesized as symmetric disulfides as the more cumbersome asymmetric synthesis 
was not conceived for our initial experiments. However, candidate fragments from this 
library often showed poor solubility according to their overall hydrophobic properties. 
Therefore, only reduced compound concentration could be achieved in solution which 
can take significant impact on the scope of our experiments. The second series was 
guided by the results of our docking experiments with CA II. They suggested 14 
promising and readily available fragments for synthesis with different linker lengths. 
In parallel a third series which was synthesized as originally planned for tethering 
experiments with another protein target (TGT) was also examined.  
7.3.1 HPLC-MS Experiments 
In order to elucidate the affinity of the candidate fragments to CA II by HPLC-MS the 
enzyme was incubated with the disulfide under reducing conditions (1 mM DTT) for at 
least 1 hour at 20 °C. Subsequently, each sample was purified by size exclusion 
chromatography to remove any unbound fragment and upon denaturation the protein 
mass was determined.  




In a typical mass spectrum of accordingly treated samples the following protein 
species can be observed: CA II-H64C-unmodified, CA II-H64C-fragment-complex 
and CA II-H64C-amine-complex (synthetic counterpart; Figure 7.3, green portion). To 
speed-up the screening attempts and to allow for a rough affinity scan under 
competitive conditions we did not only screen individual disulfides but also 
appropriately assembled mixtures or "screening cocktails". According to the applied 
fragment or fragment cocktails mass shifts of the amine-tethered complexes with a 
(CH2)2- (76 Da), (CH2)3- (90 Da) and (CH2)4-linker (104 Da) could be detected (Figure 
7.4). As the amine fragments show most likely only weak affinity to the target protein, 
the occurrence of such mass peaks indicates very limited non-covalent interactions for 
the actual candidate fragment(s) and the protein in the studied cocktail samples.  
 
Figure 7.4 Example for HPLC-MS analysis of CA II-H64C tethered with a fragment cocktail. 
CA II-H64C: 29729 Da; CA II-H64C + Amine (CH2)3: 29729 Da + 90 Da = 29819 Da; CA II-H64C + 
Amine (CH2)4: 29729 Da + 104 Da = 29833 Da; CA II-H64C + TK094: 29729 Da + 250 Da = 29979 
Da; CA II-H64C + TK108: 29729 Da + 294 Da = 29925 Da. 
The binding affinities of all fragments (series 1 - 3) were evaluated in three different 
HPLC-MS experiments. In the first experiment four to six fragments (minimal mass 
difference of 10 Da) were mixed at concentrations of 200 µM each and incubated with 
CA II-H64C. Thus, the strongest binder in each cocktail could be identified. Each 
candidate fragment was exposed to the protein in two different cocktails to elucidate 
its properties under varying conditions. In a second experiment all compounds were 
examined individually to avoid possibly imposed solubility problems in the cocktail or 
any undesired fragment-fragment interactions. Apart from the mentioned amine-
tethered byproducts, the HPLC-MS spectra showed peaks for the unmodified protein 






















Amine-4CH2: 104 Da 




complexes depends on the relative binding affinity of the applied candidate fragments 
in the composed sample. This strategy allows ranking of all compounds according to 
the rate by which the protein has been modified. In a third experiment each fragment 
was incubated with CA II-H64C under the before-mentioned reaction conditions, 
however now in the presence of the reference compound BO333 (formula p. 100) - a 
potent sulfonamide-disulfide-fragment - which should directly interact with the active-
site zinc ion. Thereby, the relative ratio of complexes formed as CA II-H64C-fragment 
to CA II-H64C-BO333 provides an additional option to estimate the relative 
compound affinity. The results of all these experiments served as basis for our 
considerations about the affinity of each fragment and were used for a final ranking of 
all tested compounds.  
HPLC-MS I: In Table 7.1 the results of the first series of experiments are listed. 29 
disulfide cocktails for tethering have been produced (column 1). Each compound has 
been present for testing the affinity towards CA II-H64C in at least two independent 
cocktails. Thereby, deviating rates of tethering can easily be detected. For each 
cocktail the percentages of fragment-tethered, amine-tethered and unmodified protein 
are given (column 4). In addition, the protein modification achieved in the second 
cocktail with the same compound is listed in column 5/6. If a compound name is 
indicated in bold it shows that this ligand originates from the first cocktail otherwise it 
indicates the second cocktail as the source (column 2). In red deviating modification 
rates detected in both cocktails are shown. From all cocktails the fragments with the 
highest affinity are highlighted in yellow.  
Which impact does the individual composition of the cocktail take on the tethering 
results? In general, similar rates can be observed for each fragment in both differently 
composed cocktails. A compound which experiences increased affinity to the target 
protein in the first cocktail is in general also identified in a second cocktail. Similarly, 
weak or non-binding fragments consistently fail in all studied cocktails. Nevertheless, 
also deviating results can be observed in both cocktails (red font). This most likely 
depends on very highly potent compounds present in the sample such as, e.g. SB114 in 
mix9 and mix24. In mix9, compound SB114 can clearly be identified as highly potent 




fragment as 65% of the protein is tethered. In addition, the amount of amine-tethered 
protein is low (15%). Nevertheless, in the second cocktail, mix24, the same fragment 
does not bind to CA II-H64C at all. This assignment as a "false negative" arises from 
the fact that SB102 is present in mix24. SB102 has been identified as one of the most 
potent fragments of all tethering series, therefore prohibiting binding of any other 
compounds to CA II-H64C. This example shows that the composition of a cocktail can 
take drastic impact on hit identification. Nevertheless, any information about the 
affinity of the other fragments present in the same sample helps to deconvolute such 
situations. 
There are also examples of easily detectable compounds, e.g. in mix2. In this sample 
the protein is mainly modified by SB103 as 71% of this protein-tethered species can be 
detected. This strong interaction is confirmed by a second cocktail, mix19. There, the 
same fragment is exclusively covalently attached to the protein (100%). In addition, 
only 0-15% of amine-tethered protein is detected in the sample (mix2).  
In order to elucidate the compound with the highest affinity towards CA II-H64C, five 
strong binders (SB100, SB114, SB103, SB102 and SB227) from cocktails 1-29 have 
been selected and mixed with each other (mix30) (Table 7.2). This sample clearly 
allows a ranking of these compounds. With protein modification of 50%, fragment 
SB103 shows the highest affinity of all.  
In Table 7.3 fragments with different linker length are compared. Compounds which 
have been synthesized with different linker length were mixed. The results show that 
in some cases the compounds seem to bind to the same binding pocket since the 
modification rates are similar. Nevertheless, in mix34 the tethering-rate deviates by 
40% which could indicate that the expanded compound TK108 is increasingly 
hindered from binding into the same area. Most likely, it is sterically impossible for 
this compound to adopt the same orientation as it is possible with the shorter analog. 
Further crystallographic investigations of these samples have to be performed to 
elucidate this question.  




HPLC-MS II & III: In the second and third experiment each compound has been 
tested individually and in competition with the sulfonamide BO333. These 
experiments should allow a ranking of all compounds to estimate their relative affinity 
towards CA II-H64C. The results are listed in Table 7.4. For each compound, the 
percentage of protein-candidate fragment complex, protein-amine complex and 
unmodified protein is shown in columns 2 and 3. In columns 4 and 5 the results from 
competition-experiments with BO333 are displayed. As the sulfonamide experiences 
high affinity to CA II, high yields of protein-fragment complex formation in such 
sample indicates strong binding of the corresponding candidate fragment. Candidate 
fragments with tethering rates of ≥ 50% in the individual experiment and/or rates of ≥ 
25% in the competition experiment were highlighted in yellow. Except for two cases 
(SB124 and SB233) these compounds have also been identified as promising 
candidates in the cocktail experiments. Remarkably, almost all fragments from series 1 
show enhanced affinity even though their solubility is partially poor. This correlates 
with the (CH2)2-linker which will be explained in the crystallographic section.  
Tethering Approach on Carbonic Anhydrase II Supported by Pre-selecting Computational Docking Experiments 
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Mix Compounds Linker Rate 2nd Rate 2nd Mix 
1 SB119 (CH2)2 25% 15% Mix28 
 SB228 (CH2)2 5% - Mix14 
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Table 7.1 Fragment cocktails investigated by HPLC-MS. In each sample the modification in % is 
shown for all fragments and the unmodified- and amine-modified protein. In column five and six the 
results for each compound in its second cocktail is shown. A compound name written in bold font 
indicates its first cocktail and in regular font the second cocktail (2nd column), those with yellow 
background have been selected as the fragments with highest affinity. Red font fragments show diverse 
affinity in both measurements. The different results are dependent on other fragments present in the 
sample. Very high affine compounds are mainly bound and prohibit other compounds in the samples 
from binding to CA II-H64C.  
 
Table 7.2 Fragments with highest affinity have been tested in mix30. SB103 shows the highest 
affinity to CA II-H64C 






































































































































































































Table 7.3 Same fragment with diverse linker lengths. 













































































































































































































The HPLC-MS experiments cannot be applied to give an absolute statement on the 
affinity of each candidate fragment. Still, these in solution experiments can provide 
initial information about the protein-ligand interaction and in most cases reveals 
consistent results in all experiments. In addition, the sum of all experiments provides a 
satisfying overview of such large library in an acceptable amount of time. In order to 
understand the estimated affinity the binding mode of selected fragments should be 
investigated by protein crystallography. All identified candidate fragments should be 
cocrystallized with CA II-H64C and the data sets collected according to a priority list 








Compound Individual Rate Competition 
with BO333 
Rate Structure 
SB095 SB095 100% SB095 55%  
(CH2)2 no modification - no modification -  
 amine - amine  -  
series 1 - - BO333 45%  
SB096 SB096 100% SB096 30%  
(CH2)2 no modification - no modification -  
 amine - amine  -  
series 1 - - BO333 70%  
SB097 SB097 85% SB097 40%  
(CH2)2 no modification 15% no modification -  
 amine - amine  -  
series  - - BO333 60%  
SB099 SB099 - SB099 -  
(CH2)2 no modification 100% no modification -  
 amine - amine -  
series 1 - - BO333 100%  
SB100 SB100 85% SB100 40%  
(CH2)2 no modification 15% no modification -  
 amine - amine -  
series 1 - - BO333 60%  
SB101 SB101 100% SB101 25%  
(CH2)2 no modification - no modification -  
 amine - amine -  
series 1 - - BO333 75%  
SB102 SB102 100% SB102 15%  
(CH2)2 no modification - no modification -  
 amine - amine -  
series 1 - - BO333 85%  
SB103 SB103 100% SB103 55%  
(CH2)2 no modification - no modification -  
 amine - amine -  
series 1 - - BO333 45%  
SB104 SB104 70% SB104 -  
(CH2)2 no modification 30% no modification -  
 amine - amine -  
































































SB113 SB113 65% SB113 40%  
(CH2)2 no modification 35% no modification -  
 amine - amine -  
series 1 - - BO333 60%  
SB114 SB114 100% SB114 65%  
(CH2)2 no modification - no modification -  
 amine - amine -  
series 1 - - BO333 35%  
SB115 SB115 100% SB115 55%  
(CH2)2 no modification - no modification -  
 amine - amine -  












































































































Compound Individual Rate Competition 
with BO333 
Rate Structure 
SB119 SB119 65% SB119 15%  
(CH2)2 no modification 35% no modification -  
 amine - amine -  
series 1 - - BO333 85%  
SB120 SB120 - SB120 -  
(CH2)2 no modification 100% no modification 85%  
 amine - amine -  
series 1 - - BO333 15%  
SB123 SB123 10% SB123 10%  
(CH2)2 no modification 90% no modification 70%  
 amine - amine -  
series 1 - - BO333 20%  
SB124 SB124 - SB124 5%  
(CH2)2 no modification 100% no modification 80%  
 amine - amine -  
series 1 - - BO333 15%  
SB127 SB127 - SB127 -  
(CH2)2 no modification 100% no modification 70%  
 amine - amine -  
series 1 - - BO333 30%  
SB128 SB128 10% SB128 15%  
(CH2)2 no modification 90% no modification 55%  
 amine - amine -  






















SB227 SB227 60% SB227 40%  
(CH2)2 no modification - no modification -  
 amine 40% amine 30%  






















SB229 SB229 80% SB229 30%  
(CH2)2 no modification - no modification -  
 amine 20% amine 30%  
series 3 - - BO333 40%  
SB231 SB231 50% SB231 30%  
(CH2)2 no modification - no modification -  
 amine 50% amine 15%  
series 3 - - BO333 55%  
SB232 SB232 40% SB232 15%  
(CH2)2 no modification - no modification -  
 amine 60% amine 30%  
series 3 - - BO333 55%  
SB233 SB233 25% SB233 20%  
(CH2)2 no modification - no modification -  
 amine 75% amine 45%  
series 3 - - BO333 35%  
TK094 TK094 45% T094 30%  
(CH2)3 no modification - no modification -  
 amine 55% amine 30%  
series 3 - - BO333 40%  
TK095 TK095 50% TK095 30%  
(CH2)4 no modification - no modification -  
 amine 50% amine 25%  


































































































































TK097 TK097 20% TK097 10%  
(CH2)3 no modification 10% no modification -  
 amine 70% amine 45%  
Series 3 - - BO333 45%  
TK098 TK098 5% TK098 5%  
(CH2)4 no modification 80% no modification -  
 amine 15% amine 20%  
series 3 - - BO333 75%  
TK099 TK099 10% TK099 15%  
(CH2)4 no modification 80% no modification 10%  
 amine 10% amine 15%  












 amine 10% amine 10%  
Series 3 - - BO333 45%  
TK101 TK101 7% TK101 7%  
(CH2)4 no modification 93% no modification 73%  
 amine - amine  -  
series 3 - - BO333 20%  
TK102 TK102 - TK102 -  
(CH2)4 no modification 100% no modification 70%  
 amine - amine  -  
series 3 - - BO333 30%  
TK103 TK103 - TK103 -  
(CH2)4 no modification 100% no modification 75%  
 amine - amine  -  
series 3 - - BO333 25%  
TK104 TK104 - TK104 5%  
(CH2)4 no modification 100% no modification 60%  
 amine - amine 5%  
series 3 - - BO333 30%  
TK105 TK105 - TK105 10%  
(CH2)4 no modification 0% no modification 65%  
 amine - amine   
series 3 - - BO333 25%  
TK106 TK106 10% TK106 15%  
(CH2)4 no modification 90% no modification 55%  
 amine - amine -  
series 3 - - BO333 30%  
TK107 TK107 20% TK107 25%  
(CH2)3 no modification 50% no modification 10%  
 amine 30% amine 20%  
series 3 - - BO333 45%  
TK108 TK108 40% TK108 35%  
(CH2)3 no modification 40% no modification 10%  
 amine 20% amine 15%  
series 3 - - BO333 40%  
TK109 TK109 30% TK109 20%  
(CH2)3 no modification 35% no modification 10%  
 amine 35% amine 25%  























































































































































TK112 TK112 35% TK112 25%  
(CH2)2 no modification 10% no modification -  
 amine 55% amine 25%  
series 3 - - BO333 50%  
TK135 TK135 30% TK135 50%  
(CH2)2 no modification - no modification -  
 amine 70% amine 20%  
series 2 - - BO333 30%  
TK136 TK136 50% TK136 30%  
(CH2)2 no modification - no modification -  
 amine 50% amine 25%  
series 2 - - BO333 45%  
TK140 TK140 40% TK140 15%  
(CH2)2 no modification - no modification -  
 amine 60% amine 35%  
series 2 - - BO333 50%  
TK141 TK141 50% TK141 25%  
(CH2)2 no modification - no modification -  
 amine 50% amine 35%  












 amine 75% amine 40%  
series 2 - - BO333 50%  
TK147 TK147 30% TK147 10%  
(CH2)2 no modification - no modification -  
 amine 70% amine 50%  
series 2 - - BO333 40%  
TK148 TK148 90% TK148 35%  
(CH2)3 no modification - no modification 10%  
 amine 10% amine 20%  
series 2 - - BO333 35%  
TK149 TK149 - TK149 10%  
(CH2)3 no modification 100% no modification 35%  
 amine - amine 20%  
series 2 - - BO333 35%  
TK150 TK150 10% TK150 20%  
(CH2)3 no modification 90% no modification 45%  
 amine - amine 10%  
series 2 - - BO333 25%  
TK157 TK157 - TK157 -  
(CH2)3 no modification 100% no modification 45%  
 amine - amine 15%  
series 2 - - BO333 40%  
TK158 TK158 25% TK158 40%  
(CH2)3 no modification 70% no modification 15%  
 amine 5% amine 15%  
series 2 - - BO333 30%  
TK162 TK162 25% TK162 40%  
(CH2)3 no modification 65% no modification 15%  
 amine 10% amine 15%  

















































































































































































TK169 TK169 10% TK169 5%  
(CH2)4 no modification 90% no modification 35%  
 amine - amine 5%  
series 2 - - BO333 55%  
TK170 TK170 95% TK170 20%  
(CH2)4 no modification 5% no modification 25%  
 amine - amine 5%  
series 2 - - BO333 50%  
TK171 TK171 60% TK171 10%  
(CH2)4 no modification 25% no modification -  
 amine 15% amine -  
series - - BO333 90%  
TK173 TK173 5% TK173 10%  
(CH2)4 no modification 95% no modification 35%  
 amine - amine 5%  
series 2 - - BO333 50%  
TK174 TK174 25% TK174 5%  
(CH2)4 no modification 75% no modification 5%  
 amine - amine -  












 amine 100% amine -  












 amine - amine -  











 amine - amine -  
 - - BO333 -  
Azide12 Azide 12 75% Azide 12 40%  
(CH2)2 no modification 25% no modification -  
 amine - amine -  
 - - - 60%   
Table 7.4 All tethering compounds tested individually and in competition with reference 































































































7.3.2 Protein Crystallographic Experiments 
The evaluation of the HPLC-MS experiments revealed that several candidate 
fragments from the disulfide library with a (CH2)2-linker experience remarkable 
affinity to CA II-H64C. The explanation for this elevated hit rate is provided by the 
determination of the crystal structure of CA II-H64C in covalent complex with 
Azide12 and SB095.  
 
Figure 7.5  Azide12 covalently bound to CA II-H64C (PDB-code: 3KIG). The solvent accessible 
surface is presented in white. The interacting protein amino acids are shown in stick representation 
(protein: C, N, O, S; ligand: C, N, O, S). The protein is shown in an orientation with the proton shuttle 
His64 (here mutated to Cys; next to the protein gap) on the left hand side. Unless it is mentioned 
differently this mode of representation is applied in all figures with protein surfaces in this chapter. The 
ligand adopts a hydrophilic canyon at the surface of CA II-H64C. An H-bond network between the 
fragment and the protein is partially mediated by three water molecules. 
Crystal structure of CA II in complex with Azide12: The crystal structure of 
Azide12 tethered to CA II-H64C was determined at a resolution of 1.39 Å (PDB-Code 
3KIG). The azide component covalently attached via a propylene disulfide linker to 
Cys64 occupies a surface exposed hydrophilic canyon next to the exit of the catalytic 
site of CA II (Figure 7.5). The carboxyl oxygen of Azide12 participates in an H-bond 
network with Asn11 (3.3 Å) and Tyr7. The latter interaction is mediated by a water 
molecule with distances of 2.5 Å and 2.9 Å (Figure 7.6). The NH of Azide12 is 
connected to a water molecule (2.7 Å) which is further bound to Gly63 (3.2 Å), 
Lys170 (3.1 Å) and Phe231 (2.6 Å). The azide moiety forms a hydrogen bond to 
Glu236 which is also mediated by a water molecule (2.5 Å; 2.4 Å). The azide group 
falls into close vicinity to the terminal oxygens of Glu239 indicating possible polar 




interactions. In addition to the described hydrogen bonds the inhibitor shows 29 van 
der Waals interactions to neighboring amino acids. The binding mode of Azide12 at 
the surface of CA II is unambiguously defined according to a very well defined 
difference electron density (Fo-Fc-density: 2.0 sigma). However, the ligand exhibits 
some residual mobility which is indicated by the average overall ligand B-factor of 
31.5 Å
2
. This mobility increases towards the terminal atoms of Azide12 from 21.8 Å
2
 
for the sulfur to 44.2 Å
2
 for the terminal nitrogen. A similar B-value distribution can be 





coordinating waters and 42.2 Å
2
 for azide-coordinating water). Across the protein, the 
average B-values are for main-chain atoms 13.2 Å
2









Figure 7.6  Binding mode of Azide12 (PDB-code: 3KIG). On the left hand side the crystal structure 
is shown with the important amino acids. The protein residues are shown in stick representation 
(protein: C, N, O, S; ligand: C, N, O, S). Water molecules are shown as red spheres. Hydrogen bond 
interactions are indicated by the dashed lines. The equivalent distances are shown in the schematic 
representation of the binding mode on the right hand side. The difference electron density (Fo-Fc) for the 
ligand and directly interaction water molecules is shown at a sigma level of 2.0. Atomic distances are 
shown in Å. Unless it is mentioned differently this mode of representation is applied in all binding mode 
figures in this chapter. The interaction to the residues Tyr7, Asn11, Gly63, Lys170, Phe231, Glu236 and 
Glu239 is partially mediated by three water molecules.   
Crystal structure of CA II in complex with SB095: The crystal structure of SB095 





























































The fragment is covalently attached to Cys64 and adopts a binding mode similar to 
Azide12 (Figure 7.7). 
 
Figure 7.7 SB095 covalently tethered to CA II-H64C (protein: C, N, O, S; ligand: C, N, O, S) 
(PDB-Code: 3M2Z). The ligand accommodates a hydrophilic canyon at the surface of CA II-H64C. An 
H-bond network between fragment and protein is partially mediated by two water molecules. 
 
Figure 7.8 Binding mode of SB095 tethered to CA II-H64C (protein: C, N, O, S; ligand: C, N, 
O, S; PDB-code: 3M2Z). The interactions to the residues Tyr7, Asn11, Gly63, Lys170 and Phe231 is 
partially mediated by two water molecules. 
The carboxyl oxygen is linked to Tyr7 by an hydrogen bond mediated via a water 
molecule (2.3 Å; 2.7 Å) (Figure 7.8). The terminal NH of Asn11 is positioned at 3.8 Å 






















































addition, the NH of SB095 forms an H-bond to a second water which is coordinated to 
Gly63 (3.0 Å), Lys170 (3.0 Å) and Phe231 (2.8 Å). Besides these hydrogen bonds, the 
benzyl group performs hydrophobic interactions to Phe231. Calculations revealed that 
SB095 experiences 29 van der Waals interactions. The binding mode is very well 
described by the difference electron density (Fo-Fc-density: 2.0 sigma). Average 
B-values of 25.9 Å
2





) indicate little mobility of the tethered fragment. The mean B-values across the 
protein are: main-chain atoms 13.7 Å
2
, side-chain atoms 17.5 Å
2
, water molecules 
25.3 Å
2
 and zinc ion 39.5 Å
2
. 
Crystal structure of CA II in complex with Saccharin: This binding site for 
fragments SB095 and Azide12 has been observed as occupied previously in our group 
by determining a crystal structure of CA II in complex with Saccharin (Figure 7.9). 
Saccharin binds to CA II with a stoichiometry of 2:1. One molecule binds to the active 
site, coordinating with its sulfolactam nitrogen the Zn
2+
 ion and in parallel a second 
molecule is fixed at the enzyme´s surface in the neighborhood of His64 and Tyr7. 
Saccharin is bound to this second binding site by means of four hydrogen bonds 
(Figure 7.10). The carboxyl oxygen of the sulfolactam performs an H-bond to the 
backbone NH of Tyr7 with a distance of 2.7 Å and in addition one sulfonyl oxygen is 
connected to the terminal NH of Asn11 (3.2 Å). Furthermore, mediated via three water 
molecules the sulfolactam nitrogen participates in an H-bond network to Trp5, His64, 
Gly63 and Phe231. Furthermore, Phe231 performs hydrophobic π-π-interactions to the 
aromatic system of Saccharin. 38 van der Waals interactions have been calculated for 
the surface-bound Saccharin molecule. The mean B-value indicates slight mobility of 
this ligand. The following averaged B-values have been observed: main-chain atoms 
13.9 Å
2
, side-chain atoms 14.5 Å
2
, water molecules 23.9 Å
2
, Saccharin 30.5 Å
2
 and 
zinc ion 29.4 Å
2
.  
The superposition of Saccharin with the two tethered fragments SB095 and Azide12 
reveals related binding modes. Asn11, Tyr7 and Gly63 are participating in the binding 
of all compounds (Figure 7.11). Furthermore, in all three complexes water molecules 




are essential for fragment binding affinity as they mediate protein-to-ligand 
interactions. 
 
Figure 7.9 Binding mode of Saccharin in complex with CA II (protein: C, N, O, S; ligand: C, N, 
O, S; PDB-Code: 2Q38). Saccharin binds to CA II with a stoichiometry of 2:1. The first molecule is 
coordinating to the active site zinc ion, and a second molecule is bound to the surface of CA II close to 
the His64 residue. 
 
Figure 7.10 Binding mode of Saccharin at the surface of CA II (protein: C, N, O, S; ligand: C, N, 
O, S; PDB-code: 2Q38). The interactions to the residues Tyr7, Asn11, Gly63, His64, and Phe231 are 
partially mediated via three water molecules. 
The carboxyl oxygen of the Saccharin sulfolactam and one of the coordinating water 
molecules in the SB095 and Azide12 complexes adopt similar positions linking the 

































































oxygen of Phe231, to the terminal nitrogen of Lys170 and to the backbone oxygen of 
Gly63 is in all three complexes mediated by a water molecule which is similarly 
located in all three structures. The binding affinity of the three compounds appears 
rather weak and full occupancy could not be achieved as indicated by the ligand-B-
values assigned by refinement. Nevertheless, their binding modes appear quite similar 
and suggest interesting complex structures to be studied by linking fragments via a 
(CH2)2-tether. 
 
Figure 7.11 Superposition of CA II complex structures with Saccharin (C, N, O, S; waters as 
blue spheres), SB095 (C, N, O, S; waters as red spheres) and Azide12 (C, N, O, S; waters as green 
spheres). The analog interacting protein residues are colored in same fashion as the bound ligand. 
Similar interaction patterns are indicated by red ellipses. 
The described crystal structures reveal that this tethering approach easily allows the 
identification of fragments binding into this area. Glu239 is available for additional 
binding interaction, that possibly increase fragment affinity. Decorating the phenyl 
ring of SB095 with an H-bond donor functionality should increase the affinity thereby 
allowing to subsequently release the fragment from its covalent leash and to inhibit the 













Timolol, a known CA II activator is proposed to bind into the same area, as suggested 
by docking experiments (Sugimoto, Ikeda et al.). Our crystal structures give a first hint 
for the existence of such a further binding site in CA II. More elaborate studies with 
enhanced fragment libraries could possibly identify new prospective fragments. CA II 
proton shuttle inhibitors could be developed by these studies. 
Crystal structure of CA II in complex with SB227: Next to these novel "surface-
binders", we were able to elucidate the binding mode of fragment SB227 to CA II. The 
crystal structure of SB227 tethered to CA II-H64C was determined at a resolution of 
1.95 Å (PDB-Code 3M5T). The fragment is covalently attached to Cys64 which 
positions the attached fragment into the active site of CA II (Figure 7.12). 
The biphenyl methane moiety of SB227 is placed with its two phenyl groups next to 
the hydrophobic residues Val121, Ile91, Phe131, Leu141, Val206, Val135, Leu198 
and Leu204. The upper phenyl ring performs edge-to-face interactions with Phe131 
and simultaneously the second ring system penetrates deeper into the catalytic binding 
pocket. The B-values attributed to the atoms of the fragment indicate that the biphenyl 
methane moiety is fully populated in one orientation whereas the linker experiences 
weak interactions with protein residues. Therefore, it adopts multiple orientations. The 
mean B-values are: main-chain atoms 21.3 Å
2





, ligand SB227 39.2 Å
2
 and zinc ion 22.7 Å
2
. 31 van der Waals 
interactions have been calculated for SB227. 
The lipophilic binding site is well known and addressed by many CA II inhibitors (e.g. 
Figure 7.13) and also neighbored to the recently described coumarin binding site 
(Maresca, Temperini et al. 2009a; Maresca, Temperini et al. 2009b; Temperini, 
Innocenti et al. 2009). However, since the crystallographic evaluation of molecules 
addressing this region requires in most cases (except the newly discovered coumarin 
type inhibitors) (Maresca, Temperini et al. 2009a; Maresca, Temperini et al. 2009b; 
Temperini, Innocenti et al. 2009) a sulfonamide or related zinc binding anchors to 
successfully accommodate protein crystals any screening with chemical diverse 
hydrophobic probes appears hardly feasible. Following the suggested tethering 
approach, new hydrophobic moieties can easily be examined by HPLC-MS and 




crystallography to identify novel binders appropriate of CA II inhibitors. Apart from 
these lipophilic interactions the current complex crystal structure also provides new 
insights into the development of CA II activators. In Figure 7.14 the binding mode of 
the known activators histamine and L-histidine is shown. 
 
Figure 7.12 Binding mode of SB227 in complex with CA II-H64C (protein: C, N, O, S; ligand: C, 
N, O, S; PDB-code: 3M5T). The binding pocket of CA II can be divided into a hydrophobic (indicated 
by red line) and a hydrophilic binding region (blue line). The fragment is covalently attached to Cys64 
orienting with its biphenyl moiety towards the hydrophobic side chains. 
 
Figure 7.13 Superposition of SB227 in complex with CA II-H64C (protein: C, N, O, S; ligand: C, 
N, O, S) with sulfonamide inhibitor (C, N, O, S; PDB-Code 1G1D). The biphenyl-moiety of SB227 
adopts similar positions as the two ring systems of the superposed ligand. 
SB227 binds in the same region as these activators. The crystallographic determination 
of the binding mode for such small ligands is rather difficult due to their lower binding 





















occupancy of the low affinity binder thereby facilitating the crystallographic 
investigation. 
 
Figure 7.14 Superposition of CA II activators L-histidine (protein: C, N, O, S; ligand: C, N, O, S; 
PDB-Code 2ABE) and histamine (C, N, O, S; PDB-Code: 1AVN) with SB227 (C, N, O, S). The 
activators form hydrogen bonds to Asn67 and Gln92 and are further coordinated to the active site Zn
2+ 
ion via three water molecules. The carbonyl-group of SB227 is located in the area where the activator-
heterocycle is bound. 
The reported crystal structures evidence that the sole identification of binding 
fragments by HPLC-MS analysis is not sufficient to conclude on their most likely site 
of interaction. As apparent in the case of Azide12 and SB095, the fragments can bind 
perfectly arranged to the surface of CA II. Moreover, this strong interaction pattern 
seems to prevent the tether to rotate towards the active site as long as no stronger 
interaction can be experienced within the active site. Fragment SB227 is able to 
perform such interactions to the lipophilic portion of the cavity next to the entrance of 
the CA II active site. In order to screen fragments for putative binding to the active site 
zinc ion or the adjacent catalytically relevant amino acids the extended linkers ((CH2)3, 
(CH2)4) were used to attach to the terminal probe fragments, possibly they avoid 
stabilizing contributions arising from the placement of the linker. This concept has 
been successful in case of a CA II-H64C complex where a terminal azide group was 
linked by (CH2)2 and subsequently by a (CH2)3 group (s. Chapter 5.4). In the structure 
with the extended linker the mobility of the probe fragment was indicated by a poorly 
defined electron density which suggests scattering of the linker across multiple binding 
orientations. Compounds that were accordingly synthesized have been tested by 
Gln92
Asn67




HPLC-MS. TK094, TK095, TK096, TK107, TK108, TK148, TK162, TK170 and 
TK171 showed increased affinity to CA II and will be tested by protein 
crystallography. 
7.3.3 Comparison Crystal Structure and Docking Experiments 
The crystallographic analysis of several (CH2)2-linked fragments in complex with CA 
II has shown in the current examples that mediated by water molecules such a linker 
distance allows placement of terminal probe skeletons to perfectly accommodate at the 
surface of CA II. Interestingly enough, two major orientations of fragments have been 
detected; the last example, the CA II-SB227-complex also probed the binding pocket. 
In the latter case the previously obtained docking poses agreed with the subsequently 
obtained crystal structure. Deviations in the exact binding mode can be observed; 
however, the hydrophobic interactions are equivalently suggested. 
In case of the smaller fragments SB095 and Azide12 the docking results did not 
confirm the crystal structure determined subsequently. Nevertheless, among the 
proposed docking modes some approximate the crystal structure. A clear deficiency 
that might deteriorate the docking attempts is the complete neglect of the water 
network which is clearly essential and actually mediates the binding of the tethered 
fragment to the protein surface.  
Nevertheless, the HPLC-MS and crystallographic experiments have shown so far that 
the selected fragments experience sufficient affinity to the surface of CA II-H64C to 
be successfully reacted with the accessible thiole group of Cys64. Most likely the size 
and introduced hydrogen-bond donor and acceptor functionalities of the tethered 
fragment take distinct impact on the docking modes and achieved scores. Repeating 
docking experiments considering the described water network could possibly improve 
the prediction of the fragment binding mode.  
7.4 Experimental Section 
Accessible cysteine residues: Prior to our initial tethering experiments, the overall 
accessibility of the cysteine residues of the target enzyme was determined. In best 




case, only one cysteine residue shows the potential to be reacted with the added 
disulfide since only then a tryptic digestion can be avoided to clearly characterize the 
tether product. In case of CA II a cysteine residue has been introduced at the entrance 
of the binding pocket. This mutant CA II-H64C exhibits next to the mutationally 
introduced Cys64 a second cysteine residue close to the enzyme surface (Cys205) 
experiencing a distance of 7 Å to the binding pocket (Figure 7.15).  
 
Figure 7.15 Accessible Cysteine residues in CA II-H64C. The active site is indicated by the dashed 
ellipse. DTNB is used to elucidate cysteine residues that can be applied to covalently attach thiole 
groups. The green arrow shows the modifiable cysteine residue while the red arrow presents the rather 
buried cysteine that is less modified. CA II-H64C provides next to the mutationally introduced Cys64 a 
second cysteine at the protein surface (Cys205). At low DTNB concentrations Cys64 is mainly 
modified. Cys205 experiences modifications only at raised concentrations. 
Even though it appeared likely that only Cys64 would be prominent to bind fragments 














CAII-H64C: 29729 Da DTNB: 396.36 Da
29927 Da
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the protein´s active site. To check for the general accessibility of both cysteines for 
tethering the wild type and the Cys mutant were incubated with Ellman´s reagent 
(5,5´-Dithiobis(2-nitrobenzoic acid) - DTNB) (Schwarzer, Mootz et al. 2002). 
Subsequently, the samples were purified over a size exclusion column to remove any 
unbound DTNB molecules and mass modification was determined by HPLC-MS. 
Unmodified CA II-H64C shows a mass of 29729 Da. Upon DTNB binding the enzyme 
mass must be increased by 198 Da (equivalent to half of DTNB). Different DTNB 
concentrations (10 µM to 150 µM) have been applied in these studies. Mass 
spectrometric analysis revealed that CA II-H64C is mainly modified by the anticipated 
mass difference which is indicated by the predominant mass peak of 29928 Da (10 µM 
DTNB) (Δ=198 Da).  
However, increasing the DTNB concentrations the protein mass is further increased 
indicating that a second DTNB attachment to CA II-H64C has been experienced 
(30124 Da; Δ=395 Da). Apparently, at increased concentrations apart from the first 
cysteine residue which is saturated the second available cysteine residue is now also 
modified. CA II-WT is also modified by DTNB at concentrations of 10 µM. In this 
case Cys205 is modified, as there is only one cysteine among the protein residues.  
To confirm these results tryptic digestions of accordingly treated protein samples have 
been accomplished. We were able to identify the protein fragment with Cys64 
modified by half of the mass equivalent of DTNB and the same for Cys205. Therefore, 
both cysteines are accessible for modification. 
In conclusion, the DTNB-experiments confirmed success of the anticipated mutational 
design for tethering of CA II. CA II-H64C provides ideal preconditions for the 
tethering approach. Successful binding can be identified by HPLC-MS; however, the 
binding mode of the attached fragment has to be examined by protein crystallography. 
Only the evaluation of the binding mode allows precise interpretation of mass 
spectrometric data.  
Library Design: Carboxylic acids are required for the synthesis of thiole containing 
fragments. Therefore, a virtual collection of carboxylic acids in mol2 format was used 




for the design of an appropriate docking library. The carboxylic acids were converted 
into Smiles codes using the program Colibri. The corresponding linker together with 
the disulfide attachment, which are required to perform the covalent docking with 
GOLD, were added via this Smiles code to each ligand resulting in three distinct 
fragment sublibraries according to the linker lengths (CH2)2 to (CH2)4 (Figure 7.16). 
The Smiles codes have been translated into 3D structures using the program Corina 
and subsequently minimized in the force field implemented into the program Sybyl. 
After formal deprotonation of the terminal sulfur-hydrogen, the fragment libraries 
were completed.  
 
Figure 7.16 Virtual library that has been applied in the docking experiments. Via smiles codes the 
library was modified by the linker-group and the disulfide group. 
The protein geometry used for docking was extracted from a crystal structure of a CA 
II-H64C mutant determined in-house. To select an appropriate binding site area for 
docking a radius of 12 Å around the hydrogen of Oγ of Thr199 was used. All 
fragments were docked into CA II-H64C, covalently attached to Cys64 which itself 
was allowed to adopt all possible rotamers during the docking runs. The standard 
GOLD 4.0 parameters were applied and 30 solutions were generated. The docking 
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fragments the best five docking solutions were visually inspected and thus the most 
promising candidates selected for synthesis. 
Optimization of reaction conditions: In general the reaction conditions described by 
Wells et al. were applied for sample preparations (Erlanson, Braisted et al. 2000). 
However, as we have preselected our fragment library by docking the affinity of the 
finally synthesized candidate fragments was anticipated to be sufficiently for tethering 
and subsequent HPLC-MS analysis. Apart from the concentration of the reducing 
agent also the solubility of the fragments and fragment cocktails influences the hit rate.  
 
Figure 7.17 DMSO vs. TCEP/DTT screening with Tethering fragment SB095 on CA II-H64C. 
The bars below the spectra indicate ratio of modified and unmodified CA II-H64C: CA II-H64C-
unmodified: blue bar; CA II-H64C-SB095: green bar. 
Therefore, a reaction setup had to be established which assures a reasonable 
identification of binders. Multiple reaction conditions were tested with one fragment 
(SB095), systematically altering the DMSO as well as DTT concentrations. The mass 
spectra of accordingly treated samples were evaluated for optimal CA II-H64C 
modification. The analysis revealed that 10-30% DMSO and 1-2 mM DTT most likely 
produce the best results (Figure 7.17). The reducing agent 2-mercaptoethanol was 
TCEP_DTT











exchanged by DTT due to toxicity classification of the former. The reaction conditions 
were as following: 15 µM CA II-H64C; 10% DMSO; 1 mM DTT; 200 µM inhibitor. 
Inhibitor-mixtures: All inhibitors were ranked according to their molecular weight. 
The ranking was applied to compose cocktails of four to six fragments with mass 
differences of 10 Da. Stock solutions of each mixture were prepared with 2 mM of 
each fragment. 5 µl of this cocktail was added to a final sample volume of 50 µl 
resulting in a final fragment concentration of 200 µM each. In order to perform 
tethering experiments with a single fragment 1 µl of a 10 mM compound stock 
solution were applied in 50 µl sample volume. 
HPLC-MS analysis: For HPLC-MS measurements 10 µl of the CA II-H64C mutant 
(75 µM), x µl DMSO (x = 5 µl – n µl fragment(s)), 10 µl DTT-solution (5 mM in Tris 
buffer) and 5 µl/1 µl of a fragment mixture/single fragment was diluted to a final 
volume of 50 µl with buffer (50 mM Tris-HCl pH 8.0). The samples were incubated at 
room temperature for at least 1 hour. 
After incubation the samples were pre-purified by size-exclusion chromatography 
(Illustra AutoSeq G-50 columns – GE Healthcare) to separate from excess substrates to 
avoid undesired side reactions. Complete desalting of the protein was achieved by 
HPLC using an Agilent 1100 system, samples were applied to a monolithic 50/1 
ProSwift RP-4H column (Dionex). Desalted protein samples were eluted by the 
following gradient of buffer A (water/0.05% formic acid) and buffer B 
(acetonitrile/0.045% formic acid) at a column temperature of 40 °C and a flow rate of 
0.2 mL/min: Isocratic elution with A (5%) for two minutes, followed by a linear 
gradient to B (95%) within 8 minutes and holding B (95%) for additional 4 minutes. 
Online mass spectrometric analysis was done with a Qstar Pulsar I mass spectrometer 
(Applied Biosystems) equipped with an ESI source. Measurement parameters were as 
follows: DP1 75, FP 265, DP2 15, CAD 2, GS1 35, CUR 25. The applied voltage was 
5000 V. Positive ions within the mass range of 500-2000 m/z were detected. For better 
performance, the “enhance all” mode was activated. 




Crystallization of CA II complexes: CA II-H64C crystals were grown using the 
sitting drop vapor diffusion method at 18 °C by mixing the protein solution (5 µl: 
~10 mg/ml) with well solution (5 µl: 2.75 M (NH4)2SO4, 0.1 M Tris-HCl pH 8.0). 
Crystals appeared within 2 – 4 weeks in space group P21 and took up to 2 months to 
reach their maximum size. Complex structures were obtained by cocrystallization or 
soaking of the enzyme with DTT (500 µM) and the fragment (1 mM). For 
cryoprotection, crystals were briefly soaked in mother liquor containing 25% glycerol 
(Acros organics).  
Data Collection, Phasing, and Refinement: The data sets were collected at the 
synchrotron BESSY II in Berlin/Germany on PSF beamline 14.2 (PDB codes: 3KIG, 
3M2Z) and at our in-house source (2Q38, 3M5T). Data were processed and scaled 
with Denzo and Scalepack as implemented in HKL2000 (Otwinowski, Minor et al. 
1997). The structures were determined by the molecular replacement method with 
Phaser (Storoni, McCoy et al. 2004) with our first inhouse CA II-H64C structure 
search model. Refinement was continued with CNS (Brünger, Adams et al. 1998) and 
SHELXL-97 (Sheldrick, Schneider et al. 1997). For each refinement step at least 10 
cycles of conjugate minimization were performed, with restraints on bond distances, 
angles, and B-values. Intermittent cycles of model building were done with the 
program COOT (Emsley and Cowtan 2004). The coordinates have been deposited in 
the PDB (http://www.rcsb.org/pdb/) with the following accession codes: 3KIG, 3KNE. 
The data collection statistics are summarized in the Appendix 13.1. 
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8 The Sulfamide Head Group: A Versatile Zinc Chelator for 
Carbonic Anhydrase Inhibition of Remarkable Structural 
Variability  
8.1 Introductory Remarks 
In this chapter a series of CA II inhibitors (sulfamides) is presented which have been 
synthesized by Dr. Schümmelfeder in the former group of Prof. Haake (inhibitors 1 - 
12) and by Prof. Winum from Montpellier (inhibitor 13) and have been enzyme 
kinetically tested in the group of Dr. Supuran from Florence, Italy. These compounds 
have been investigated by protein crystallography to determine the binding mode in 
CA II. The chapter has been prepared for submission to a scientific journal. 
8.2 Introduction 
-Carbonic anhydrases are Zn
2+
-dependent enzymes that catalyze the reversible 
hydration of carbon dioxide to hydrogen carbonate and a proton. They play an 
important role in physiological anion-exchange processes, pH homoeostasy, 
respiration and fluid balance, electrolyte secretion, biosynthetic reactions, or 
tumorgenesis (Maren 1988). CAs are thus involved in many physiological and 
pathologic processes (Pastorekova, Parkkila et al. 2004; Maestrelli, Mura et al. 2002; 
Supuran, Scozzafava et al. 2003; Stiti, Cecchi et al. 2008; Supuran 2008; Winum, 
Rami et al. 2008). The 16 different α-CA isoforms described so far in mammals, 
including homo sapiens, are involved in all these processes and are drug targets for 
various applications (diuretics, antiglaucoma, antiobesity, anticonvulsant or antitumor 
drugs among others) (Maren 1988). The dominant CA-isoenzyme, the carbonic 
anhydrase II (CA II) is located in many organs, showing very high catalytic efficacy. 




 CA II is one of the fastest enzymes known so far 
(Khalifah 1971).  
At the bottom of the 15 Å deep funnel-like active site, the catalytic active Zn
2+
 ion is 
coordinated by three histidine residues, His94, His96 and His119. A water 
molecule/hydroxide ion completes the tetrahedral coordination of the Zn
2+
 ion and acts 
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as a nucleophile in the conversion of carbon dioxide (Silverman and Lindskog 1988; 
Christianson and Fierke 1996); (Merz and Banci 1997). Along the catalytic mechanism 
the metal-bound bicarbonate ion is displaced by a water molecule and liberated into 
solution, leading to the catalytically inactive acid form of the enzyme, with water 
coordinated to Zn
2+
. Subsequently, a proton is transferred from the active site to the 
environment which regenerates the basic form of the enzyme. This proton shuffling 
may be assisted either by active site residues (such as His64 in several isoforms) or by 
buffers present in the medium. This step is rate limiting for the catalytic reaction (Nair 
and Christianson 1991b; Nair and Christianson 1991a).  
Three main classes of CA inhibitors (CAIs) are known: the metal complexing anions, 
the unsubstituted sulfonamides (and their isosteres), which bind to the Zn
2+
 ion of the 
enzyme either by competitively substituting the substrate at Zn
2+
 or coordinating to the 
metal center by generating trigonal-bipyramidal species, and the coumarins (Supuran 
and Scozzafava 2000; Supuran and Scozzafava 2002; Supuran 2003; Supuran, 
Scozzafava et al. 2003; Pastorekova, Parkkila et al. 2004; Supuran, Scozzafava et al. 
2004; Maresca, Temperini et al. 2009a; Maresca, Temperini et al. 2009b). The most 
investigated CAIs, the sulfonamides, coordinate with the terminal deprotonated 
nitrogen to the active site Zn
2+
 ion forming a tetrahedral geometry (Supuran and 
Scozzafava 2000; Supuran and Scozzafava 2002; Supuran 2003; Supuran, Scozzafava 
et al. 2003; Pastorekova, Parkkila et al. 2004; Supuran, Scozzafava et al. 2004). The 
proton bound to this nitrogen donates a hydrogen bond to Thr199 which itself is 
further linked as H-bond donor to Glu106. In addition, one of the sulfonamide oxygens 
interacts via an H-bond to the backbone NH of Thr199 (Abbate, Supuran et al. 2002; 
Casini, Antel et al. 2003; Fiore, Simone et al. 2005; Menchise, De Simone et al. 2005; 
Simone, Fiore et al. 2005). Carbonic anhydrase inhibitors belonging to the sulfonamide 
class led to important drugs, such as the antihypertensives of benzothiadiazine and 
high-ceiling diuretics type (Supuran and Scozzafava 2000), the sulfonamides with CA 
inhibitory properties mainly used as antiglaucoma agents, with at least 25 such agents 
in clinical use (Supuran and Scozzafava 2000; Supuran and Scozzafava 2002; Supuran, 
Scozzafava et al. 2003; Supuran, Scozzafava et al. 2004).  
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However, in the last years, the focus of CA II inhibitor design has changed toward 
other classes of compounds. Especially, new zinc binding groups have been tested 
(Winum, Scozzafava et al. 2007; Winum, Scozzafava et al. 2008). Compounds derived 
from the sulfamide skeleton were among the important ones (Winum, Scozzafava et al. 
2006). Sulfamides are widely used by medicinal chemists for the design of a plethora 
of biologically active derivatives involved in different pharmacological applications. 
This scaffold can be altered to at least five types of derivates, by successively 
substituting one of the four hydrogen atoms present at the two nitrogens. They have 
been tested on several protein targets such as carbonic anhydrases, proteases, serine 
proteases, metalloproteases and matrix metalloproteinases families (Winum, 
Scozzafava et al. 2006).  
This study focuses on CA inhibitors of the sulfamide type. A first inhibition study with 
respect to some CA isoenzymes with the parent sulfamide skeleton (H2NSO2NH2) has 
been reported previously (Briganti, Pierattelli et al. 1996). This compound develops 
weak inhibition against the classical cytosolic isoforms CA I (0.31 mM) and CA II 
(1.13 mM). A crystal structure revealed the binding mode of such sulfamide to CA II 
(Abbate, Supuran et al. 2002). Similar to the sulfonamide type of inhibitors the 
sulfamide coordinates with one terminal deprotonated nitrogen to the active site Zn
2+
 
ion (1.8 Å) and is further coordinated to Thr199 (2.8 Å) by means of a hydrogen bond. 
In addition, Thr199 is linked to Glu106 by an H-bond (2.6 Å). Another hydrogen bond 
involves one of the sulfamide oxygens and the backbone NH of Thr200 (2.8 Å). The 
latter amino acid forms a second H-bond to the non-Zn
2+
 coordinating sulfamide 
nitrogen (3.3 Å). This well organized binding mode and the synthetic availability of 
the terminal nitrogen for additional substitution predicts a remarkable potential for this 
sulfamide scaffold. It has been shown that this group can be derivatized by means of 
reactions with sulfonyl halides, arylsulfonyl isocyanates, or aromatic/heterocyclic 
aldehydes, leading to derivatives with inhibition constants against isozymes CA I, 
CA II and CA IV in the low nanomolar range (Briganti, Pierattelli et al. 1996). 
Derivatives of the RR´NH-SO2-NH2-type such as N,N-disubstituted- and N-
substituted-sulfamides were tested in another series. The disubstituted compounds 
showed only weak inhibition constants against CA I and CA II, whereas the mono-
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substituted derivatives (incorporating aliphatic, cyclic, and aromatic moieties) as well 
as bis-sulfamide, exhibit a micro-to-nanomolar inhibition (Casini, Winum et al. 2003). 
Here we present the crystallographic investigation of 13 (RR´NH-SO2-NH2-type) in 
complex with CA II, which has been kinetically evaluated earlier (Casini, Winum et al. 
2003). In addition, we investigated a new series of 12 sulfamides of the RR´N=SO2-
NH2-type against hCA I, hCA II, hCA IX and hCA XII with several inhibition 
constants in the one-digit nanomolar range. Remarkably, some compounds of this 
series show high selectivity towards CA II (nanomolar) compared to the other 
isozymes (micromolar). Three of these selective compounds were cocrystallized with 
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Scheme 8.1 Compounds that have been investigated for affinity against CAs. 
8.3.1 Inhibition Data 
The inhibition data for compounds 1-13 and the sulfamide lead (Scheme 8.1) are 
shown in Table 8.1. The sulfamide lead is a very weak inhibitor against all isoforms 
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(310 – 1130 µM) except in case of hCA XI with 9.6 µM. The inhibition constants of 
most inhibitors fall into the µM range. Some of the compounds experience increased 
affinity against certain isoforms, e.g. 2 against hCA XII; 11 and 13 against hCA II. In 
the contrary, some inhibitors are just very weak as, e.g. 10 against hCA I, hCA II and 
hCA XII or 3 against hCA I.  
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*From 3 different assay (error */- 10%) 
a
 Recombinant, full length enzymes; 
b
 Recombinant enzyme, catalytic domain. 
c
 From Casini et al., BMCL 2003, 13, 837-40 
8.3.2 X-ray Crystallography  
The binding modes of sulfamides 6, 11, 12 and 13 to hCA II were analyzed by 
determining the crystal structures of the protein-inhibitor complexes (Scheme 8.1). 
Crystals of the adducts were isomorphous with those of the uncomplexed protein 
(Eriksson, Jones et al. 1988), allowing for the determination of the crystal structures by 
difference Fourier techniques. The structures were refined at resolutions ranging from 
1.17 to 1.87 Å. The statistics for data collection and refinement are shown in the 
Appendix 13.1. 
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Figure 8.1 Binding mode of 13 in complex with CA II (PDB-Code: 2M2Y). The solvent accessible 
surface is presented in white. The interacting protein amino acids are shown in stick representation 
(protein: C, N, O, S; ligand: C, N, O, S). The binding pocket of CA II can be divided into a hydrophobic 
(red line) and a hydrophilic binding region (blue line). The protein is shown in an orientation with the 
proton shuttle His64 (next to the gap on the left hand side. This mode of representation is applied in all 
surface-figures in this chapter. 13 is bound to CA II in a stoichiometric ratio of 2:1. One inhibitor 
molecule is coordinated to the active site Zn
2+
 ion and a second molecule is located in a pocket formed 
by the N-terminal residues His4 to Phe20. 
 
Figure 8.2 Binding mode of 13 in complex with CA II (surface-bound molecule; PDB-Code: 
2M2Y). On the left hand side the crystal structure is shown with the important amino acids. The protein 
residues are shown in stick representation (protein: C, N, O, S; ligand: C, N, O, S). Water molecules are 
shown as red spheres. Hydrogen bond interactions are indicated by the dashed lines. The equivalent 
distances are shown in the schematic representation of the binding mode on the right hand side. The 
difference electron density (Fo-Fc) for the ligands and directly interacting water molecules are shown at 
a sigma level of 2.0. Atomic distances are shown in Å. This mode of representation is applied in all 
crystal structures in this chapter. 13 is bound to the protein surface by means of three hydrogen bonds to 
His15, Asp19 and mediated by a water molecule to the backbone NH of Trp5. The endocyclic nitrogen 
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Complex structure CA II ∙ 13: The inhibitor binds to CA II in a stoichiometric ratio 
of 2:1. One inhibitor molecule is fixed to a cavity formed next to the N-terminus while 
a second molecule coordinates to the active site zinc ion (Figure 8.1). The remote 
pocket at the N-terminus is flanked by residues His4 to Phe20. Full occupancy of 13 in 
this pocket is clearly indicated by the excellent difference electron density (Fo-Fc-
density: 2.0 sigma). The ligand is fixed by means of three H-bonds (Figure 8.2). The 
terminal sulfamide-nitrogen forms two hydrogen bonds to His15 and Asp19 of 3.0 Å 
(His 15) and 2.7 Å (Asp19). Furthermore, one sulfamide-oxygen interacts with the 
backbone nitrogen of Trp5 via an H-bond network that is mediated by a water 
molecule (2.8 Å and 3.1 Å). The second sulfamide-oxygen is not involved in any 
direct interactions. Asn11 (3.8 Å) is too distant to undergo sufficient H-bond 
interactions. Similarly, the cyclic sulfamide-nitrogen is not coordinated to further 
residues. 25 van der Waals contacts can be counted between ligand and protein. The 
average B-values provide an additional proof for the unambiguous fully populated 
binding mode of 13 at this surface-exposed site as residues 1 to 20 show an average 
B-value of 13.4 Å
2
, and the ligand atoms of 12.8 Å
2
. 
The second sulfamide ligand binds to the active site zinc ion adopting a binding mode 
that agrees well with those known for sulfonamides (Figure 8.3). The presumably 
deprotonated, negatively charged terminal nitrogen is coordinated to the zinc ion at a 
distance of 2.0 Å. The tetrahedral coordination geometry of the zinc ion is slightly 
distorted due to the sulfamide-oxygen which occupies the fifth coordination site 
(3.1 Å). Similar to sulfonamide inhibitors the sulfamide-nitrogen forms an H-bond to 
the terminal oxygen of Thr199 which is further coordinated by a hydrogen bond to 
Glu106. This H-bond network is established at common distances known from 
sulfonamide inhibitors (2.8 Å and 2.6 Å). The typical interaction pattern of CA II-
sulfonamide complexes is completed by the hydrogen bond of the Thr199 backbone 
NH to the second sulfamide-oxygen at a distance of 3.0 Å.   
Furthermore, the endocyclic nitrogen of 13 is not involved in any interactions with the 
protein. The ring system is oriented towards the lipophilic pocket which is formed by 
Leu198, Pro202, Leu204, Val121, Val135 and Phe131. In addition to the described 
hydrogen bonds, the inhibitor shows 26 van der Waals interactions to the neighboring 
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amino acids. The binding mode of 13 in the active site of CA II is well defined and 
clearly apparent from the difference electron density (Fo-Fc-density: 2.0 sigma). 
Additionally, the B-value of 12.3 Å
2 
averaged across the ligand is similar to the 
average B-value for all protein atoms indicating full occupancy of the ligand in the 
binding site. 
 
Figure 8.3 Binding mode of 13 in complex with CA II (active site-bound molecule; PDB-Code: 
2M2Y). The sulfamide moiety is coordinated to the active site Zn
2+
 ion and connected to Thr199 by 
means of H-bonds as is well established for many sulfonamide inhibitors. The ring system performs 
hydrophobic interactions to the side chains Leu198, Pro202, Leu204, Val121, Val135 and Phe131. 
 
Figure 8.4 Difference electron density at the proton shuttle His64. The sigma level of this 
additional density is approx. 28 and allows the assignment of a Zn
2+
 ion. On the right hand side the 
geometry is rotated by 90°. The density is shown at a sigma level of 2.0 left and 4.0 right, to illustrate 
the well defined binding mode. As both residues cannot be present at the same time the occupancies 
have been refined for His64 (62%) and Zn
2+
 (38%). 
During the refinement of this structure we observed a difference density peak at very 
high sigma level (28 sigma) next to NE2 of His64. The imidazole moiety of His64 is 
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cocrystallized CA II solely with the inhibitor, and applied usual crystallization 
conditions, we propose that this density peak can be assigned to a second zinc ion. The 
spatial restraints prevent His64 and zinc to be localized at the same location in time 
and space (presumable distance NE2 – Zn
2+
 1.37 Å). Therefore, a partial occupation 
for both portions has been assigned. His64 is refined to a population to 62%, the zinc 
ion to 38% (B-value 11.0 Å
2
). The backbone oxygen of Asn62 coordinates the metal 
ion at a distance of 2.9 Å. Other neighboring potentially weakly coordinating residues 
are the backbone oxygen of Gly63 (4.0 Å) and the backbone NH of His64 (3.6 Å) 
(Figure 8.4). 
Complex structure CA II ∙ 6: In this complex, only one single inhibitor molecule is 
bound and located in the active site (Figure 8.5). In contrast to 13 described above, in 
this compound the non-terminal sulfamide-nitrogen is not part of a ring system. 
Furthermore, the attached thiazole ring contains a sulfur and a nitrogen atom. The 
terminal negatively charged nitrogen of the anchor group coordinates to the zinc ion 
with a distance of 1.9 Å (Figure 8.6). The tetrahedral coordination geometry at the zinc 
ion is slightly distorted due to one sulfamide oxygen which occupies the fifth 
coordination site (3.0 Å). Furthermore, the former nitrogen forms a hydrogen bond to 
the terminal oxygen of Thr199 (2.8 Å) which is additionally involved in an H-bond to 
Glu106 (2.6 Å). The binding mode is further fixed by the backbone nitrogen of Thr199 
as it interacts via an H-bond to the second sulfamide oxygen at a distance of 2.8 Å. 
Thr200 forms with 6 three hydrogen bonds. Its terminal hydroxyl group functions as 
an H-bond donor to the inner-most sulfamide nitrogen (3.2 Å) and is addressed 
simultaneously as H-bond acceptor by the endocyclic nitrogen at a distance of 3.0 Å. 
In addition, a water molecule mediates an interaction between the hydroxyl group of 
Thr200 (2.9 Å) and the negatively charged terminal nitrogen atom (2.9 Å). The 
heterocycle of 6 is oriented towards the hydrophobic substrate binding pocket. The 
sulfur atom of the heterocycle is not involved in any interactions to the protein 
residues. In addition to the described hydrogen bonds, 28 van der Waals interactions 
can be observed. The ligand exhibits only minor mobility which is indicated by the 
very well resolved difference electron density (Fo-Fc-density: 2.0 sigma) and a 
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comparison of the average B-values: protein main-chain 13.8 Å
2





, inhibitor 6 16.5 Å
2




Figure 8.5 CA II in complex with 6 (PDB-Code: 3M14). A water molecule (red sphere) participates 
in the interaction of 6 with CA II. 
 
Figure 8.6 Binding mode of 6 in complex with CA II (PDB-Code: 3M14). The sulfamide group is 
coordinated to the active site Zn
2+
 ion and connected to Thr199 and Thr200 by means of five hydrogen 
bonds with one water molecule participating in the binding mode. The ring system performs 
hydrophobic interactions to the lipophilic binding pocket. 
Complex structure CA II ∙ 11: The inhibitor 11 binds to the active site of CA II with 
its two ring moieties facing different parts of the large funnel-shaped sub-pockets 
(Figure 8.7). The phenoxy group is oriented towards the hydrophobic pocket wall of 
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Gln92, Asn67, Asn62 and Glu69 on the opposite side. An additional H-bond is formed 
between the terminal oxygen of the heterocycle and the carboxamide nitrogen of 
Asn62, a remarkable feature of the binding mode (Figure 8.8). With a distance of 
2.9 Å the ring system is in good contact geometry and thereby pulled into the observed 
binding mode.  
 
Figure 8.7 CA II in complex with 11 (PDB-Code: 3M2X). The inhibitor 11 binds to the active site 
of CA II with both ring systems pointing towards different sub-pockets. The phenoxy moiety is bound to 
the lipophilic residues while the morpholino ring performs interactions with the hydrophilic side chains. 
 
Figure 8.8 Binding mode of 11 in complex with CA II (PDB-Code: 3M2X). The inhibitor is bound 
to four protein residues by means of six hydrogen bonds. One water molecule is involved in the 
coordination to Pro201. The sulfamide-anchor is coordinated to the active site zinc ion. The interaction 
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The second ring system, a phenoxy group, is pointing towards the lipophilic side 
chains of Leu198, Pro202, Leu204, Val121, Val135 and Phe131. In addition to these 
hydrophobic interactions, the observed binding mode is stabilized by a water-mediated 
H-bond (3.3 Å), formed by the iminoester oxygen towards the backbone carbonyl 
oxygen of Pro201 (2.6 Å) and a second hydrogen bond to Thr200 Oγ. This atom is also 
in favorable distance to hydrogen-bond to the second sulfamide oxygen (2.9 Å), most 
likely a furcated H-bond is formed. The binding geometry of this zinc anchor is 
characterized by a contiguous H-bond network starting at the terminal negatively 
charged nitrogen via Thr199 Oγ (2.7 Å) to Glu106 (2.6 Å). The first sulfamide-oxygen 
coordinates in bidentate fashion along with the negatively charged nitrogen (1.9 Å) to 
the active site zinc ion (3.5 Å) while the second oxygen forms a hydrogen bond to the 
backbone nitrogen of Thr199 at a distance of 2.9 Å. In comparison to ligand 6 the ring 
system is closer to the residues of the hydrophobic portion of the funnel-shaped pocket 
exhibiting 57 van der Waals interactions. Similar to 13 and 6 the difference electron 
density of 11 is very well defined (Fo-Fc-density: 2.0 sigma). 
Complex structure CA II ∙ 12: Similar to 11, 12 bears two ring systems as terminal 
substituents. Apart from a phenoxy moiety, a second aniline-type substituent is present 
decorated by two methoxy-groups in 3- and 4- position. In contrast to 11, the phenoxy 
group of 12 is now orienting towards the hydrophilic well of the binding pocket while 
the dimethoxy substituted ring system is placed next to the hydrophobic portion of the 
pocket (Figure 8.9). Similar to 11, the difference electron density of 12 is very well 
defined (Fo-Fc-density: 2.0 sigma). The sulfamide anchor adopts the same orientation 
as in 11. The terminal negatively charged nitrogen coordinates to the active site zinc 
ion (1.9 Å) and forms via its remaining hydrogen a bond to Thr199 (2.6 Å) which is 
further connected to Glu106 (2.6 Å) (Figure 8.10). One sulfamide oxygen is placed to 
the fifth coordination site at the zinc ion (3.3 Å) thereby distorting the tetrahedral 
coordination formed by His94, His96, His119 and the deprotonated sulfamide 
nitrogen. The second sulfamide oxygen forms, as in other complexes, an H-bond to the 
backbone NH of Thr199 (2.8 Å). Furthermore, the inner-most sulfamide nitrogen 
forms a hydrogen bond to the terminal oxygen of Thr200, similarly to 6 (3.0 Å). 
Interestingly enough, the nitrogen of the dimethoxyaniline substituent forms an 
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intramolecular H-bond with the neighboring sulfamide oxygen which is also engaged 
in an interaction with Thr199. The internal contact stabilizes the bound conformation. 
At the exit of the binding pocket the two neighboring methoxy groups capture an 
H-bonded water molecule via distances of 2.9 Å each. The interactions to this water 
molecule seem to be rather weak since its B-factor (38.7 Å
2
) is significantly augmented 






Figure 8.9 CA II in complex with 12 (PDB-Code: 3M04). The ring systems of 12 are swapped in 
comparison to 11. The phenoxy-moiety is oriented towards the hydrophilic residues in the active site 
and the dimethoxy substituted second aromatic portion is interacting with the hydrophobic residues. 
 
Figure 8.10 Binding mode of 12 in complex with CA II (PDB-Code: 3M04). The sulfamide moiety 
is coordinating to the Zn
2+
 ion, further stabilized by H-bonds to Thr199 and Thr200. In addition an 
intramolecular hydrogen bond and the interaction to a water molecule is observed. 
Only minor ligand mobility is indicated as a very well defined difference electron 
density is given and the average B-values support this hypothesis: protein main-chain 
18.2 Å
2
, side-chain 21.3 Å
2
, waters 28.2 Å
2
, ligand 12 18.8 Å
2
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Similar to 11, the aromatic portion of this substituent performs strong hydrophobic 
interactions with the lipophilic part of the binding pocket. The terminal methoxy 
groups enhance these contacts. In addition to the described hydrogen bonds 67 van der 
Waals interactions were calculated. 
8.4 Discussion 
8.4.1 Inhibition Data 
The inhibition data for all compounds against CA isoforms I, IX and XII show some 
inhibitors experiencing enhanced affinities and in parallel several with only very weak 
affinity to these isoforms. Since there is no data from crystal structure analysis 
available, detailed analysis of structure activity relationships are not possible at the 
moment. 
The sulfamide ion is a very weak inhibitor for CA II (KI of 1.13 mM), but all its 
derivatives show a highly enhanced affinity for this isoform, with inhibition constants 
in the range of 15.1 nM – 58.6 M (Table 8.1). Thus, compounds 1-9 show a rather 
compact behaviour of medium potency inhibitors, with a small variation of the KIs (of 
4.5 –12.0 M). They all incorporate a very similar motif, of -sulfamoylated-
guanidine/urea/thiourea. Inhibitor 11 shows the highest affinity with 15.1 nM. A 
similar inhibitor 10, which is substituted by a piperidine ring instead of the morpholino 
ring in 11, shows drastically decreased affinity. Also inhibitor 13 shows very strong 
affinity towards CA II with inhibition constant of 179 nM. 
Depending on the substituted residues linked to the nitrogen and carbon of the imine 
functionality, the ligands can undergo fast E/Z-isomerization via rotation or inversion 
of the C=N bond. Considering, that compounds, such as 10 – 12, which are substituted 
by a phenoxy group and a nitrogen show very fast isomerization (dissertation 
Dr. Schümmelfeder), both isomers are present in the experiments. In addition, the NH-
tautomerism which is possible for some of these compounds also allows rotation 
around the imine nitrogen. Therefore, the protein can select the isomer that fits best 
into the active site. 
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8.4.2 Structural Comparison 
Inhibitor 13: The superposition of 13 with the parent sulfamide ion shows that 13 is 
tilted away from Thr200. It does not form a hydrogen bond with its cyclohexylamino 
nitrogen to this residue (Figure 8.11a). Obviously, the cycloalkyl substituent is too 
bulky to allow the same orientation as found for the parent sulfamide ion (Winum, 
Scozzafava et al. 2006). Supposedly, the gain of lipophilic contacts to the hydrophobic 
portion of the CA II binding pocket and the enhanced Zn
2+ 
coordination compensates 
the unbalanced hydrogen bonding inventory of this ligand. The superposition of 13 
with a substituted sulfonamide inhibitor (PDB-code 1ZGE) reveals that the binding 
modes for both chemically diverse anchor groups are virtually identical (Figure 8.11b) 
(Ilies, Vullo et al. 2003). The terminal nitrogen and both oxygen atoms occupy exactly 
the same positions. Since the piperidinyl nitrogen of 13 does not perform any 
interaction with the protein its ring system orients almost identical as the phenyl 
moiety of the superimposed ligand. The binding affinity of the superimposed inhibitor 
(50 nM) can explain to some degree the enhanced affinity of 13 (179 nM) as their 
binding modes are similar. Nevertheless, considering the observed interactions the 
measured affinity of 13 is surprisingly high. 
 
Figure 8.11 Superposition of 13 bound to CA II (ligand: C, N, O, S; protein: C, N, O, S). Waters 
are shown as red spheres. Dashed lines indicate interatomic distances in Å. This mode of representation 
is applied in all superpositions in this chapter. (a) Superposition of 13 with the structure of the sulfamide 
ion. 13 is shifted away from Thr200. (b) Superposition of 13 (C, N, O, S) with a typical sulfonamide 
inhibitor (C, N, O, S; PDB-code 1ZGE). The anchor groups adopt exactly the same orientation with the 
hydrogen bond network typical for sulfonamides with Thr199 Oγ. The ring systems fall in the same 
plane. The endocyclic nitrogen of 13 does not influence the binding mode, as it is not interacting with 
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Inhibitor 6: The superposition of 6 with the parent sulfamide ion reveals that 6 is 
shifted by about 1 Å in order to form hydrogen bonds to Thr200 (Figure 8.12a). 
At first sight, as the anchor group distances of 6 are similar to those of 13 in complex 
with CA II, the binding mode of 6 seems to resemble that of typical sulfonamide 
inhibitors. However, detailed comparison reveals differences in the interaction pattern, 
giving 6 the advantage of two additional hydrogen bonds which might explain its 
improved binding affinity. Superposition of 6 with 13 illustrates the impact of the two 
nitrogen atoms of 6 on the binding mode (Figure 8.12b). The terminal negatively 
charged nitrogen and the oxygen atom which interact with Thr199 remain at the same 
positions. However, the second sulfamide oxygen experiences a shift of 1.2 Å due to 
an inclination of the inhibitor towards Thr200 to form the two additional H-bonds.  
 
Figure 8.12 Superposition of 6 bound to CA II. (a) Superposition of 6 (C, N, O, S) with the 
sulfamide ion. 6 is shifted by 1 Å forming an additional hydrogen bond to Thr200. (b) Superposition of 
ligands 6 (C, N, O, S) and 13 (C, N, O, S) binding to CA II. The NH-Zn- and NH-Thr199- distances 
have almost the same values. However, one oxygen atom is shifted by 1.2 Å since thereby 6 can 
perform additional hydrogen bonds to Thr200. 
The cyclic moieties of 13 and 6 adopt almost the same position filling the hydrophobic 
binding pocket. Furthermore, the interaction pattern to the active site zinc ion is similar 
as the respective distances remain the same. Also a similar amount of van der Waals 
interactions is counted. Considering all these facts it is difficult to understand the 
enhanced affinity of 13 compared to 6. The formation of two additional, most likely 
strong, hydrogen bonds should increase the binding affinity of 6. Nevertheless, in an 
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13 (179 nM). The present data do not provide an obvious explanation for this affinity 
difference. Additional experiments, e.g. ITC measurements, should be performed to 
elucidate the reasons.  
Inhibitor 11: Superimposing 11 with the parent sulfamide ion shows that 11 is shifted 
toward the hydrophilic binding pocket, losing one hydrogen bond to Thr200 in order to 
gain an interaction with Asn62 (Figure 8.13a). 
 
Figure 8.13 Superposition of 11 bound to CA II. (a) Superposition of 11 (C, N, O, S) with the 
sulfamide ion. (b) Superposition of 11 (C, N, O, S) and 6 (C, N, O, S) binding to CA II. Due to the 
hydrogen bond of the morpholino ring to Asn62 the sulfamide-group is shifted by 0.9 Å to 2.2 Å. 
Comparing the hydrogen-bond network formed by 11 and 6, similar distances can be 
observed (Figure 8.13b). However, similar to the previous case, the superposition of 6 
and 11 reveals major rearrangements in the sulfamide coordination pattern. Due to the 
interaction of the morpholino ring with Asn62, the ligand is shifted towards the 
hydrophilic pocket. In contrast to 6, the inner-most sulfamide nitrogen of 11 is rotated 
by 2 Å away from the terminal oxygen of Thr200 and cannot perform any interactions 
to this residue. Therefore, one hydrogen bond interaction is lost by this movement. 
However, the oxygen of the anchor group which typically interacts with the backbone 
NH of Thr199 is also shifted towards Thr200 by 2.2 Å compared to the situation with 
6. It regains the hydrogen bond by occupying a position similar to the nitrogen in 6. 
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of 6. The secondary amine of 6 donates an H-bond to Thr200. The spatial orientation 
of this nitrogen does not allow additional hydrogen-bond interactions. In contrast, the 
iminoester oxygen in 11 exhibits two acceptor functionalities and can, in addition to 
the interaction with Thr199, participate in a water-mediated H-bond with Pro201. 
Due to the ligand´s inclination towards the hydrophilic residues, 11 cannot form a 
short directed H-bond from its inner sulfamide-nitrogen group to Thr200 Oγ. This loss 
is compensated by hydrogen bonds between Thr200 Oγ the iminoester oxygen and the 
S=O group of the sulfamide. Compared to 6, 11 looses the NH Thr200 Oγ contact but 
gains two additional hydrogen bonds via two oxygens. These supposedly more 
favorable interactions explain the increased binding affinity further enhanced by 
pronounced van der Waals interactions particularly formed by the phenoxy group with 
the hydrophobic portion of the binding pocket.  
Inhibitor 12: Ligand 12 adopts virtually the same orientation with respect to its 
sulfamide anchor as the parent sulfamide ion (Figure 8.14a). Differences in the 
H-bonding pattern are observed between 11 and 12 (Figure 8.14b). The interactions to 
the active site zinc ion and Thr199 are similar in both structures (two hydrogen bonds 
and Zn
2+
 coordination). However, the two oxygens and the inner nitrogen of the 
sulfamide group are shifted by approx. 1 Å towards Thr199 in 12. Thereby, this 
nitrogen can interact with Thr200 Oγ, a contact not feasible to undergo for the 
corresponding nitrogen in 11. In contrast, 11 forms additional H-bonds to Thr200, 
Pro201 and Asn62 via its oxygens. 12 shows, in comparison to 11, different E/Z 
stereochemistry at the innermost imine nitrogen. The described E/Z equilibrium can 
easily adjust the most favorable conformation for binding. As a result, the iminoester 
oxygen moiety is now facing the hydrophilic wall of the funnel-shaped binding pocket 
and the dimethoxy aniline portion is oriented toward the hydrophobic side. It thereby 
places the NH group in a position to form an intramolecular H-bond to the sulfamide 
oxygen, thus stabilizing the geometry of the bound conformation.  
Interestingly, the two adjacent methoxy groups capture a water molecule which is in 
no further contacts with the protein. In total, 11 forms six hydrogen bonds (two 
furcated ones) to the protein while 12 only participates in three H-bonds, but it 
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establishes two additional hydrogen bonds to a water molecule and experiences an 
intramolecular contact to fix the arrangement of the bound conformation. 
Both ligands exhibit diverse affinities with inhibitor 11 binding approx. 265 fold 
stronger than 12. It is remarkable that even so sharing parts of their scaffold in 
common they bind with reversed placement of their substituents. This is achieved by 
deviating E/Z-orientation at the C=N bond. Soley counting the interaction inventory 11 
outnumbers 12 in terms of favorable H-bonds. Possibly the intramolecular H-bond 
which is formed in the complex with 12 is not accessible for inhibitor 11. Thus the 
latter enables the coordination with its ring system to Asn62.  
This observed E/Z-isomerization might also explain the dramatic loss of affinity of 10 
compared to 11. Possibly, as the piperidine ring system cannot form an H-bond to 
Asn62 (compared to 11), inhibitor 10 might not be pushed into the same configuration 
and therefore, binds in a similar orientation as 12 forming the same intramolecular 
H-bond.  
 
Figure 8.14 Superposition of 12 bound to CA II. (a) Superposition of 12 (C, N, O, S) with the 
sulfamide ion. (b) Superposition of ligand 12 (C, N, O, S) and 11 (C, N, O, S) in complex with CA II. 
The sulfamide oxygen atoms are shifted towards the Zn
2+
 ion by 0.9 Å and 1.1 Å, respectively. The 
innermost sulfamide nitrogen is rotated towards Thr200 thereby allowing a hydrogen bond to this 
residue. 
8.5 Experimental Section 
CA inhibition: An Applied Photophysics stopped-flow instrument has been used for 
assaying the CA catalyzed CO2 hydration activity (Khalifah 1971). Phenol red (at a 
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maximum of 557 nm, with 20 mM Hepes (pH 7.5) as buffer, and 20 mM Na2SO4 (for 
maintaining a constant ionic strength), following the initial rates of the CA-catalyzed 
CO2 hydration reaction for a period of 10-100 s. The CO2 concentrations ranged from 
1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants 
(5 different substrate concentrations have been used). For each inhibitor at least six 
traces of the initial 5-10% of the reaction have been applied for determining the initial 
velocity. The uncatalyzed rates were determined in the same fashion and subtracted 
from the totally observed rates. Stock solutions of inhibitor (0.1 mM) were prepared in 
distilled-deionized water and dilutions up to 0.01 nM were done thereafter with 
distilled-deionized water. Experiments were done using 6 different inhibitor 
concentrations, varying from 100 M to 0.1 nM. Inhibitor and enzyme solutions were 
preincubated together for 15 min to 24 h at room temperature (15 min) or 4 °C (all 
other incubation times) prior to assay, in order to allow for the formation of the E-I 
complex or for the eventual active site mediated hydrolysis of the inhibitor. Data show 
the inhibition after 15 min incubation, as there were no differences of inhibitory power 
when the enzyme and inhibitors were kept for longer periods in incubation (Maren 
1988). The inhibition constants were obtained by non-linear least-squares methods 
using PRISM 3, as reported earlier (Briganti, Mangani et al. 1997; Temperini, 
Scozzafava et al. 2005; Temperini, Scozzafava et al. 2006b; Temperini, Innocenti et al. 
2007; Temperini, Innocenti et al. 2008) and represent the mean from at least three 
different determinations. CA isozymes were prepared as reported earlier (Bayram, 
Senturk et al. 2008; Innocenti, Hilvo et al. 2008; Innocenti, Vullo et al. 2008b; 
Innocenti, Vullo et al. 2008a; Maresca, Temperini et al. 2009a; Maresca, Temperini et 
al. 2009b; Temperini, Innocenti et al. 2009). 
Synthesis: The synthesis of compound 13 was performed by the group of 
Prof. Winum, the synthesis of the other compounds by the group of Prof. Haake, in 
particular by Dr. Schümmelfeder. 
Crystallization, X-ray data collection and refinement: Crystals of hCA II (from 
Sigma-Aldrich) in complex with each inhibitor were obtained by the sitting drop 
technique, using 10 mg/mL protein with 2 mM inhibitor (13, 6, 11 and 12 respectively) 
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in 50 mM Tris-HCl buffer (pH 8.0). The drops consisted of 5 µL of the enzyme-
inhibitor solution and 5 µL of the precipitant solution containing 3.0 M (NH4)2SO4 in 
100 mM Tris-HCl (pH 8.0) and 0.15 mM p-chloromercurybenzoic acid to promote the 
growth of highly oriented crystals. The drops were equilibrated by vapor diffusion 
against the precipitant solution at 18 °C, and crystals appeared after 1-4 days.  
The data sets of CA II-13 and CA II-11 complexes were collected at the synchrotron 
BESSY II in Berlin/Germany on PSF beamline 14.2. The experiment was performed at 
100 K using synchrotron ration of 0.91841 Å wavelength on a MAR CCD 165 mm 
detector. The data set of CA II-6 complex was collected at the Swiss Light Source 
(SLS) in Villigen/Switzerland on Beamline SLS X06DA on a MAR CCD 225 mm 
detector at 100 K using radiation of 1.000 Å wavelength. The data of CA II-12 
complex were collected on an MAR 345 mm plate detector with Incoatec IµS copper 
microfocus source at a wavelength of 1.54178 Å (100 K). The data collection 
parameters and refinement statistics are reported in the Appendix 13.1.  
Data were processed and scaled with Denzo and Scalepack as implemented in 
HKL2000 (Otwinowski, Minor et al. 1997). The complex structures were analyzed by 
difference Fourier techniques, using the PDB file 2OQ5 as starting model for 
refinement. Refinement was continued with CNS (Brünger, Adams et al. 1998) and 
SHELXL-97 (Sheldrick, Schneider et al. 1997). For each refinement step at least 10 
cycles of conjugate minimization were performed, with restraints on bond distances, 
angles, and B-values. For each crystal the 2Fo-Fc and Fo-Fc maps were calculated and 
the inhibitor binding mode assigned from the difference electron density. Intermittent 
cycles of model building were done with the program COOT (Emsley and Cowtan 
2004). The coordinates have been deposited in the PDB (http://www.rcsb.org/pdb/) 










9 Bidentate Zinc Chelators for α-Carbonic Anhydrases that Produce 
a Trigonal Bipyramidal Coordination Geometry 
9.1 Introductory Remarks 
The following chapter has been submitted to a scientific journal for publication. In the 
following the original text is depicted. A series of new zinc binders is presented. The 
crystallographic investigation was performed during this thesis, the compounds have 
been provided by the group of Prof. Seth Cohen (San Diego, USA) and enzyme 
kinetically tested on 13 CA isoforms in the group of Dr. Supuran (Florence, Italy; 
enzyme preparation: Daniela Vullo; kinetic assay: Alessio Innocenti). 
9.2 Abstract 
A series of new zinc binding groups (ZBGs) has been evaluated kinetically on 13 
carbonic anhydrase isoforms. The fragments show affinity for all isoforms with IC50 
values in the range of 2 to 11 µM. The crystal structure of hCA II in complex with one 
such fragment reveals a bidentate binding mode with a trigonal-bipyramidal 
coordination geometry at the Zn
2+
 center. The fragment also interacts via hydrogen 
bonding to Thr199 and Thr200 and participates in a water network. Further 
development of this ZBG should increase the binding affinity leading to a structurally 
distinct and promising class of CA inhibitors. 
9.3 Introduction 
Carbonic anhydrases constitute one of the most extensively studied group of 
metalloenzymes (Supuran, Scozzafava et al. 2003; Supuran, Scozzafava et al. 2004). 
They belong to a superfamily of ubiquitous metalloproteins present in prokaryotes and 
eukaryotes and are encoded by five distinct evolutionarily unrelated gene families: α-
class (present in vertebrates, bacteria, algae, and cytoplasm of green plants), β-class 
(predominantly in bacteria, algae, and chloroplasts), γ-class (mainly in Archaea and 
some bacteria), and δ- and -classes present in marine diatoms. They catalyze the 
reversible hydration of carbon dioxide into hydrogen carbonate and a proton. The 
catalytically relevant metal ion (which is Zn
2+
 in the -CAs but may be Fe
2+
 in - or 






 in -CAs, among others) of CAs is located (for the α-class enzymes) at the 
bottom of the 15 Å deep active site, coordinated by three histidine residues - His94, 
His96 and His119 - and a water molecule forming a tetrahedral geometry at the active 
site (Supuran, Scozzafava et al. 2003; Supuran, Scozzafava et al. 2004).  
Sixteen different isoforms have been described in mammals, each differing by their 
relative hydrase activity, their sub-cellular localization, and their susceptibility to 
inhibition. Because these CAs are involved in several physiological processes it is not 
surprisingly that carbonic anhydrase inhibitors (CAIs) have been developed for the 
treatment of various pathologies such as glaucoma, neurological disorders, and 
osteoporosis (Scozzafava, Mastrolorenzo et al. 2006; Supuran 2008). The recent 
discovery of CA isoforms that are involved in cancer or obesity has demonstrated the 
need for potent, novel classes of CAIs. However, the large number of diverse α-CAs 
leads to the lack of inhibitor selectivity, especially for first-generation CAIs, i.e., 
sulfonamides and their bioisosteres. In order to reduce unwanted side effects of CAI 
therapy, the design of novel inhibitors has to discriminate between the different 
isozymes (Supuran, Scozzafava et al. 2003; Pastorekova, Parkkila et al. 2004; 
Scozzafava, Mastrolorenzo et al. 2004; Supuran, Scozzafava et al. 2004). 
So far, most rationally designed CAIs are based on a zinc-binding group (ZBG) that 
interacts with the Zn
2+
 ion of the enzyme and Thr199. To this ZBG a diversely 
substituted aromatic ring, heterocyclic, aliphatic group, or sugar moiety is linked that 
interacts with hydrophobic and hydrophilic pockets neighboring the active site. The 
sulfonamide group (Scheme 9.1) is the predominantly ZBG present in CAIs; this is in 
contrast to other Zn
2+
 metalloenzymes, such as the matrix metalloproteinases (MMPs), 
where hydroxamic acids serve as the dominant ZBG (Scheme 9.1) (Jacobsen, Major 
Jourden et al.). The sulfonamide moiety coordinates with its terminal deprotonated 
nitrogen atom to the Zn
2+
 ion (2.0 Å) and participates in a hydrogen-bonding network 
to Thr199 (2.8 Å) and Glu106 (2.7 Å). The latter amino acids are referred to as the 
"door-keepers" in the CA active site (Christianson and Fierke 1996). In addition, one 
sulfonamide oxygen forms a hydrogen bond to the backbone NH of Thr199 (3.0 Å). 
With this interaction pattern, many highly potent sulfonamide CAIs have been 




developed (Supuran and Scozzafava 2000; Supuran and Scozzafava 2002; Supuran, 
Scozzafava et al. 2003; Supuran, Scozzafava et al. 2004). 
The side effects of sulfonamide CAIs have led to new strategies for selective inhibitor 
design, such as modifications of the inhibitor backbone (Supuran, Scozzafava et al. 
2003; Supuran, Scozzafava et al. 2004; Scozzafava, Mastrolorenzo et al. 2006; 
Supuran 2008). One attractive approach to new CAIs is the use of non-sulfonamide 
ZBGs. A range of ZBGs have been tested so far, including sulfamates, sulfamides, 
substituted sulfonamides, Schiff bases, ureas and hydroxyureas, as well as hydroxamic 
acids. These studies revealed sulfamates and sulfamides, structurally related to 
sulfonamides, to be amongst the most promising alternative ZBGs (Winum, 
Scozzafava et al. 2005; Winum, Scozzafava et al. 2006; Winum, Scozzafava et al. 
2007).  
In order to find new ZBGs for use in CAIs, ligands from other Zn
2+
-dependent 
metalloenzymes are of particular interest. Recently, Cohen et al. have developed a 
series of new ZBGs, which include hydroxypyr(thi)ones and hydroxypyridine(thi)ones, 
that have been examined as alternative ZBGs for MMP inhibitors (Scheme 9.1). These 
ZBGs showed potent affinity, were nontoxic, biocompatible, and showed promise for 
incorporation into a new family of MMP inhibitors (Lewis, Tran et al. 2005; Puerta, 
Griffin et al. 2006). The studies reported here examine the use of these alternative 
ZBGs as warheads for CAIs. Here we present the investigation of four ligands from 
this series. Compounds 1 to 4 have been tested in a kinetic enzyme assay on all 
catalytically active mammalian CAs (Scheme 9.1). The crystal structure of CA II in 
complex with 4 was determined and revealed an intriguing bidentate binding mode. 
Fragment 4 coordinates the active site Zn
2+
 ion in a chelating, bidentate mode and also 
interacts with Thr199 and Thr200. In addition, the compound participates in a 
hydrogen bonding network which is translated via water molecules within the entire 
active site of CAII. 
9.4 Results 
Inhibition data: The inhibition data for compounds 1 to 4 against 13 CA isoforms 
(hCA - mCA XV) are given in Table 9.1. All of these compounds show affinities 




against the tested isoforms in the range of 2-11 µM. The inhibition of each isoform 
with compounds 1 to 4 is generally very similar (<2.5 µM range). The best inhibition 
was obtained with maltol (1) against mCA XV with a Ki value of 2.74 µM; the weakest 
inhibition was observed for 1,2-HOPTO (4) against hCA XIII with a Ki value of 10.81 
µM. Isoforms hCA I, hCA III, hCA IX, hCA XIII, and hCA XIV show generally 
weaker inhibition, with Ki values ranging from 7.53 to 10.81 µM, when compared to 


























Scheme 9.1 Zinc-binding groups (ZBGs) used in this study as CA inhibitors. 
 
Table 9.1 Inhibition data against 1 – 4 on CA isoforms. 
 
Isoform     Ki ( M)* 
                       1 (maltol)    2 (thiomaltol)     3 (HOPO)      4 (HOPTO)          5  
hCA I   9.07  8.31  9.66  9.37  7.00 
hCA II   3.62  4.00  3.87  4.06    50nM 
hCA III  9.50  8.43  9.12  7.53  - 
hCA IV  4.25  4.61  3.90  4.37  - 
hCA VA  4.60  4.15  4.35  4.02  - 
hCA VB  4.31  4.02  4.43  3.81  - 
hCA VI  3.47  3.24  3.89  3.62  - 
hCA VII  3.44  3.57  3.81  3.55  - 
hCA IX  9.54  9.95  9.27  9.23  27nM 
hCA XII  3.96  4.45  4.74  4.76  - 
hCA XIII  10.41  10.37  10.76  10.81  - 
hCA XIV  7.15  6.71  6.80  7.14  - 
mCA XV  2.74  3.14  4.89  4.71  - 
* Errors in the range of  10% of the reported value, from 3 different assays. 
 




X-ray Crystallography: The crystal structure of CA II in complex with fragment 4 
(1,2-HOPTO) was determined at a resolution of 1.35 Å. As expected, fragment 4 binds 
to CA II coordinating to the active site Zn
2+
 ion. The exocyclic sulfur- and oxygen 
atoms participate in the coordination of the metal ion at distances of 2.4 Å (S) and 
2.5 Å (O) (Figure 9.1). Importantly, the coordination of the Zn
2+
 ion changes upon 
binding of 4 from a 4-coordinate, tetrahedral geometry (including the bound OH
-
 ion, 
PDB-Code: 3D92) (Domsic, Avvaru et al. 2008) to a distorted, 5-coordinate trigonal-
bipyramidal geometry. Two nitrogen atoms (NE2-His94 and NE2-His96) and the 
sulfur atom of 4 form the equatorial plane, while the ND1 of His119 and the oxygen 
atom of 4 reside at the axial positions. A similar coordination change from 4- to 
5-coordinate has been proposed for the binding of fragment 4 to MMPs (Puerta and 
Cohen 2003). 
 
Figure 9.1 Coordination geometry of the active site Zn
2+
 ion upon binding of 4. The protein 
residues are shown in stick representation (protein: C, N, O, S; ligand: C, N, O, S). The tetrahedral 
geometry is changed to distorted trigonal-bipyramidal arrangement with NE2-His94 (2.0 Å), NE2-His96 
(2.0 Å) and the sulfur of 4 (2.4 Å) in the equatorial plane, whereas ND1-His119 (2.1 Å) and the oxygen 
of 4 (2.5 Å) are in the axial positions. The angles in the plane are 143.5° (S-Zn-His96), 109.5° (S-Zn-
His94) and 101.7° (His94-Zn-His96). The two axial ligands and the zinc ion form an angle of 161.2°. 
The equatorial plane shows Zn
2+
 distances of 2.0 Å for NE2-His94, 2.0 Å for NE2-
His96, and 2.4 Å for the sulfur atom with angles of 143.5° (S-Zn-His96), 109.5° 
(S-Zn-His94), and 101.7° (His94-Zn-His96). The Zn
2+
 ion is positioned 0.25 Å away 










forms a distance of 2.5 Å and ND1-His199 is positioned 2.1 Å away from the metal 
ion. The two axial coordinating ligand atoms and the Zn
2+
 ion form an angle of 161.2°. 
In addition to metal coordination, 4 also participates in three hydrogen bonds (Figure 
9.2). The terminal oxygen of Thr200 forms a hydrogen-bond to the oxygen in 4 at a 
distance of 3.2 Å. Furthermore, the same oxygen in 4 acts as the donor in a hydrogen-
bond network via the terminal oxygen of Thr199 (3.6 Å) to the terminal group of 
Glu106 (2.5 Å). This network is well known for typical sulfonamide inhibitors; 
however, the distance to Thr199 is increased as the fragment most likely cannot move 
closer to Thr199. Interestingly, fragment 4 participates in a hydrogen-bonding network 
that is spread over the entire binding pocket, which provides additional stabilization in 
the active site of CA II. The interactions are mediated by five water molecules which 
address all residues in the hydrophilic pocket of CA II, i.e. Tyr7, Asn62, His64, 
Asn67, Glu69, and Gln92. Fragment 4 is linked via two water molecules to the 
terminal OH of Tyr7 and ND1 of the proton shuttle His64 in the "in" conformation. In 
addition, 4 is connected via two water molecules to Asn67 that forms an additional 
hydrogen-bond network to Glu69 at the exit of the binding pocket mediated by a 
water. The terminal NH of Gln92 and Asn62 are also participating in this network via 
a water molecule (Figure 9.3). In addition to these direct interactions with water 
molecules, several other water molecules close to the exit of the binding pocket are 
involved in this network (Figure 9.3). The distribution of B-values of the participating 









 and 17.1 Å
2
). 
The conjugated ring system of 4 also experiences lipophilic interactions as it is 
pointing towards a hydrophobic binding pocket. In total, 26 van der Waals interactions 
can be identified. The difference electron density of 4 is very well defined and the 
orientation of the fragment is unambiguous because the sulfur atom and the ring 
system can be clearly assigned due to the difference electron density and assigned 
B-values.  





Figure 9.2 Binding mode of 4 in complex with CA II. On the left hand side the crystal structure is 
shown with the important amino acids. The protein residues and the ligand are shown in stick 
representation (protein: C, N, O, S; ligand: C, N, O, S). Water molecules are shown as red spheres. 
Hydrogen bond interactions are indicated by the dashed lines. The equivalent distances are shown in the 
schematic representation of the binding mode on the right hand side. The difference electron density (Fo-
Fc) for the ligands and directly interaction water molecules is shown at a sigma level of 2.0. Atomic 
distances are shown in Å. The fragment coordinates with its sulfur and oxygen atom to the active site 
zinc ion. Hydrogen bonds to Thr200 and Thr199 as well as a water network which is spread over the 
entire binding pocket linking the fragment to the common hydrophilic residues can be observed. 
 
Figure 9.3 Binding mode of 4 in complex with CA II. The solvent accessible surface is represented 
in white. The interacting protein amino acids and the ligand are shown in stick representation (protein: 
C, N, O, S; ligand: C, N, O, S). The binding pocket of CA II can be divided into a hydrophobic (red 
line) and a hydrophilic binding region (blue line). The fragment is stabilized by an H-bond network 
which is mediated by five water molecules (red spheres) addressing the typical hydrophilic residues in 
the active site of CA II. The remaining waters in the binding pocket (yellow spheres) are connected to 


























































































The positioning of the oxygen was ambiguous at the beginning of the refinement. 
However, repeated refinement cycles using different fragment orientations (ring flip) 
and considerations about a consistent H-bond network render the assigned binding 
mode as the most likely. The B-values for 4 are somewhat larger compared to the 
protein residues which is probably related to weak fragment affinity or reduced 
occupancy. The B-values are: main chain 14.1 Å
2
, side-chain 18.2 Å
2
, waters 27.1 Å
2
, 




 ion 8.4 Å
2
. 
The superposition of 4 with a sulfonamide inhibitor 5 (PDB-Code 1ZGE) reveals that 
the sulfur atom of 4 adopts a position shifted by 0.9 Å to the sulfonamide sulfur 
(Figure 9.4) (Ilies, Vullo et al. 2003). The fact that in 4 no terminal nitrogen atom is 
available to coordinate the Zn
2+
 ion influences the position of the sulfur. Furthermore, 
the ring system is shifted compared to the benzyl-group of the sulfonamide inhibitor. 
Because the oxygen atom is coordinated to the Zn
2+
 ion and stabilized by Thr199 and 
Thr200, the ring system is slightly rotated and shifted towards Zn
2+
 ion when 
compared to the sulfonamide fragment. 
 
Figure 9.4 Superposition of 4 and sulfonamide inhibitor 5 in complex with CA II. The protein 
residues and ligands are shown in stick representation (protein: C, N, O, S; 4: C, N, O, S; sulfonamide 
5: C, N, O, S, Cl - PDB-Code 1ZGE). The sulfur atoms are located at the same position. Fragment 4 
forms an additional coordination to the Zn
2+
 ion. The ring system of 4 is shifted compared to the 










The inhibition of 1 to 4 with respect to the considered CA isoforms is not 
exceptionally strong; however, they reveal a new and promising anchoring motif for 
CA inhibitors. The crystallographic analysis of the CA II-4 complex reveals a 
bidentate binding mode to the Zn
2+
 ion with interactions to Thr199, which itself 
donates a hydrogen-bond to Glu106. Such a binding has been observed earlier only in 
the hCA II – N-hydroxyurea complex, in which the Zn
2+
 is coordinated by the N and O 
atoms of the inhibitor (which is presumably deprotonated) (Temperini, Innocenti et al. 
2006). In addition, 4 accepts an H-bond from Thr200. The weaker affinity towards 
some of the isoforms can easily be understood since these show variable amino acid 
compositions within the active site, e.g. at position 200. For example, in hCA XIII a 
valine and in hCA I a histidine is present at this position (and many others, mainly 
towards the exit of the cavity). These residues cannot produce a similar interaction 
with 4, which leads to a more than 2-fold loss in affinity against these isoforms.  
From the inhibition, the crystallographic, and previously reported modeling data we 
can also infer the binding mode of 1 to 3 (Puerta and Cohen 2003). As the inhibition 
profile of all four compounds is the same against each isoform, and their metal 
complexes with a tris(histidine) active site model complex are all similar, the binding 
mode of 1 to 3 are most likely nearly identical to that of 4 (Puerta and Cohen 2003). 
Indeed, in a previously reported tris(pyrazolyl)borate Zn
2+
 model complex, fragment 4 
was shown to bind in a bidentate fashion to the Zn
2+
 center, generating a 5-coordinate, 
distorted trigonal-bipyramidal coordination geometry at the Zn
2+
 ion. In this model 
complex, the Zn-S distance was 2.32 Å and the Zn-O distance was 2.08 Å (Puerta and 
Cohen 2003). In the structure reported here, the Zn-S distance is ~2.4 Å, very close to 
that observed in the model complex. The Zn-O distance in the complex of 4 with CA is 
longer than found in the model complex, at 2.5 Å, probably due to the asymmetric 
coordination of the ligand enforced by the CA active site. Nonetheless, it is likely that 
the related fragments 1, 2 and 3 also coordinate in a chelating fashion with oxygen 
and/or sulfur atoms to the Zn
2+
 ion in bidentate manner. 
A similar CA II complex has been determined crystallographically and recently 
published by Barrese et al (Barrese, Genis et al. 2008). Investigating the inhibition 




profile and binding mode of thioxolone 6 in CA II, they observed that the inhibitor, 
most likely a prodrug, is hydrolyzed upon binding forming the fragment 







       (6)
       4-Mercaptobenzene-1,3-diol
(hydrolysis product of thioxolone, 7)  
Scheme 9.2 Thioxolone (6) and its hydrolysis-fragment (7) from PDB-Codes 2OSF. 
However, superposition of 7 with 4 shows significant differences in binding mode. 
Although, both inhibitor ring systems are similarly substituted with oxygen and sulfur 
donor atoms, the interaction pattern with CA II is completely different. The ring 
systems are rotated by 180° relative to each other and in 7 the oxygen donor atom is 
not interacting with Thr199 and Thr200. Also, the sulfur atom in 7 resides in a 
different position, in total shifted by 1.2 Å. It appears that the nitrogen atom in the 
heterocycle of 4, which is not present in the compared fragment 7, as well as the thione 
(C=S) nature of the donor functionality in 4 influences the binding mode and improves 
the Zn
2+
 coordination in CA II. The trigonal-bipyramidal coordination of 4 and the 
interactions to Thr199 and Thr200 result in an excellent set of interactions of fragment 
4 with the active site Zn
2+
 ion. The thiol formed from thioxolone is a monodentate zinc 
ligand whereas 4 is a bidentate one. 
The binding affinities of 1-4 to CA II are significantly better when compared to other 
alternative ZBGs such as the sulfamide (1130 µM) and sulfamic acid (390 µM) groups 
(Winum, Scozzafava et al. 2007). The observed bidentate binding mode of 4 to CA II 
is very promising and rarely observed in CAIs. The substitution of 4 with additional 
functional groups should notably increase the affinity toward CAs, as shown 
previously e.g. for sulfamides (Winum, Scozzafava et al. 2006). Lipophilic moieties 
can be attached to interact with the hydrophobic cavities found inside CAs. In addition, 
hydrophilic residues such as Asn62, Asn67, Glu69, and Gln92 should be targeted for 
hydrogen bonding. Further development of this ZBG could lead to a new, promising 
class of CAIs.  





Figure 9.5 Superposition of 4 with a structurally related fragment 7 from a crystal structure 
(PDB-code: 2OSF (C, N, O, S). The sulfur atoms are shifted by 1.2Å. The ring system of the 
superimposed ligand is rotated by 180°. In contrast to this ligand, 4 can form hydrogen bonds to Thr199 
and Thr200. 
9.6 Experimental Section 
CA inhibition: The inhibition assay is described in section 8.5. 
Synthesis: Maltol (1), 1,2-HOPO (3), and 1,2-HOPTO (4) were obtained from 
commercial sources (Aldrich). Thiomaltol (2) was synthesized as previously described 
(Lewis, Puerta et al. 2003). 
Crystallization, X-ray data collection and refinement: Crystals of hCA II (from 
Sigma-Aldrich) in complex with 4 were obtained by the sitting drop technique, using 
10 mg/ml protein with 2 mM inhibitor in 50 mM Tris –HCl buffer (pH 8.0). The drops 
consisted of 5 µL of the enzyme-inhibitor solution and 5 µL of the precipitant solution 
containing 3.0 M (NH4)2SO4 in 100 mM Tris-HCl (pH 8.0) and 0.15 mM 
p-chloromerurybenzoic acid to promote the growth of highly oriented crystals. The 
drops were equilibrated by vapor diffusion against the precipitant solution at 18 °C and 
crystals appeared after 1-4 days.  
The data were collected at the synchrotron BESSY II in Berlin/Germany on PSF 
beamline 14.2. The experiment was performed at 100 K using synchrotron radiation of 















P21 with the following cell parameters: a = 42.3 Å, b = 41.4 Å, c = 72.4 Å, β = 104.4°. 
The data collection parameters and refinement statistics are reported in the Appendix 
13.1.  
Data were processed and scaled with Denzo and Scalepack as implemented in 
HKL2000 (Otwinowski, Minor et al. 1997). The complex structures were analyzed by 
difference Fourier techniques, using the PDB file 2OQ5 as starting model for 
refinement. Refinement was continued with CNS (Brünger, Adams et al. 1998) and 
SHELXL-97 (Sheldrick, Schneider et al. 1997). For each refinement step at least 10 
cycles of conjugate minimization were performed, with restraints on bond distances, 
angles, and B-values. For each crystal the 2Fo-Fc and Fo-Fc maps were calculated and 
the inhibitor binding mode assigned from the difference electron density. Intermittent 
cycles of model building were done with the program COOT (Emsley and Cowtan 
2004). The coordinates have been deposited in the PDB (http://www.rcsb.org/pdb/) 
with the reference code 3M1K. 
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10 Conclusion and Outlook 
In this thesis a variety of rather diverse fragment-based lead discovery approaches with 
the target protein carbonic anhydrase II were performed. The different projects were 
strongly supported and tailored towards protein crystallography; a method which is 
currently emerging as a routine analytical tool. This maturation mainly results from 
improved radiation sources and enhanced computing power. About 200-250 datasets 
were collected in due course of this thesis answering miscellaneous questions in the 
context of several ambitious projects focused on structural biology. How can 
interactions of proteins with small molecules be exploited? Are we able to, e.g. 
monitor in situ reactions using protein crystallography? Will a tethering approach 
fixing weak initial binders increase the success rate of fragment-based 
crystallography?  
In order to cover this broad scope of diverse projects access to large amounts of CA II 
is a prerequisite. Therefore, the gene coding for CA II was cloned into a high-level 
expression system, the GST gene fusion system. The expression system was optimized 
yielding target protein of up to 30 mg from 1 L of original cell culture. Several CA II 
mutants were produced via site-directed mutagenesis and a mercury-free protein 
crystallization protocol had to be established for both the wild type and all mutants.  
Initial goal of the first project of this thesis was the accomplishment of a prominent 
click chemistry reaction, the Huisgen reaction – Cu
+
 catalyzed 2+3 dipolar 
cycloaddition – within or next to the active site of CA II. Therefore, an artificial 
copper center had to be introduced at the surface of CA II which should be used by 
azide and alkyne building blocks to catalyze triazole formation. Favorable Cu 
coordinating residues, such as cysteines or histidines which are well-known to 
participate in the metal center coordination in naturally occurring copper enzymes, 
were arranged at the surface of CA II according to a rational design concept partially 
introduced by site-directed mutagenesis. A variety of mutants was produced and 
investigated with respect to its Cu coordinating facilities. Unfortunately, this rational 
design strategy remained unsuccessful which shows that our limited understanding of 
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amino acid modifications still might provoke unpredictable effects while tampering 
with complex biological systems such as a highly functionalized protein. Finally, by 
serendipity the formation of an artificial Cu center at the surface of CA II could be 
achieved. A square planar coordination by residues Ser2, His3 and His4 occurred upon 
soaking crystals with a Cu
+
 solution of the CA II-H64C mutant which had previously 
been tethered with an azide fragment. In further experiments beyond the scope of this 
thesis a set of click reaction building blocks should be designed and synthesized to 
address this introduced copper ion. Thereby its catalytic potential can be screened 
again with strong support by protein crystallography. In addition, further mutational 
studies should be performed guided by the properties of human metallochaperone 
HAH1, a copper containing protein. A four-membered amino acid loop of the latter 
protein which coordinates the metal ion should be introduced at the N-terminus of 
CA II. Possibly the thus modified CA II mutants will show an accurate Cu 
coordination center.  
In parallel to the formerly described metal center design, the click chemistry project 
was also promoted by a new tether-assisted approach. By covalently attaching one 
building block to the protein surface and linking the second reactant via a reversible 
sulfonamide anchor to the active site Zn
2+
 ion, both components were brought into 
vicinity favorable to undergo cycloaddition reaction. The reaction could be induced by 
either Cu
+
 ions or the environment of CA II, respectively. As the azide component was 
tethered to a mutationally introduced cysteine residue at position 64 and the alkyne 
reversibly bound to the active site, a crystal structure of two initially designed building 
blocks in complex with CA II-H64C could be determined. The crystal structure 
revealed that both reactants are fixed to the protein in a distinct binding mode. In order 
to initiate triazole formation based on this setup, crystals from the same crystallization 
well were soaked with a Cu
+
 solution. The crystallographic analysis following this 
experiment showed pronounced structural reorganization of the reagents now 
suggesting triazole formation at some level. Complementary mass spectrometric 
analysis of this reaction mixture showed very poor cyclization rates suggesting that the 
initial design of the reaction components had not been ideal. Similar experiments 
performed with improved building blocks revealed much higher yields of triazole 
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formation. This was studied by HPLC-MS even allowing recording a time-dependent 
transformation rate. Crystallographic analysis of CA II-H64C cocrystallized with the 
optimized azide and alkyne component supported the 'in solution' transformation. The 
protein environment of CA II-H64C induced triazole formation upon the exposure to 
crystallization without further supplementation of any catalyst such as Cu
+
. 
Remarkably, the triazole formation was executed with regio- and stereoselectivity. The 
1,5-S-triazole was selectively formed from a racemic building block mixture. Most 
likely, the spatial organization of the reactants under exchange equilibrium conditions 
within the binding pockets facilitates the formation of one certain triazole product. In 
solution experiments analyzed by HPLC-MS revealed that this tethered cycloaddition 
can be further accelerated by copper supplementation and increased temperatures. In 
further studies, the stereo- and regioselectivity should be investigated in more detail by 
HPLC-MS. In crystallization experiments the cyclization product from both alkyne 
enantiomers, individually cocrystallized with differently tethered azides, should be 
investigated and compared with results under solution conditions. To improve the 
"catalytic" effect of CA II-H64C and to transform the protein into a full catalyst for 
click reactions, the cyclization product has to leave the binding pocket after the 
reaction. Possibly the substitution of the alkyne component with a rather weak zinc 
coordinating group and the application of a reducing agent to cleave the disulfide 
tether can accomplish this task.  
Apart from this click chemistry approach, the tethering method was also applied for a 
fragment screening on CA II. Tethering allows the identification of fragments with 
rather weak affinity to the target protein which are extracted from a library of thiole 
containing compounds under reducing conditions. Stimulated by a CA II Saccharin 
complex crystal structure and the observation of a novel binding site at the surface of 
CA II, this approach was, among others, setup to explore this novel binding region. 
Thereby, possibly new CA II inhibitors can be developed which interact with this area 
adjacent to the proton shuttle His64, which is important for the catalytic rate of CA II. 
A computational docking study was applied to screen a virtual library and select a 
feasible number of compounds for synthesis. The 'in solution' experiments monitored 
by HPLC-MS revealed many candidate fragments with promising affinity to CA II. 
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The crystallographic analysis of several CA II-H64C tethered complexes showed that 
the Saccharin binding pocket at the surface could be successfully addressed by the 
tethering approach. Also a second surface exposed binding area, known from CA II 
activators could be screened. According to the ranking from the mass spectrometric 
experiments, further tethering complexes should be investigated by protein 
crystallography. Guided by the results from our crystal structure determinations an 
improvement of the potency of these first leads could be planned. Furthermore, 
fragments which have been identified to bind in separate areas of the CA II binding 
pocket could be linked together to one larger ligand to achieve increased binding 
affinity. In conclusion this tethering approach highly facilitates the crystallographic 
investigation of protein fragment complexes and provides the opportunity for further 
application, e.g. the identification of new building blocks for in situ click chemistry or 
the setup of an inhibition assay by variation of the inhibitor or reducing agent 
concentration.  
In a different fragment based lead discovery approach, four novel head groups for zinc 
coordination, originally synthesized in the group of Prof. Seth Cohen (San Diego, 
USA), have been investigated with respect to CA isoform inhibition by the group of 
Dr. Claudiu Supuran (Florence, Italy). In our laboratory they have been analyzed by 
protein crystallography. A complex structure of CA II and 1,2-HOPTO revealed a 
novel bidentate Zn
2+ 
binding mode with favorable interactions to Thr199. The 
interaction to Thr199 is usually found in typical sulfonamide inhibitors; in addition the 
fragment binds to Thr200. The fragment which is perfectly coordinated by a water 
network suggests a new class of putative CA inhibitors. The binding affinity can be 
improved by adding substituents to occupy to the hydrophilic and hydrophobic portion 
of the CA II binding pocket. In further crystallographic trials the binding mode of the 
remaining three inhibitors should be investigated and eventually optimized for 
improved inhibition.  
Apart from this novel zinc binding functionality, also for a series of 13 sulfamides 
from a different thesis (group of Prof. Haake) binding affinities against several CA 
isoforms (group of Dr. Supuran) and for several examples the CA II complex crystal 
structures have been determined. Several of these inhibitors experience interactions 
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with Thr199 and Thr200. The different complex structures showed that the E/Z-
isomerisation which all inhibitors can undergo allows the enzyme to select the isomer 
configuration that fits best into its binding pocket. Remarkably, two compounds with 
similar substituents showed strongly deviating binding modes. The interaction patterns 
were influenced on the one hand side by favorable hydrogen-bond interactions to the 
hydrophilic portion of the protein binding pocket, on the other hand side an 
intramolecular H-bond is established which stabilizes the bound conformation. The 
inhibition data of a series of further 41 sulfamides still leave some open questions to 
set up a conclusive structure-activity relationship. Further crystallographic analyses of 
CA II-sulfamide complexes will be necessary in order to understand the impact of in 
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11 Zusammenfassung und Ausblick 
Im Rahmen dieser Dissertation wurde eine Auswahl recht verschiedener Ansätze der 
Fragment-basierten Leitstruktursuche (fragement-based lead discovery) mit dem 
Zielprotein Carboanhydrase II durchgeführt. Die verschiedenen Projekte wurden 
entscheidend durch die Protein Kristallographie unterstützt und methodisch gelenkt. 
Durch Verbesserung von Strahlungsquellen und der Rechenleistung von Computern 
hat sich die Protein-Kristallographie in den letzten Jahren zu einem analytischen 
Werkzeug entwickelt, welches routinemäßig zur Strukturaufklärung eingesetzt werden 
kann. Circa 200 bis 250 Datensätze wurden im Rahmen dieser Arbeit gesammelt um 
Fragestellungen der verschiedenen ambitionierten Projekte mit Focus auf die 
Strukturbiologie zu beantworten. Wie kann die Wechselwirkung zwischen Proteinen 
und kleinen Substanzen für eine Wirkstoffentwicklung ausgenutzt werden? Ist es 
möglich, z.B. Reaktionen, die in situ ablaufen, durch Protein Kristallographie zu 
verfolgen? Kann die Erfolgsquote von Fragment-basierter Kristallographie durch einen 
Tethering-Ansatz, welcher schwach bindende Fragmente am Protein fixiert, erhöht 
werden? 
Die Verfügbarkeit großer Mengen an CA II ist die Grundvoraussetzung um solch eine 
Bandbreite sehr verschiedener Projekte durchführen zu können. Daher wurde das 
CA II Gen in das GST gene fusion System kloniert, ein System welches Gen-
Expression auf sehr hohem Niveau ermöglicht. Das Expressionssystem wurde 
hinsichtlich der Proteinausbeute optimiert und stellt 30 mg Protein aus 1 L Zellkultur 
bereit. Etliche CA II Mutanten wurden durch positionsgerichtete Mutation hergestellt 
und eine quecksilberfreie Protein-Kristallisation für den Wildtyp und die Mutanten 
etabliert.  
Die Durchführung einer prominenten Click-Chemie-Reaktion, der Huisgen Reaktion – 
eine Cu
+
 katalysierte 2+3 dipolare Cycloaddition – in der Bindetasche der CA II war 
das anfängliche Ziel des ersten Projektes dieser Dissertation. Dafür sollte ein 
künstliches Kupfer-Zentrum an der Oberfläche der CA II eingeführt, und dieses neue 
katalytische Zentrum für die Bildung von Triazolen aus Alkinen und Aziden 
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ausgenutzt werden. Gemäß eines rationalen Design-Konzeptes wurden Kupfer-
koordinierende Aminosäuren, wie z.B. Cysteine oder Histidine, die bekannter Weise in 
Metall-Zentren natürlicher Kupfer-Proteine favorisiert vorkommen, teilweise per 
positionsgerichteter Mutation an der Oberfläche der CA II angeordnet. So wurde eine 
Vielfalt von CA II Mutanten hergestellt und auf ihre Kupfer-koordinierenden 
Eigenschaften hin untersucht. Leider blieben diese Versuche eines rationalen Designs 
erfolglos. Dies zeigt auf, dass unser begrenztes Verständnis von Aminosäure-
Mutationen im Hinblick auf die Proteinarchitektur in komplexen biologischen 
Systemen, wie z.B. in hoch entwickelten Proteinen, schwer vorhersehbare 
Auswirkungen mit sich bringen kann. Schließlich, eher durch einen glücklichen Zufall 
als rationales Design, konnte ein Kupfer-Zentrums an der Oberfläche der CA II 
eingebracht werden. Nachdem ein Kristall der CA II-H64C Mutante, zuvor mit einem 
Azid-Fragment gekuppelt, mit einer Cu
+
 Lösung versetzt wurde, konnte die Bildung 
eines quadratisch-planaren Metall Zentrums durch die Reste Ser2, His3 und His4 
beobachtet werden. In weiteren Experimenten, über diese Dissertation hinaus, sollten 
die Ausgangssubstanzen für die Click-Reaktion so entworfen und synthetisiert werden, 
dass diese das Kupfer-Zentrum adressieren. Somit kann das katalytische Potential mit 
Hilfe der Protein-Kristallographie untersucht werden. Zusätzlich sollten weitere 
Mutations-Studien durchgeführt werden, die sich an den Eigenschaften eines Kupfer-
Proteins, des humanen Metallochaperons HAH1, orientieren. Ein Loop aus vier 
Aminosäuren, der das Metallion in diesem Protein koordiniert, sollte am N-Terminus 
der CA II eingefügt werden. Möglicherweise wird diese CA II Mutante die 
Eigenschaft haben ein Kupfer-Zentrum präzise zu formen.  
Neben dem zuvor beschriebenen Design eines Metall-Zentrums, wurde das Click-
Chemie-Projekt ebenso durch einen neuartigen Tethering-unterstützten Ansatz 
vorangetrieben. In diesem Ansatz wird eine Reaktionskomponente kovalent an die 
Proteinoberfläche gebunden, während die zweite Komponente durch einen 
Sulfonamid-Anker an das Zinkion im aktiven Zentrum bindet. Dadurch werden beide 
Edukte in eine für die nachfolgende Zyklisierung günstige räumliche Anordnung 
gebracht. Die Reaktion könnte entweder durch Cu
+
 Ionen oder aber durch die 
Proteinumgebung ausgelöst werden. Die Tatsache, dass die Azid-Komponente an ein 
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in Position 64 mutiertes Cystein und die Alkin-Komponente reversibel in der aktiven 
Tasche gebunden wird, ermöglichte die Aufklärung einer Kristallstruktur von CA II im 
Komplex mit den ursprünglich entworfenen Edukten. Diese Kristallstruktur zeigte, 
dass beide Edukte in einem eindeutigen Bindungsmodus getrennt voneinander an das 
Protein binden. Um die Triazolbildung in diesem System auszulösen, wurde ein 
Kristall aus dem gleichen Kristallisationstropfen mit einer Cu
+
 Lösung versetzt. 
Eindeutige Veränderungen im Bindungsmodus beider Komponenten konnten durch die 
Strukturanalyse beobachtet werden und verweisen auf eine partielle Triazolbildung. 
Ergänzende massenspektrometrische Untersuchen dieser Reaktionsansätze zeigten eine 
sehr schwache Cycloadditionsgeschwindigkeit und verdeutlichten, dass das 
anfängliche Design der Reaktionskomponenten nicht ideal war. Die Edukte für die 
Click-Reaktion wurden optimiert und die gleichen Experimente erneut durchgeführt. 
Die Reaktionsgeschwindigkeiten und Ausbeuten konnten so deutlich gesteigert 
werden. Die HPLC-MS Untersuchungen ermöglichten zusätzlich die Aufzeichnung 
einer zeitabhängigen Transformationsrate. Kristallographische Untersuchungen von 
CA II-H64C im Komplex mit diesem optimierten Alkin und Azid unterstrichen die 
Versuche, die in Lösung durchgeführt wurden. Die CA II-H64C Proteinumgebung 
induzierte die Triazolbildung aus den Edukten während der Kristallisation ohne, dass 
die Zugabe eines Katalysators, wie z.B. einer Cu
+
 Lösung, von Nöten war. 
Bemerkenswerterweise erfolgte die Triazolbildung mit einer Regio- sowie 
Stereoselektivität. Aus dem racemischen Alkingemisch wurde selektiv das 
1,5-S-Triazol gebildet. Höchstwahrscheinlich wurde das langsamer reagierende 
S-Alkin in einer Gleichgewichtsreaktion gegen das R-Alkin ausgetauscht und so durch 
die räumliche Organisation beider Ausgangssubstanzen in der Bindetasche die Bildung 
eines stereochemisch eindeutigen Triazols ermöglicht. Durch Experimente, die in 
Lösung durchgeführt und per HPLC-MS untersucht wurden, konnte bewiesen werden, 
dass diese kovalent fixierte Cycloaddition zusätzlich durch Kupfer-Zugabe und 
erhöhte Temperaturen beschleunigt werden kann. In weiterführenden Experimenten 
sollte diese Stereo- und Regioselektivität mit Hilfe von HPLC-MS Messungen 
untersucht werden. Weiterhin sollten beide Alkin-Enantiomere individuell mit 
verschiedenen, kovalent an das Protein verknüpften Aziden kristallisiert und die 
entstehenden Cyclisierungsprodukte mit den Ergebnissen aus den 
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massenspektrometrischen Experimenten verglichen werden. Um den "katalytischen" 
Effekt von CA II-H64C zu erhöhen und das Protein in einen vollwertigen Katalysator 
für Click-Reaktionen zu überführen, sollte das Cyclisierungsprodukt nach der Reaktion 
die Bindetasche wieder verlassen. Dies könnte möglicherweise erreicht werden, indem 
das Alkin mit einer Gruppe verknüpft wird, die nur sehr schwach an das aktive Zink 
bindet und indem zusätzlich reduzierende Bedingungen angewandt werden um die 
Disulfidbrücke wieder zu lösen.  
Die Tethering-Methode wurde abgesehen von diesem Click-Chemie-Ansatz ebenso für 
ein Fragment Screening mit der CA II angewandt. Der Tethering-Ansatz ermöglicht 
die Identifizierung von Fragmenten mit eher schwacher Affinität zum Zielprotein. 
Diese werden unter reduzierenden Bedingungen aus einer Bibliothek von Thiol-
Fragmenten gefischt. Durch eine Kristallstruktur eines CA II Saccharin Komplexes 
konnten wir im Vorhinein eine neue Bindestelle für Inhibitoren an der Oberfläche von 
CA II identifizieren. Mit Hilfe der Tethering-Methode sollte diese Binderegion besser 
ausgeleuchtet werden. Auf diesem Wege könnte möglicherweise eine neue Gruppe 
von CA II Inhibitoren entwickelt werden, welche mit dem His64 wechselwirken. 
His64, das so genannte "Proton Shuttle", spielt eine entscheidende Rolle in der 
katalytischen Aktivität von CA II. Eine Inhibition dieses Mechanismus würde folglich 
die katalytische Umsatzrate drastisch verringern. Durch einen computerbasierten 
Docking-Ansatz wurde eine virtuelle Bibliothek von Fragmenten getestet um so eine 
plausible Anzahl an Substanzen für die Synthese auszuwählen. Verschiedene 
Tethering Experimente wurden in Lösung durchgeführt und mittels HPLC-MS 
analysiert. Dadurch konnten viele Fragmente mit einer vielversprechenden Affinität zu 
CA II identifiziert werden. Einige dieser Substanzen wurden im kovalenten Komplex 
mit CA II kristallographisch untersucht und zeigten, dass die Saccharin Bindetasche 
mit diesem Tethering-Ansatz erfolgreich untersucht werden kann. Zusätzlich konnte 
eine zweite Bindetasche an der Oberfläche, bekannt für die Bindung von CA II 
Aktivatoren, untersucht werden. Die massenspektrometrischen Experimente, die in 
Lösung durchgeführt wurden, und die dadurch identifizierten vielversprechenden 
Fragmente sollten weiterhin kristallographisch untersucht werden. Die Ergebnisse 
dieser Untersuchungen sollten schließlich angewandt werden um die Affinität dieser 
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ersten Komponenten zu erhöhen. Außerdem könnten Fragmente, die in verschiedenen 
Bereichen der aktiven Tasche der CA II binden, miteinander zu einem Liganden mit 
erhöhter Affinität verknüpft werden. Abschließend lässt sich sagen, dass dieser 
Tethering-Ansatz die kristallographische Untersuchung von Protein-Fragment-
Komplexen in höchstem Maße vereinfacht und weitere Anwendungsmöglichkeiten mit 
sich bringt. So könnten z.B. neue Ausgangssubstanzen für in situ Click-Chemie oder 
aber auch ein Inhibitionsassay durch Variation der Inhibitor oder DTT Konzentration 
entwickelt werden.  
In einem weiteren Ansatz der Fragment-basierten Leitstruktursuche wurden vier neue 
Zink koordinierende Kopfgruppen an CA Isoenzymen getestet. Die Substanzen, die 
ursprünglich in der Gruppe von Prof. Seth Cohen (San Diego, USA) synthetisiert bzw. 
zusammengestellt wurden, sind in der Gruppe von Dr. Claudiu Supuran (Florenz, 
Italien) auf ihre Inhibition von CA Isoenzymen hin getestet worden. Im Rahmen dieser 
Arbeit wurden diese neuen Kopfgruppen proteinkristallographisch untersucht. Eine 
Komplexstruktur von CA II mit 1,2-HOPTO zeigt einen neuartigen zweizahnigen Zn
2+
 
koordinierenden Bindungsmodus mit Wechselwirkungen zu Thr199. Die 
Wechselwirkung zu Thr199 ist üblicherweise bekannt von Sulfonamid-Inhibitoren. 
Zusätzlich wechselwirkt die Substanz mit Thr200. Das Fragment, welches zusätzlich 
perfekt durch ein Wassernetzwerk koordiniert ist, verspricht eine neue Klasse von CA-
Inhibitoren. Durch die Addition von Substituenten, die mit den hydrophilen und 
lipophilen Bereichen der CA II Bindetasche wechselwirken, kann die 
Bindungsaffinität verbessert werden. In weiteren kristallographischen Experimenten 
sollten die Bindungsmodi der verbleibenden drei Verbindungen untersucht und im 
Anschluss optimiert werden. 
Abgesehen von dieser neuen Zink-koordinierenden Gruppe konnte ebenfalls für eine 
aus einer anderen Dissertation stammenden (Gruppe Prof. Haake) Serie von 13 
Sulfamiden die Bindungsaffinitäten gegen einige CA-Isoformen (Group Dr. Supuran) 
und für einige ausgewählte Beispiele eine Komplexstruktur mit CA II aufgeklärt 
werden. Einige dieser Inhibitoren interagieren mit Thr199 und Thr200. Die 
verschiedenen Strukturen zeigten, dass die E/Z-Isomerisierung, welche einige der 
Inhibitoren erfahren, es dem Protein ermöglicht, die isomere Konfiguration 
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auszuwählen, die am besten in die Bindetasche passt. Bemerkenswerterweise zeigen 
zwei ähnlich substituierte Inhibitoren einen deutlich abweichenden Bindungsmodus. 
Die Wechselwirkungsprofile wurden auf der einen Seite durch vorteilhafte 
Wasserstoffbrückenbindungen zu hydrophilen Bereichen der Protein Bindetasche und 
auf der anderen Seite durch intramolekulare Wasserstoffbrücken beeinflusst. Die 
Inhibitionsdaten einer Serie von weiteren 41 Sulfamiden lässt noch einige Fragen 
offen, um zusammenhängende Struktur-Wirkungs-Beziehungen aufstellen zu können. 
Die kristallographische Untersuchung von weiteren CA II-Sulfamid-Komplexen ist 
erforderlich um den Einfluss der E/Z-Isomerie auf die Bindungsaffinität vollständig 
nachzuvollziehen.  
Materials and Methods 
163 
 
12 Materials and Methods 
12.1 Materials 
12.1.1 Chemicals 











Complete mini protease inhibitor, EDTA free 
Coomassie Brilliant Blue R250 
Dimethylsulfoxid (DMSO) 










Peptone from Casein 
Rotiphorese gel 30 
Tris(hydroxamethyl)aminomethane (Tris) 
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12.1.2 Laboratory Devices 







Entsalzungsanlage Purelab Plus 
Feinwaage Type 404/13 
Heizrührer IKA-COMBIMAG REG 
PCR Mini Cycler 
pH-Meter 744 
Pipetten 
Schüttelinkubator Innova 4200 
Schüttelinkubator Innova 4300 
SDS-Gelelektrophoresekammer Mini-V8*10 
DNA Mini Speedvaq 
Sterilbank 8511 
Thermomixer Comfort 2 ml 
Ultraschall Sonifier 
UV-Leuchttisch Transilluminator 
UV-Vis-Spektrometer Smart Spec 3000 
Vakuumpumpe DNA Mini 
Vortexter VF2 
Waage Typ 572/45 
Zentrifuge Avanti J-25 
Zentrifuge Biofuge pico 
Zentrifuge Multifuge 3 
 
Amersham Pharmacia Biosciences 
Syntec Tuttnauer 3850EI 








New Brunswick Scientific 
New Brunswick Scientific 
Life Technologie 
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12.1.3 Solutions and Buffers 



















Tris-Puffer pH 8.0 
Kristallisationspuffer CA II 
 







10% (w/v) Ammoniumpersulfat ad 10 ml 
1.0 g Ampicilin ad 10 ml, steril filtrieren 
0.34 g Chloramphenicol ad 10 ml, steril filtrieren 
10% (v/v) Essigsäure, 40% (v/v) Methanol ad 1 L 
10% Essigsäure, 40% Methanol, 1 g Coomasie Brilliant Blau R250 ad 1 L 
1 M IPTG, steril filtrieren 
0.25 M Tris, 2 M Glycerin, 1% (w/v) SDS, pH 8.3 
0.1 M NaOH 
140 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 1.8 mM KH2PO4, pH 7.3 
50 mM Tris-HCl, 10 mM reduziertes Glutathion, pH 8.0 
6 M Guanidine-HCl  
1 M Tris, pH 6.8 
10% (w/v) SDS ad 50 ml 
250 mM Tris, 8% (v/v) SDS, 40% (v/v) Glycerol, 0.04% (w/v) 
Bromphenolblau, 8% (v/v) ß-Mercaptoethanol, pH 6.8 
1 M Tris, pH 8.8 
50 mM Tris-HCl pH 8.0 
2.5 - 3 M (NH4)2SO4, 50 mM Tris pH 8.0 (evtl. 0.15 mM 
p-Chlormercuribenzoesäure) 
3 Teile Kristallisationspuffer CA II, 1 Teile Glycerol 
1.0% (m/v) Pepton aus Casein, 0.5% (m/v) Hefe, 1% (m/v) NaCl, 
autoklaviert 
1.0% (m/v) Pepton aus Casein, 0.5% (m/v) Hefe, 1% (m/v) NaCl, 1.5% 
(m/v) Agar-Agar, autoklaviert 
PBS-Puffer, Protease-Inhibitoretablette (Complete™), Lysozym 
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12.1.4 Primer and Bacterial Strains 
Table 12.4 Primer 





















CGG AAT TCA TGT CCC ATC ACT GGG GGT A 
ACC GCT CGA GTT ATT TGA AGG AAG CTT TGA TTT GC 
ATG TCC CAT CAC TGT GGG TAC GGC AAA CA 
TGT TTG CCG TAC CCA CAG TGA TGG GAC AT 
ATC CTC AAC AAT TGT CAT GCT TTC AAC 
GTT GAA AGC ATG ACA ATT GTT GAG GAT 
GAG GAT CCT CAA CAA TGG TTG CGC TTT CAA CGT GGA GTT TG 
CAA ACT CCA CGT TGA AAG CGC AAC CAT TGT TGA GGA TCC TC 
GAG GAT CCT CAA CAA TGG TAT GGC TTT CAA CGT GGA GTT TG 
CAA ACT CCA CGT TGA AAG CCA TAC CAT TGT TGA GGA TCC TC 
GAT TGA TTC AGT TTC ACT TTG AGT GGG GTT CAC TTG ATG GAC 
GTC CAT CAA GTG AAC CCC ACT CAA AGT GAA ACT GAA TCA ATC 
GAT TGA TTC AGT TTC ACT TTA AAT GGG GTT CAC TTG ATG GAC 
GTC CAT CAA GTG AAC CCC ATT TAA AGT GAA ACT GAA TCA ATC 
CTT GAT GGA CAA GGT TCA CTG CAT ACT GTG GAT AAA AAG 
CTT TTT ATC CAC AGT ATG CAG TGA ACC TTG TCC ATC AAG 
GAC CTA CCC AGG CTC ACT GGT GAC CCC TCC TCT TCT GGA ATG 
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Table 12.5 Used E. coli strains 























B) gal, (DE3), ompT., endA 











12.2.1 Biomolecular Methods 
12.2.1.1 Polymerase Chain Reaction (PCR) 
The PCR-sample was prepared as follows:  
   10 µl   5x Polymerase buffer 
     1 µl   Template DNA (10 ng/µl) 
     1 µl   Primer 1 (200 µM) 
     1 µl   Primer 2 (200 µM) 
     1 µl   dNTP-Mix (25 mM each) 
   35 µl   dd H2O 
     1 µl   Polymerase 
 
PCR-protocol:  
 1.  30 sec  98 °C 
 2.  10 sec  98 °C 
   3.  30 sec   65 °C x3        
 4.  30 sec   98 °C 
 5.  7 min  72 °C 







The success of the PCR was controlled via standard agarose gel electrophoresis and the 
PCR-fragment extracted according to the standard protocol of the S.N.A.P. UV-Free 
Gel Purification Kit (Invitrogen). 
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12.2.1.2 Restriction  
The PCR-fragment was incubated with the restriction endonuclease XhoI and EcoRI. 
The sample was incubated for 2 hours at 37 °C.  
   50 µl   PCR-fragment 
  0.8 µl   XhoI 
  0.8 µl   EcoRI 
  5.8 µl   10x buffer  
  0.6 µl   dd H2O 
    
Subsequently the restricted PCR-fragment was purified with QIAquick spin columns 
(QIAGEN) according to the standard protocol. 
The plasmid was incubated with EcoRI and XhoI for 2 h at 37 °C.  
   10 µl   pGEX-4T1 
  0.8 µl   EcoRI 
  0.8 µl   XhoI 
     3 µl   3x buffer  
15.4 µl   dd H2O 
 
The restricted plasmid was purified via agarose gel electrophoresis and subsequently 
extracted with the S.N.A.P. UV-Free Gel Purification Kit.  
12.2.1.3 Ligation 
The PCR-fragment and plasmid were incubated for ligation with T4-DNA-ligase for 
2 hours at room temperature.  
  0.4 µl   T4-DNA-ligase 
     4 µl   5x buffer 
     2 µl   pGEX-4T1 (~ 40 – 50 ng) 
  2.6 µl   CA II (PCR-fragment) 
   11 µl   dd H2O 
12.2.1.4 Mutagenesis of CA II-DNA 
In order to introduce the desired mutation into the CA II DNA-sequence the 
QuickChange II site-directed mutagenesis kit (Quiagen) is applied in a polymerase 
chain reaction (PCR). The PCR-samples are prepared as follows:  
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   10 µl   5x Phusion buffer 
     5 µl   pGEX-4T1-CA II plasmid (~ 6 ng/µl ≈  30 ng) 
1.25 µl   Primer 1 (100  ng/µl) 
1.25 µl   Primer 2 (100 ng/µl) 
     1 µl   dNTP-Mix 
30.5 µl   dd H2O 
     1 µl   Phusion polymerase 
 
PCR-protocol:  
1.     30 sec   95 °C 
2.    30 sec   95 °C 
     3.  60 sec              55 °C    x16        
4.      6 min  68 °C 
5.   10 min  68 °C 







Subsequently, 1 µl of DpnI is added to the sample which specifically cuts methylated 
DNA. Thereby, the parental DNA is digested and the DNA containing the desired 
mutation can be isolated. The plasmid is transformed into XL2-Blue cells (12.2.1.5). 
Upon plasmid isolation from these cells the plasmid is send for sequencing to the 
MWG-company. Sequencing results are listed in the Appendix 13.2. For gene 
expression the plasmid were transformed into BL21Codon plus cells. 
12.2.1.5 Plasmid Transformation 
Plasmids are transformed by heat shock into the desired competent cells. Therefore, the 
XL2-Blue or BL21Codon plus cells are thawed for 30 min on ice and supplemented 
with 100 to 200 ng plasmid DNA. Upon 10 min incubation on ice the cells are exposed 
to a heat shock of 45 sec at 42 °C. Subsequently, the cells were chilled for 2 min on ice 
and incubated at 37 °C overnight on agar plates which are treated with the accordingly 
antibiotic (XL2-Blue – amp; BL21codon plus – amp, cam). 
12.2.1.6 Determination of DNA- and Protein-Concentration 
DNA- and protein concentrations are determined by UV-spectroscopy. The nullification 
is performed with the according buffer.  










12.2.2 X-ray Analysis 
12.2.2.1 Data Collection 
Apo crystals or soaked crystals are transferred for about 10 seconds into a solution 
containing 25% glycerol as cryo-protectant and afterwards directly flash-frozen in 
liquid nitrogen. 
Data sets were collected at one of our two in-house sources, at the BESSY in Berlin or 
at the SLS in Villigen, Switzerland (s. also Appendix 13.1).  
At the first in-house source data are collected at cryo conditions (100K) with CuKα 
radiation (λ = 1.54178 Å) using a Rigaku RU-H300R rotating-anode generator at 50 kV 
and 90 mA equipped with focusing mirrors and an R-AXIS IV (Xenocs mirrors) or 
R-AXIS IV ++ (MCS, USA) image-plate system.  
At the second in-house soure data are collected at cryo conditions (100K) with IµS 
copper microfocus source (λ = 1.54178 Å) using a MAR345 DTB image plate detector 
system. 
                                                 
5
 calculated: http://www.expasy.ch/tools/protparam.html 
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Additionally, data sets are collected at the BESSY-PSF Beamline 14.1 and 14.2 in 
Berlin at cryo conditions (100K) (13.1). Synchrotron radiation is used. A MAR CCD 
165 mm or MAR CCD 225 mm detector is utilized for data collection. 
Furthermore, data sets are collected at the SLS PXIII X06DA beamline in Villigen, 
Switzerland at cryo conditions (100K). Synchrotron radiation is used. A MAR CCD 
225-mm detector is utilized for data collection. 
The protein usually crystallizes in the monoclinic space group P21 containing one 
monomer per asymmetric unit with Matthews coefficient of 2.1 to 2.2. Unit cell 
dimensions for all crystals are listed in the Appendix 13.1. Data processing and scaling 
were performed using the HKL2000 package. Data collection and processing statistics 
are given in the Appendix 13.1.  
12.2.2.2 Structure Determination and Refinement 
For all crystals coordinates of the CA II apo-structure (1OQ5) or of an in-house CA II-
H64C structure are directly used for an initial rigid-body refinement, followed by 
simulated annealing, positional and B-factor refinement using the CNS program 
package (Brünger, Adams et al. 1998). The generally high resolution of the structures 
allows further refinement with the program SHELXL (Sheldrick, Schneider et al. 1997). 
Here, at least 20 cycles of conjugate gradient minimization are performed with default 
restraints on bond geometry and B-values: 5% of all data are used for Rfree calculation. 
Amino acid side-chains are fitted to ζA-weighted |Fo| - |Fc| and 2 |Fo| - |Fc| electron 
density maps using COOT (Emsley and Cowtan 2004). In the electron density water, 
glycerol molecules and the ligand are located and subsequently included in further 
refinement cycles. In a final refinement, riding H-atoms are placed for the protein (not 
for the ligand) without using additional parameters. A final validation of the model was 











13.1 Crystal Data 
Crystal Data WT-Saccharin H64C-Click-reactants H64C-Click WT-HK1939 
PDB-Code 2Q38 3KIG 3KNE 3M04 
A. Data collection and processing 
Beamline 
No. Crystals used 
Wavelength (Å) 
Space group 





B. Diffraction data 
Resolution range (Å)* 







Program used for refinement 
Resolution range (Å) 
Reflections used in refinement 
Rfree (Fo; Fo > 4 ζFo) 
Rwork (Fo; Fo > 4 ζFo) 




RMSD, angle (deg.) 
RMSD, bond (Å) 
Ramachandran Plot 
Most favoured regions (%) 
Additionally allowed regions (%) 
Generously allowed regions (%) 
Disallowed regions (%) 




Ligand 1 atoms 
Ligand 2 atoms 
Zinc atom 
Matthews´coefficient (Å3/Da) 








































10.5 (Saccharin 1) 












































































































































Crystal Data WT-HK5053 WT-1,2-HOPTO W5C-H64C open W5C-H64C closed 
PDB-Code 3M14 3M1K 3M1Q 3M1W 
A. Data collection and processing 
Beamline 
No. Crystals used 
Wavelength (Å) 
Space group 





B. Diffraction data 








Program used for refinement 
Resolution range (Å) 
Reflections used in refinement 
Rfree (Fo; Fo > 4 ζFo) 
Rwork (Fo; Fo > 4 ζFo) 




RMSD, angle (deg.) 
RMSD, bond (Å) 
Ramachandran Plot 
Most favoured regions (%) 
Additionally allowed regions (%) 
Generously allowed regions (%) 







Ligand 1 atoms 



























































































































































































Crystal Data WT-HK1375 WT-BO338 H64C-SB095 H64C 
PDB-Code 3M2X 3M2Y 3M2Z 3M5S 
A. Data collection and processing 
Beamline 
No. Crystals used 
Wavelength (Å) 
Space group 





B. Diffraction data 








Program used for refinement 
Resolution range (Å) 
Reflections used in refinement 
Rfree (Fo; Fo > 4 ζFo) 
Rwork (Fo; Fo > 4 ζFo) 




RMSD, angle (deg.) 
RMSD, bond (Å) 
Ramachandran Plot 
Most favoured regions (%) 
Additionally allowed regions (%) 
Generously allowed regions (%) 







Ligand 1 atoms 

























































































12.3 (BO338 1) 

































































































Crystal Data H64C-SB227 
PDB-Code 3M5T 
A. Data collection and processing 
Beamline 
No. Crystals used 
Wavelength (Å) 
Space group 





B. Diffraction data 








Program used for refinement 
Resolution range (Å) 
Reflections used in refinement 
Rfree (Fo; Fo > 4 ζFo) 
Rwork (Fo; Fo > 4 ζFo) 




RMSD, angle (deg.) 
RMSD, bond (Å) 
Ramachandran Plot 
Most favoured regions (%) 
Additionally allowed regions (%) 
Generously allowed regions (%) 







Ligand 1 atoms 






















































13.2 Tethering Compound Library  
Series 1 Initially synthesized compounds from in house carboxylic acids. The compounds were 





















































































































SB097 - MW: 227.28
SB095 - MW: 181.26
SB096 - MW: 226.26
SB099 - MW: 260.15
SB100 - MW: 195.29
SB104 - MW: 145.22
SB113 - MW: 237.37
SB114 - MW: 211.28
SB115 - MW: 231.32
SB123 - MW: 187.31
SB124 - MW: 307.15
SB101 - MW: 213.28
SB102 - MW: 240.28
SB103 - MW: 225.31
SB119 - MW: 215.36
SB120 - MW: 229.39
SB106 - MW: 173.16
SB107 - MW: 234.32
SB109 - MW: 207.30




Series 2  Synthesized compounds from CA II-H64C docking. These fragments were synthesized 
according to the skeletons shown in Figure 7.3 (the molecular weight is shown in Da). An amine is 




























































































































TK135 - MW: 171.22
TK136 - MW: 221.30
TK140 - MW: 255.23
TK141 - MW: 229.37
TK142 - MW: 255.34
TK147 - MW: 197.26
TK148 - MW: 237.32
TK149 - MW: 211.28
TK150 - MW: 248.35
TK157 - MW: 211.28
TK158 - MW: 239.34
TK162 - MW: 243.39
TK163 - MW: 269.37
TK164 - MW: 199.27
TK165 - MW: 229.37
TK169 - MW: 251.35
TK170 - MW: 251.35
TK171 - MW: 255.34
TK173 - MW: 262.38
TK174 - MW: 239.34
TK175 - MW: 254.35
TK176 - MW: 283.39
BO333 - MW: 156.23






Series 3 Synthesized compounds from TGT-V233G docking. These fragments were synthesized 
according to the skeletons shown in Figure 7.3 (the molecular weight is shown in Da). An amine is 






































































































































SB226 - MW: 245.35
TK098 - MW: 273.40
TK107 - MW: 259.37
SB227 - MW: 285.41
TK0099 - MW: 313.47
SB228 - MW: 237.32
TK103 - MW: 265.38
 SB233 - MW: 237.34
TK096 - MW: 251.37
SB229 - MW: 280.17
TK108 - MW: 294.20
SB231 - MW: 207.30
TK105 - MW: 308.23
TK094 - MW: 250.32
SB232 - MW: 248.35
TK095 - MW: 252.31
TK097 - MW: 239.34
TK100 - MW: 264.35
TK101 - MW: 266.34
TK102 - MW: 265.40
TK104 - MW: 253.37
TK106 - MW: 276.40
TK109 - MW: 262.38
TK110 - MW: 225.31
TK111 - MW: 238.29




13.3 Sequencing of CA II and CA II-Mutants 
CA II 
EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
 
EMBOSS_001       251 KNRQIKASFK    260 
                     |||||||||| 




EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
                     ||||.||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 MSHHCGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
 
EMBOSS_001       251 KNRQIKASFK    260 
                     |||||||||| 




EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
                     ||||.||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 MSHHCGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
                     |||||||||||||.|||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 YDQATSLRILNNGCAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
 
EMBOSS_001       251 KNRQIKASFK    260 
                     |||||||||| 






EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001         1 MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVS     50 
 
EMBOSS_001        51 YDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
                     |||||||||||||.|||||||||||||||||||||||||||||||||||| 
EMBOSS_001        51 YDQATSLRILNNGCAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSL    100 
 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       101 DGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVG    150 
 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       151 SAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTP    200 
 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
EMBOSS_001       201 PLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPL    250 
 
EMBOSS_001       251 KNRQIKASFK    260 
                     |||||||||| 
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